Repertoire selection and effector differentiation during NKT cell development by Gordy, Laura Elizabeth
	   	   i	  
REPERTOIRE SELECTION AND EFFECTOR DIFFERENTIATION DURING 
NKT CELL DEVELOPMENT 
 
By 
Laura Elizabeth Gordy 
 
Dissertation 
Submitted to the Faculty of the 
Graduate School of Vanderbilt University 
in partial fulfilment of the requirements 
for the degree of  
DOCTOR OF PHILOSOPHY 
In 
Microbiology and Immunology 
May, 2012 
Nashville, Tennessee 
 
Approved: 
Professor Luc Van Kaer 
Professor Mark Boothby 
Professor Eric Sebzda 
Professor Ann Richmond 
Professor Sebastian Joyce 
	   ii	  
 
 
 
 
 
 
 
To Mom and Dad, for their limitless love and support 
& for introducing me to Mr Wizard and the wonderful world of science  
and  
To my love, Daniel, for being my everything 
 
 
 
 
 
 
	   iii	  
 
ACKNOWLEDGMENTS 
 
 The studies reported in this work were financially supported by the 
Immunobiology of Blood and Vascular Systems Training Grant (HL069765) and 
the Cellular and Molecular Microbiology Training Grant (AI007611); research 
grants (AI061721 and AI042284); and Core Facility grants (CA068485 and 
DK058404) from the National Institutes of Health.  
I am especially grateful to the past Department of Microbiology and 
Immunology and the current Department of Pathology, Microbiology and 
Immunology and those whom made it a supportive and an enriching environment 
conducive to the growth of a budding scientist. Over the years I have had the 
great pleasure of working with and learning from numerous inspiring scientists. In 
particular I am indebted to my Dissertation Committee Chair, Luc Van Kaer, and 
Dissertation Committee: Mark Boothby, Eric Sebzda, and Ann Richmond, who 
have always had words of wisdom, confidence in my ability as a scientist, and a 
comforting smile during high and low points of my graduate career. 
 I am thankful for the many friends I have made along the way, of which 
many are past lab members. It is the infectious enthusiasm of one particular lab 
member that drew me to the Joyce lab and our years of late night experiments 
with loud music and countless chocolates that led me to think of her now as a big 
sister, Jelena Bezbradica. None of this would have been possible if not for my 
mentor, Professor Sebastian Joyce. Shaping me into a scientist was hard work 
	   iv	  
for him and one of the many things boss taught me is that you can always work 
harder and do better. We have come a long way and I have learned more about 
science and myself than I thought possible, for that I am forever grateful!  
Finally, words cannot express my gratitude and love for my mom and dad. A 
loving home, support to follow my dreams and the tools to achieve them… what 
more could a child want? They are the reason I strive to be better at everything I 
do. Most importantly, I wish to thank my loving and supportive husband, Daniel, 
who was both my rock and my teddy bear over the course of this rollercoaster 
called graduate school. 
	   v	  
TABLE OF CONTENTS 
 
 
    Page 
DEDICATION........................................................................................................... ii 
 
ACKNOWLEDGEMENTS........................................................................................ iii 
 
LIST OF TABLES ...................................................................................................viii 
 
LIST OF FIGURES ................................................................................................. ix 
 
LIST OF ABBREVIATIONS ....................................................................................xi 
 
Chapter 
 
I.      INTRODUCTION .............................................................................................1 
 
CONVENTIONAL T CELLS VS NKT CELLS.....................................3 
NKT CELL AGONISTS ......................................................................5 
ANTIGEN RECOGNITION BY NKTCR..............................................10 
NKT CELL ACTIVATION BY ENDOGENOUS AND EXOGENOUS 
ANTIGENS.........................................................................................12 
ROLE IN HEALTH AND DISEASE ....................................................21 
LINEAGE COMMITMENT..................................................................23 
POSITIVE AND NEGATIVE SELECTION .........................................31 
DIFFERENTIATION AND MATURATION..........................................34 
THYMIC EMIGRATION AND HOMING .............................................41 
MAINTENANCE AND HOMEOSTASIS.............................................41 
OUTSTANDING QUESTIONS...........................................................43 
 
 
 
	   vi	  
II. NUR77 MEDIATES NEGATIVE SELECTION IN NKT CELLS 
   
ABSTRACT........................................................................................46 
INTRODUCTION................................................................................47 
RESULTS...........................................................................................48 
NKT cell development is altered in Nur77tg mice ....................48 
Nur77 overexpression induces apoptosis of developing NKT 
cells and can not be rescued by expression of rearranged  
Vα14 Jα18 TCR ......................................................................51 
Dominant negative Nur77 mouse: a model for T cell negative 
selection ..................................................................................61 
NKT cells develop and mature in Nur77ΔNtg mice ..................66 
Positive selection precedes Nur-77-mediated negative 
selection during NKT cell development ...................................68 
Block of negative selection in Nur77ΔNtg mice has a modest 
effect on positively selected αGalCer reactive NKTCR 
repertoire .................................................................................69 
C57BL/6 and Nur77ΔNtg NKT cells react differently to a 
variety of lipid agonists ............................................................80 
DISCUSSION ....................................................................................84 
 
 
III.  IL-15 REGULATES HOMEOSTASIS AND TERMINAL MATURATION OF 
NKT CELLS 
ABSTRACT........................................................................................93 
INTRODUCTION................................................................................94 
RESULTS...........................................................................................95 
IL-15 induces Bcl-2 family survival factors with thymic but not 
peripheral NKT cells ................................................................95 
Bcl-xL over expression in IL-150 mice supports NKT cell 
survival ....................................................................................100 
IL-15 regulates terminal maturation of NKT cells ....................105 
IL-15 regulates multiple gene expression changes during ST2 
to ST3 NKT cell transition.........................................................107 
IL-15 regulates functional maturation of NKT cells .................113 
	   vii	  
IL-15 dependent NKT cell effector maturation is essential to 
survive lethal F. tularensis infection ........................................116 
DISCUSSION ....................................................................................120 
 
IV.       DISCUSSION AND FUTURE DIRECTIONS................................................125 
 
V.        MATERIALS AND METHODS .....................................................................134 
 
REFERENCES ........................................................................................................146 
 
APPENDIX...............................................................................................................173 
 
	   viii	  
LIST OF TABLES 
 
Tables           Page 
1-1. Exogenous NKT cell agonists ..........................................................................8 
1-2. Endogenous agonists.......................................................................................9 
1-3. NKT cell developmental factors........................................................................27 
2-1. NKTCR CDR3 sequences................................................................................73 
5-1. Mouse strains used in this study ......................................................................135 
5-2. qPCR primer pairs used to validate gene expression data ..............................140 
5-3. PCR primers for V-gene specific amplification and sequencing.......................142 
	   ix	  
LIST OF FIGURES 
 
Figure           Page 
1-1.  Chemical structures of NKT cell antigens........................................................6 
 
1-2.  Two distinct strategies for NKT cell activation by microbes.............................13 
 
1-3.  NKT cell developmental stages and signalling requirements ..........................25 
 
2-1.  Nur77 transgenic (tg) mice as models for negative selection...........................50 
 
2-2.  Nur77 affects the development of NKT cells ...................................................52 
 
2-3.  Overexpression of Bcl-xl restores NKT cell development in Nur77tg mice ......53 
 
2-4.  Absence of Vα14Jα18 transcript in Nur77 transgenic T cells..........................55 
 
2-5.  Nur77 negatively selects T cells ......................................................................57 
 
2-6.  Nur77 negatively selects Vα14tg NKT cells......................................................59 
 
2-7.  Nur77 transgenic (tg) mice as models for negative selection...........................62 
 
2-8.  Nur77 transgenic (tg) mice as models for negative selection...........................64 
 
2-9.  Nur77 affects the development of NKT cells ...................................................67 
 
2-10. Positive selection precedes negative selection in NKT cells ..........................70 
 
2-11. Nur77 plays a minor role in modelling the NKTCR repertoire ........................72 
 
	   x	  
2-12. Defective Nur77 expression alters in vitro NKT cell response to antigens.....81 
 
2-13. Comparable in vivo functional NKT cell response in C57BL/6 and Nur77 
defective mice..................................................................................................85 
 
3-1.  Defective NKT cell development and maintenance in IL-150 mice..................96 
 
3-2.   IL-15 up-regulates expression of the survival factors Bcl-2, Bcl-xL, and Mcl-
1 within thymic and splenic NKT cells .............................................................99 
 
3-3.  Bcl-xL over expression restores NKT cell development in IL-150 mice............101 
 
3-4.  Normal TCRα rearrangement in IL-150 mice...................................................106 
 
3-5.  IL-15 regulates terminal maturation of NKT cells ............................................108 
 
3-6.   IL-15 induces Tbx21 and T-bet-regulated genes in developing NKT cells .....111 
 
3-7.  IL-15 regulates functional maturation of NKT cells..........................................114 
 
3-8.  NKT cells are essential for tempering lethal disease caused by Francisella 
infection ...........................................................................................................118 
 
4-1.  Gene regulatory network .................................................................................130 
	   xi	  
LIST OF ABBREVIATIONS 
 
 
α-galactosylceramide (αGalCer) 
α-galactosyldiacylglycerol  
(αGalDAG) 
β-glucosylceramide (βGlcCer) 
β-hexosaminidase-B (HexB) 
adapter protein (AP)-3 
antigen presenting cells (APC) 
colony stimulating factor 2 (CSF-2) 
dendritic cells (DC) 
diacylglycerol (DAG) 
dominant negative (ΔN) 
double negative (DN) 
double positive (DP) 
experimental autoimmune 
encephalomyelitis (EAE) 
fetal thymic organ culture (FTOC) 
follicular helper NKT (NKTFH) 
Francisella tularensis subsp. 
novicida (Ft novicida) 
GATA binding protein 3 (Gata-3) 
glycosphingolipid (GSL) 
Helix-loop-helix E protein (Raberger 
et al.) 
IL-15-deficient (IL-150) 
IL-17 secreting NKT (NKT-17) 
IL-2 inducible tyrosine kinase (ITK) 
inducible T cell costimulatory (ICOS) 
interferon regulatory factor (IRF)-1 
interferon-γ (IFN-γ) 
Interleukin (IL) 
isoglobotrihexoslyceramide (iGb3) 
Jak3 (Janus kinase-3) 
lipopolysaccharide (LPS) 
lysophosphatidyle-choline  
(LPtDCho) 
Macrophage inflammatory protein 1α 
(MIP-1α) 
myeloid differentiation primary 
response gene (MyD88) 
natural killer (NK) 
natural killer T (NKT)  
neuropilin-1 (Nrp-1) 
NKT cell receptor (NKTCR) 
pathogen associated molecular 
patterns (PAMPs) 
pattern recognition receptors (PRRs) 
phosphatidyl-ethanolamine (PtdEtN) 
phosphatidyl-inositol (PtdIno) 
plasmacytoid DC (pDC) 
programmed death-1 (PD-1) 
promyelocytic leukaemia zinc finger 
(PLZF) 
recent thymic emigrants (RTE) 
Regulated on activation, normal T 
expressed and secreted (RANTES) 
regulatory FoxP3+ NKT (FoxP3+ 
NKTreg)I 
retinoic acid orphan receptor-γt 
(RORγt) 
runt related transcription factor 1 
(Runx1) 
signalling lymphocytic activation 
molecule (SLAM) 
	   xii	  
T cell receptor (TCR) 
T-cell-specific T-box transcription 
factor (T-bet) 
tail-deleted (TD) 
Th-inducing POZ/Kruppel-like factor 
(ThPOK) 
TIR-domain-containing-adaptor-
inducing-interferon-β (Trif) 
Toll-like receptors (TLRs) 
tramtrack bric-a-brac-zinc finger 
(BTB) 
transforming growth factor (TGF) 
transforming growth factor-β (TGFβ) 
transgenic (tg) 
Tumour necrosis factor-α (TNF-α) 
vitamin D receptor (VDR) 
wild type (wt) 
ZAP ( ζ chain-associated protein)-70 
	   1	  
CHAPTER I 
 
INTRODUCTION 
 
Prevention of disease by recognition and elimination of foreign substances 
and microbial and parasitic pathogens is the main objective of the immune 
system. As with any battle, multiple lines of defence help to sway the outcome. 
Thus, the vertebrate immune system has inherited the innate immune system 
from its predecessors and additionally evolved an adaptive immune system to 
defend the host against invasive molecules and organisms. The initial line of 
defence, i.e., the innate immune system has evolved to recognize conserved 
molecular patterns shared by the classes of microbes. This recognition allows 
for rapid responses and elimination of the pathogen. Over time pathogens have 
in turn evolved to evade this system of recognition. Thus, a second line of 
defence has evolved, the adaptive immune response. The adaptive immune 
response is composed of B and T lymphocytes, which are capable of 
recognizing a specific pathogen and maintaining memory to the same pathogen 
to prevent future infection and disease. One outcome of the innate immune 
response is to alert the adaptive immune system of a threatening situation, 
inform it about the nature if the incoming treat and instruct the initiation of the 
appropriate type of adaptive response. Alternatively, when the first line of 
defense fails in any of those tasks, it is important to quickly alert and bring in the 
second line of defense. It is at this step that natural killer T (NKT) cells are 
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thought to act; they act as a bridge between innate and adaptive immunity and 
play an important role in jump-starting the adaptive immune response. 
The hallmark of innate immunity is that of microbial pattern recognition. 
Cells of the innate immune system such as antigen presenting cells (APCs: 
dendritic cells (DCs) and macrophages) and natural killer (NK) cells express an 
array of pattern recognition receptors (PRRs) (Medzhitov, 2001). PRRs come in 
a variety of flavors such as the membrane bound Toll-like receptors (TLRs) and 
the mannose receptor or the intracellular family of TLRs and NOD proteins. 
These receptors recognize the conserved pathogen associated molecular 
patterns (PAMPs). PAMPs include patterns commonly displayed by pathogens 
(e.g., viruses and bacteria) and not by the host, such as double-stranded RNA, 
flagellin and lipopolysaccharide (LPS), or structures found in abnormal locations 
within host cells (e.g., cytosolic DNA) indicating the presence of the foreign 
agent. Stimulation through PRRs induces a number of host defense genes 
including pro-inflammatory cytokines, co-stimulatory molecules and tissue repair 
agents. Pattern recognition and the ensuing induction of cytokines and co-
stimulatory molecules are critical to permit the activation of the adaptive immune 
cells upon their recognition of foreign antigens displayed by MHC class I and II 
molecules. Interestingly, antigen recognition by NKT cells can be likened to that 
of pattern recognition by innate cells. This is because NKT cells express a semi-
invariant T cell receptor (NKTCR) and recognize diverse ligands presented by 
CD1d molecules through the germline-encoded regions of the receptor (Li et al., 
2010; Scott-Browne et al., 2007). Furthermore, like innate cells, NKT cells 
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respond to lipid antigen rapidly, within hours, and without the need for days-long 
priming phase seen in the typical initiation of the adaptive response. 
 
CONVENTIONAL T CELLS VS NKT CELLS 
NKT cells are a unique subset of T cells, which are developmentally 
divergent and functionally distinct from conventional T cells. They get their name 
from the fact that they express markers and functions of both conventional T 
cells (TCR, CD4, CD44) and NK cells (NK1.1, Ly49 family members). NKT cells 
can be broken down into two main subgroups, NKT type I and type II. Type I or 
the invariant NKT cells recognize ligands with a semi-invariant TCR consisting of 
an invariant mouse Vα14Jα18 (Lantz and Bendelac, 1994) (human Vα24Jα18 
(Exley, 1997;Lantz, 1994)) α-chain that pairs with either Vβ8.2 (homologous to 
the human Vβ11), Vβ7, or Vβ2 β-chain (Arase et al., 1992; Hayakawa et al., 
1992). They make up to 80% of NKT cells (Park et al., 2001) and can be 
identified by using multimeric α-galactosylceramide (αGalCer)-loaded CD1d 
molecule (MacDonald, 2000; Matsuda et al., 2000). On the other hand, type II 
NKT cells are a small and more diverse subset of NKT cells expressing a 
heterogeneous array of αβ TCRs of which two recurring TCR are Vα3.2-
Jα9/Vβ8 and Vα8/Vβ8 (Park et al., 2001). Sulfatide and lyso-sulfatide have been 
identified as antigens for type II cells but neither is recognized by the Vα3.2-Jα9 
and Vα8 NKT cells (Arrenberg et al., 2010; Roy et al., 2008). Thus, study of this 
population has been hindered by the limited knowledge of cell specific markers 
	   4	  
and known agonists. Therefore, the type I invariant NKT cells will be the focus of 
the rest of this thesis and referred to simply as NKT cells.  
Both conventional T cells and NKT cells undergo the same early thymic 
development but it is their divergent developmental program upon positive 
selection by cognate antigen (discussed later) that shapes their immunological 
roles. While conventional T cells develop to recognize foreign peptide in the 
context of MHC class I or class II molecules, NKT cells are thymus-derived 
lymphocytes whose functions are regulated by recognition of foreign or self 
glycolipid ligands presented by the MHC class I-like molecule CD1d. 
Additionally, developing NKT cells are unique in that upon maturation they attain 
a memory-like phenotype, which includes the expression of cell surface CD44, 
CD69, CD122 and CD127 markers and transcripts encoding effector molecules 
(Park et al., 2000). The NKT cell’s hybrid features give insight to its role as a 
bridge between the adaptive and innate immune response. Upon agonistic 
ligand recognition, their memory-like phenotype allows NKT cells to rapidly, 
within 30—60 minutes, secrete large amounts of immunoregulatory cytokines 
and upregulate costimulatory molecules to initiate and modulate the type, 
magnitude and duration of the effector functions elicited by myeloid and 
lymphoid cells. By doing so, NKT cells regulate microbial and tumour immunity 
as well as autoimmune diseases (Bendelac et al., 2007; Van Kaer, 2005). Thus, 
NKT cells are often referred to as immunoregulatory lymphocytes, and they 
acquire this immunoregulatory potential during development through poorly 
understood processes. NKT cell frequency varies both between mouse strains 
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—highest in BALB/c (1—2 million in thymus, liver and spleen) and the lowest in 
the autoimmune disease predisposed strains NOD and SJL (0.1—0.3 million)— 
and between healthy human individuals —ranging from 0.01—5.0% in peripheral 
blood (Godfrey et al., 2010). Hence, understanding how NKT cells develop, 
regulate their frequency and acquire functional potential is of fundamental and 
clinical importance because the new insight can lead to the design of NKT cell-
based therapies.  
 
NKT CELL AGONISTS   
Kirin Pharmaceuticals identified the first NKT cell antigen in a screen for 
anticancer agents. A glycolipid derived from a marine sponge was found to be 
capable of enhancing survival of tumour bearing mice. Identification of the active 
anti-tumor principle revealed it to be the α-linked glycolipid αGalCer (Fig. 1-1) 
(Morita et al., 1995). Further study into its mechanism of action revealed 
αGalCer’s ability to robustly stimulate NKT cells, which in turn initiates and 
modulates the anti-tumor functions of myeloid and lymphoid cells (Carnaud et 
al., 1999; Kawano et al., 1997; Singh et al., 1999; Yamaguchi et al., 1996). 
Identification of this potent agonist enhanced the ability to track NKT cells and 
their functions with αGalCer-loaded CD1d tetramers or dimers (MacDonald, 
2000; Matsuda et al., 2000). This advance also provided gross structural insight 
into what type of ligands NKT cells are able to see, and hence led to the 
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Figure 1-1. Chemical structures of NKT cell antigens 
Top row: α-anomeric GSL, bottom row: β-anomeric GSL 
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identification of additional glycolipid exogenous antigens (Table 1-1) and 
endogenous agonists (Table 1-2) (Joyce et al., 2011; Venkataswamy and 
Porcelli, 2010).  
Early studies addressing the nature of NKT cell antigens revealed 
autoreactivity of these cells to the cell types expressing CD1d (Bendelac et al., 
1994; Bendelac et al., 1995; Exley et al., 1997). This reactivity was dependent 
upon proper trafficking of mouse CD1d through late endosomal vesicles, 
indicating that a self-antigen(s) reside therein (Chiu et al., 1999; Chiu et al., 
2002; Salio et al., 2010). This raised the question: What is the endogenous 
selecting NKT cell ligand(s)? CD1d assembly studies revealed the ability of 
CD1d to bind phospholipids (De Silva et al., 2002; Joyce et al., 1998; Park et al., 
2004). In turn, a few NKT cell hybridomas were identified which react to 
phospholipids (Gumperz et al., 2000; Rauch et al., 2003), indicating a possible 
role for phospholipids as selecting ligands. However, the inability of CD1d-
expessing cells deficient for β-glucosylceramide (βGlcCer) synthase to activate 
NKT cells suggested a role for a β-GlcCer or its derived glycosphingolipid (GSL) 
products (Stanic et al., 2003). Initially, isoglobotrihexoslyceramide (iGb3), an 
endosome-resident product of β-GlcCer metabolism, was implicated as a 
probable candidate for the selecting ligand. This candidate emerged from 
studies using β-hexosaminidase-B (HexB) deficient mice. HexB is an lysosomal 
enzyme required for production of iGb3 from its precursor iGb4. Mice lacking 
HexB do not develop NKT cells and HexB-deficient DCs are incapable of 
stimulating NKT hybridomas (Zhou et al., 2004).  
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Table 1-1. Exogenous NKT cell agonists  
Source Ligand Reference 
Mycobacterium 
tuberculosis 
phosphatidylinositol tetramannoside  
(PtdInoMan4) 
(Fischer et 
al., 2004) 
Sphingomonas α-galacturonosylceramide (αGalACer) (Kinjo et 
al., 2005; 
Mattner et 
al., 2005; 
Sriram et 
al., 2005) 
Borrelia 
burgdorferi 
α-galactosyldiacylglycerol (αGalDAG) (Kinjo et 
al., 2006) 
Helicobacter pylori cholesteryl-6-O-acyl α-glucoside (Chang et 
al., 2011b) 
Streptococcus 
pneumoniae 
(DAG; 1,2-di-O-acyl-(α-glucopyranosyl)-(13)-
glycerol)  
(α-galactopyranosyl)-(12)-(α-glucopyranosyl)-
(13)-glycerol)  
(Kinjo et 
al., 2011) 
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Table 1-2. Endogenous agonists  
Source Ligand Reference 
β-D-glucopyranosylsylceramide 
(βGlcCer; d18:1;C24:1);  
(Brennan et 
al., 2011) 
β-D-galactopyranosylsylceramide 
(βGalCer) 
(Parekh et 
al., 2004) 
β-mannosylceramide (βManCer) (O'Konek et 
al., 2011) 
Glycosphingolipids 
isoglobotrihexosylceramide (iGb3) (Wu et al., 
2003; Zhou 
et al., 2004) 
phosphatidyl-inositol (PtdIno) (Fox et al., 
2009) 
phosphatidyl-ethanolamine (PtdEtN) (Gumperz et 
al., 2000) 
Glycerophospholipids 
lysophosphatidyle-choline (LPtdCho) (Rauch et al., 
2003) 
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While this implies iGb3 as a NKT cell antigen and points to a role as the 
endogenous selecting ligand, an underlying glycolipid storage disorder, which 
mistargets cellular lipids, in HexB-deficient mice might complicate the 
interpretation of the results described above (Gadola et al., 2006b). Moreover, 
mice lacking iGb3 synthase —the enzyme dedicated to iGb3 biosynthesis— 
display normal NKT cell development (Porubsky et al., 2007). Thus, while 
originally defective NKT cell activation in the absence of βGlcCer synthase had 
been attributed to the downstream effect on iGb3, the role of βGlcCer itself as an 
NKT cell antigen was recently brought to light. βGlcCer acts as a potent and 
abundant self antigen which accumulates in cells upon infection or TLR 
stimulation (Brennan et al., 2011). The antigen accumulation within activated 
APCs, is consistent with data indicating that primary NKT cells become activated 
in CD1d-dependent manner upon triggering of APC with microbial products such 
is LPS. Finally, while the search for NKT cell antigens has been focused on 
GSLs, a recent study revealed that in some cases NKT cells could be activated 
even in the absence of GSL (Pei et al., 2011), thus, revealing the need to 
broaden the current candidate list for NKT cell self antigens.  
 
ANTIGEN RECOGNITION BY NKTCR 
While NKT cell antigens are all glycolipids, the NKTCRs can recognize 
rather structurally diverse array of both foreign and self-ligands. Additionally, the 
ability of synthetic antigen αGalCer to stimulate all invariant NKT cells 
irrespective of Vβ usage raises questions about the recognition logic of the 
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NKTCR. A number of mutational and crystallographic studies have investigated 
the unique features of ligand recognition by the NKTCR (Godfrey et al., 2010; 
Joyce et al., 2011) Antigen recognition by conventional T cells is dependent on 
diagonal orientation of the TCR over peptide-MHC complex allowing critical 
interactions of this complex with the variable, non-germline encoded CDR loops 
of the TCR (Marrack et al., 2008). On the other hand, NKT cells have been 
shown to have a more parallel orientation of TCR to glycolipid-CD1d (Borg et al., 
2007a; Borg et al., 2007b; Pellicci et al., 2009). And it is the germline-encoded 
surface of the TCR that is responsible for the interaction with and proper 
recognition of glycolipid-CD1d ligands (Li et al., 2010; Scott-Browne et al., 
2007). Recognition by germline encoded CDR loops (CDR1α, CDR3α, CDR2β) 
is thought to drive the Vβ usage bias seen within NKTCR (Mallevaey et al., 
2009). Thus, it has been proposed that the NKTCR acts like a pattern 
recognition receptor. It uses the conserved germline sequences to recognize 
multiple lipid ligands within the CD1d groove similarly, by focusing most of its 
recognition logic on the conserved ‘hotspots’ within diverse CD1d-ligand 
structures. Additionally, NKTCR uses some beta-chain sequences to further 
adapt itself to a few unique aspects of diverse CD1d-restricted ligands, 
presumably allowing for fine-tuning of the ‘hotspot’ recognition logic and the 
appropriate downstream response (Florence et al., 2009). This ability renders 
NKT cells important players in various infections and disease.  
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NKT CELL ACTIVATION BY ENDOGENOUS AND EXOGENOUS ANTIGENS 
NKT cells are capable of responding to a wide range of pathogens because 
they employ two different modes of activation during an immune response: direct 
and indirect activation (Fig. 1-2) (Brigl and Brenner, 2010; Tupin et al., 2007). In 
the direct activation pathway, some microbial lipid antigens (Table 1-1) have 
been identified that are capable of directly activating NKT cells. This direct 
activation is critically dependent upon loading of such antigens onto CD1d, but 
appears independent of TLR signalling and of its downstream adaptor 
molecules: myeloid differentiation primary response gene (MyD88) and TIR-
domain-containing-adaptor-inducing-interferon-β (Trif). As such, NKT cells in 
MyD88 and Trif deficient mice are just as responsive to Sphingomonas (Kinjo et 
al., 2005; Mattner et al., 2005) and Borrelia infection as are wild type mice (Kinjo 
et al., 2006). To rule out the contribution of the endogenous antigen iGb3 to this 
recognition, HexB deficient APC were analysed and also found to be equally 
effective in eliciting NKT cell response to Sphingomonas (Mattner et al., 2005). 
Thus, NKT cell activation is the result of direct recognition of Sphingomonas and 
Borrelia glycolipids. 
While direct NKT cell lipid ligands have been identified from a few bacteria 
(see Table 1-1), several bacteria do not synthesize NKT cell ligands but 
nonetheless are capable of activating NKT cells. Studies reveal that these 
pathogens activate NKT cells through an indirect activation pathway (Fig. 1-2) 
(Tupin et al., 2007). Indirect activation entails four activation strategies that do 
not involve direct NKTCR recognition of pathogen-derived lipid ligands. 
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Figure 1-2. Two distinct strategies for NKT cell activation by microbes   
Left: Microbes containing TLR ligands such as LPS activate NKT cells by 
inducing IL-12 production by DC, which amplifies weak responses elicited upon 
the recognition of CD1d bound with self-glycolipids by the NKT cell receptor. 
iGb3 has been suggested to function as an endogenous glycolipid for stimulating 
iNKT cell responses. The generation of iGb3 requires the action of HexB. 
Right: Some microbes such as Sphingomonas capsulata, which belong to the 
class of  α-Proteobacteria, synthesize α-anomeric glycolipids (Table 1-1) for their 
cell walls. These glycolipids, when presented by CD1d, activate NKT cells 
directly, without the need for endogenous iNKT cell antigens.  
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The first is a form of autoreactivity in which expression of weak endogenous NKT 
antigen in the context of stimulatory cytokines activate NKT cells. NKT cells 
utilize this mode of activation in the recognition of Salmonella. Dendritic cells 
stimulated by heat-killed Salmonella are capable of activating NKT cell in a HexB 
(Zhou et al., 2004), TLR, and interleukin-12 (IL-12)-dependent manner (Brigl et 
al., 2003). Thus, TLR activated APC in turn activate NKT cells by presenting an 
endogenous lipid antigen and supplying the necessary co-stimulatory cytokine IL-
12 (Brigl et al., 2003; Mattner et al., 2005; Paget et al., 2007; Salio et al., 2007). 
Indirect recognition pathway assumes either upregulation of endogenous 
antigen, upregulation of CD1d or both, and the models are not mutually 
exclusive. Indeed a number of reports indicate that bacteria are capable of 
inducing upregulation of CD1d on APC (Raghuraman et al., 2006; Skold et al., 
2005). This up-regulation can lead to enhanced NKT cell stimulation in the 
context of IL-12. Furthermore, studies by Brennan et al. (2011) revealed that 
there are situations where endogenous antigen is upregulated in response to 
TLR, and yet again, in combination with IL-12 activates NKT cells. Thus it has yet 
to be determined whether a change in the endogenous antigen expressed and/or 
the level of CD1d expression is key to NKT cell activation process.  
A second form of indirect activation involves stimulation by endogenous 
antigen alone. NKT cell response to Schistosoma mansoni eggs is HexB 
dependent yet TLR and IL-12 independent (Faveeuw et al., 2002; Mallevaey et 
al., 2006). As with the previous strategy, it is unclear whether there is a change 
in the endogenous antigen expressed or its expression level. Additionally it is not 
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known whether APC are stimulated in a non-TLR-dependent manner to secrete 
stimulatory cytokines other than IL-12.  
Thirdly, NKT cells can be stimulated by a combination of pro-inflammatory 
cytokines alone. Escherichia coli LPS is capable of stimulating NKT cells in a 
CD1d-independent manner. IL-12 and IL-18 production by TLR stimulated DC is 
critical to this process (Nagarajan and Kronenberg, 2007). Similarly, NKT cell 
response to murine cytomegalovirus is dependent upon IL-12 and independent 
of CD1d (Tyznik et al., 2008; Wesley et al., 2008).  
The fourth and final endogenous-pathway activation strategy involves NKT 
cell activation through the cross-talk of plasmacytoid DCs (pDC) and myeloid 
DCs. Activated human pDC are capable of inducing an NKT cell response yet 
lack CD1d expression. In a study, cytokines produced by pDCs allowed NKT 
cells to respond to myeloid DCs (Montoya et al., 2006) by mechanisms that still 
remain unclear. Thus, there are numerous mechanisms by which NKT cells can 
be rapidly activated against a pathogen insult. 
 Whether activated directly or indirectly, NKT cells respond quickly with the 
secretion of cytokines (Carnaud et al., 1999; Singh et al., 1999). As part of their 
memory-like phenotype, NKT cells have stores of transcribed IL-4 and 
interferon-γ (IFN-γ) mRNA and perhaps other effector transcripts as well (Stetson 
et al., 2003). Upon stimulation with αGalCer, NKT cells begin to secrete IL-4 
within a matter of an hour (Carnaud et al., 1999; Yoshimoto and Paul, 1994). 
This is followed by the induction and secretion of IFN-γ and by the modulation of 
their cell surface markers. First, the TCR is down regulated followed more slowly 
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by NK1.1 (Crowe et al., 2003; Eberl and MacDonald, 1998; Harada et al., 2004; 
Wilson et al., 2003). It is at this point the NKT cells undergo a phase of rapid 
proliferation and expansion. During expansion they begin to re-express the TCR 
and NK1.1. The previously activated NKT cells acquire an anergic or 
unresponsive phenotype (Hayakawa et al., 2004; Parekh et al., 2005; Uldrich et 
al., 2005) due to the induction of programmed death (PD)-1, an inhibitory 
receptor (Chang et al., 2008; Parekh et al., 2009). This anergic state to further 
stimulation persists for up to a month past the last stimulation during which time 
NKT cell numbers undergo a contraction phase (Parekh et al., 2005). 
Administration of αGalCer to anergic NKT cells reveals impaired proliferation 
and impaired IFN-γ production but not IL-4 (Parekh et al., 2005). This altered 
cytokine profile has implications for the therapeutic use of αGalCer. Therapies 
which depend upon Th2 immune responses (i.e. EAE) are not impaired while 
those that depend upon Th1 immune responses (i.e. anti-tumor immunity to B16 
melanoma) are impaired by NKT cell anergy (Parekh et al., 2005). Anergy also 
impacts NKT cell response to microbes. For example, after the initial activation 
and expansion of NKT cells during Mycobacterium bovis infection, there is a 
contraction of NKT cell numbers and they become hypo-responsive (Chiba et 
al., 2008). This hypo-responsiveness occurs despite a continuing active infection 
(Chiba et al., 2008). Overactivation of NKT cells can be detrimental and result in 
immunopathology. This suggests that the controlled shutdown of an NKT cell 
response by contraction of cell numbers and anergy is important during a NKT 
cell response to microbes. 
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In addition to IL-4 and IFN-γ, NKT cells are capable of secreting a wide 
array of cytokines such as: IL-2, IL-3, IL-5, IL-6, IL-9, IL-10, IL-13, IL-17, IL-21, 
granulocyte macrophage colony stimulating factor (CSF-2), tumor necrosis 
factor (TNF)-α, macrophage inflammatory protein (MIP)-1α, MIP-1β, 
transforming growth factor (TGF)-β, osetopontin, lymphotactin, and RANTES 
(Arase et al., 1993; Bendelac et al., 1992; Coquet et al., 2008; Exley et al., 1997; 
Hayakawa et al., 1992). This diverse arsenal of Th1, Th2, Th17 and other 
cytokines give NKT cells the ability to communicate with and direct the effector 
functions of a variety of cell types. Obviously, it would not be beneficial for a 
single NKT cell to make all these cytokines at once, so models are emerging 
which describe phenotypically distinct subsets of NKT cells dedicated to at least 
some of these specialised functions. For example, IL-17 production is highly 
restricted to NK1.1-CD4-RORγ+ NKT cells, as discussed later. This ability to 
quickly respond to infections and communicate with other cells of the immune 
system make NKT cells an important subset of immunoregulatory cells. For 
example, stimulation-induced cytokines and costimulatory molecules produced 
by NKT cells enhance IL-12 and costimulatory molecule expression by DCs 
(Fujii et al., 2004; Kitamura et al., 1999; Singh et al., 1999; Tomura et al., 1999). 
The enhanced expression of IL-12 in turn trans-activates NK cells to secrete 
IFN-γ (Carnaud et al., 1999; Eberl and MacDonald, 2000). In addition to NK 
cells, NKT cells mediate maturation of DCs, which allows transactivation and 
cross-priming (presentation of extracellular antigens) of cytotoxic T cells (Fujii et 
al., 2004; Fujii et al., 2003; Hermans et al., 2003; Nishimura et al., 2000; 
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Semmling et al., 2010). By trans-activating NK cells and cytotoxic T cells, NKT 
cells help to activate immune responses against viruses and other intracellular 
microbes. On the other hand, secretion of TGFβ, IL-10 and IL-2 by NKT cells 
has been shown to play a role in promoting T regulatory cell activation (La Cava 
et al., 2006). Thus, NKT cells can also initiate suppression of immune 
responses.  
Early allergy studies revealed a role for NKT cells in B cell antibody 
responses. Mice lacking CD4+ NKT cells were not capable of making an IgE 
antibody response upon polyclonal stimulation with anti-IgD antibody  
(Yoshimoto et al., 1995). In other immune hypersensitivity models such as lupus, 
NKT cells were found to stimulate B1 B cells to produce dsDNA autoantibodies 
(Takahashi and Strober, 2008). NKT cell mediated B cell help can also play a 
protective role. During infections such as Borrelia burgdorferi (Kumar et al., 
2000), and Streptococcus pneumoniae (Kobrynski et al., 2005) CD1d deficiency 
results in impaired antibody production. Likewise, αGalCer exhibits adjuvant 
effect upon humoral responses (Devera et al., 2008; Ko et al., 2005). Specific 
responses to T cell dependent and T cell independent model antigens improved 
when co-administered with αGalCer (Lang et al., 2006). NKT cells provide help 
to B cells through direct receptor mediated interactions (i.e. CD28 and CD154) 
and secretion of soluble factors (i.e. IL-4, IFN-γ) (Lang, 2009). The above 
represent a few of many examples in which NKT cells can suppress or stimulate 
an immune response.   
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The cytokine profile of NKT cells is dependent upon a number of factors 
such as the lipid agonist, the APC type, and age/maturation status of the NKT 
cells (Matsuda et al., 2008; Parekh et al., 2004). The prototypical agonist 
αGalCer induces Th1, Th2 and Th17 cytokines. Conversely, a preferential Th2-
like polarization is seen when NKT cells are stimulated with OCH (Fig. 1-1), a 
truncated αGalCer variant (Miyamoto et al., 2001) or C20-diene (Fig. 1-1), 
another variant with di-unsaturated acyl chain (Yu et al., 2005). It is thought that 
immature NK1.1NEG NKT cells secrete IL-4 with more mature NK1.1+ NKT cells 
gaining the ability to secrete IFN-γ. This however, is an over simplification and a 
number of studies have begun to address the functional potential of NKT cells 
through the classification of subsets based on additional cell surface markers 
and their ability to secrete various cytokines. One such study looked at the 
differences in anti-tumour potential between CD4+ and CD4NEGCD8NEG double 
negative (DN) NKT cells (Crowe et al., 2005). DN NKT cells showed greater 
anti-tumour activity than the CD4+ counterparts. This function of DN NKT cells 
was enriched within liver NKT cells compared to those from thymus and spleen 
(Crowe et al., 2005). Three recently identified new subsets of NKT cells include 
IL-17 secreting NKT (NKT-17) cells, regulatory FoxP3+ NKT (FoxP3+ NKTreg) 
cells, and follicular helper NKT (NKTFH) cells. Upon stimulation, NKT-17 cells 
robustly secrete IL-17 a proinflammatory cytokine (Michel et al., 2007). Similar to 
conventional CD4+ TH17 cells, NKT-17 cells express RORγt (Michel et al., 2008; 
Rachitskaya et al., 2008) yet do not require IL-6, IL-23, and transforming growth 
factor-β (TGF-β) to produce IL-17. NKT-17 cells are NK1.1NEGCD4NEG and found 
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distributed throughout tissue where NKT cells are ordinarily found (thymus, 
spleen, liver, lung, and lymph node). Another study found that all TH17 producing 
NKT cells were IL-17 receptor β+ and CD122NEG (Watarai et al., 2012). This 
population could be further subdivided into CD4+ IL-25 dependent or CD4NEG IL-
23 dependent. Recently, neuropilin-1 (Nrp-1) was identified as a marker for 
recent thymic emigrants (RTE) and IL-17 producing NKT cells are found within 
the RTE population (Milpied et al., 2011), indicating that NKT-17 cells may 
actually be a transitory population lost upon maturation. Another subset of NKT 
cells, FoxP3+ NKTreg cell may be important to the establishment of 
immunological tolerance (Monteiro et al., 2010). Identified in mice protected from 
experimental autoimmune encephalomyelitis (EAE) after αGalCer 
administration, these cells are characterized by FoxP3+ expression and potent 
immunosuppressive properties. As with NKT-17, FoxP3+ NKTreg require certain 
cytokine signals for their development, specifically transforming growth factor-β 
(TGFβ) (Moreira-Teixeira et al., 2012). The newest subset to join the NKT cell 
family is that of NKTFH cells. Identified as CXCR5+ PD-1HI, NKTFH cells are found 
in germinal centers in the spleen and provide cognate help to B cells. Like 
conventional TFH, NKTFH cells development is dependent upon the transcription 
factor Bcl-6 (Chang et al., 2012; King et al., 2012). Further delineation of 
different functional subsets of NKT cells and the identification of specific 
developmental requirements, is critical for understanding their roles in health 
and disease. 
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ROLE IN HEALTH AND DISEASE 
The ability to secrete Th1, Th2 and Th17 cytokines along with the up-
regulation of costimulatory molecules make NKT cells important regulatory cells 
during infections (bacterial, parasitic, and viral), allergy, autoimmune disease, 
cancer, and allograft survival. Depending upon the antigen and/or mode of 
activation and/or specific NKT subset activated, a final NKT cell response can be 
skewed toward either Th1-, Th2-, or Th17-like, which in turn can help to 
ameliorate or promote disease (Diana and Lehuen, 2009; Exley et al., 2011; 
Tupin et al., 2007; Wu and Van Kaer, 2011).   
The identification of bacterial lipid agonists implicated a role for NKT cell 
activation during bacterial infections. NKT cells have been shown to play 
protective roles in the host during several bacterial infections, either by reducing 
pathogen burden or by reducing immune-response mediated immunopathology. 
As an example for the former mode of action, NKT cells were shown to assist in 
the reduction of bacterial burden during Streptococcus pneumoniae infection 
(Kawakami et al., 2003). Similarly, NKT cells are important in reducing the 
parasite burden during Leishmania infections (Ishikawa et al., 2000; Mattner et 
al., 2006). Conversely, the protective role NKT cells play during Trypanosoma 
cruzi infection is one of preventing inflammation and immunopathology (Duthie 
et al., 2005a, b). Likewise, CD1d-deficient mice have increased symptoms of 
arthritis during Borrelia burgdorferi infection (Kumar et al., 2000).  
A number of viruses are known to down regulate CD1d as an immune 
escape mechanism indicating a probable role of NKT cells during viral infections 
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(Lin et al., 2005; Renukaradhya et al., 2005). While a protective role for NKT 
cells is implicated in herpes simplex virus (Grubor-Bauk et al., 2008) and 
respiratory syncytial virus (Johnson et al., 2002) infections, NKT cells play a 
detrimental role in the induction of chronic lung disease during Sendai virus 
infection (Kim et al., 2008). This detrimental effect possibly emerged as a result 
of NKT cell’s attempt to jump-start the immune response, which resulted in 
uncontrolled immune amplification through downstream positive feed-back loops 
leading to excessive lung immunopathology and disease. A detrimental role for 
NKT cells is also seen during Chlamydia muridarum infection where production 
of Th2 cytokines by NKT cells results in impaired bacterial clearance (Bilenki et 
al., 2005). All of these studies indicate a complex role NKT cells play during 
infections.  
Non-infectious disease states such as autoimmunity and cancer are also 
influenced by the immunoregulatory properties of NKT cells. As with infections, 
NKT cells can promote or ameliorate disease. NKT cells play a role in a number 
of autoimmune diseases including type I diabetes, multiple sclerosis, rheumatoid 
arthritis, lupus, myasthenia gravis, and primary biliary cirrhosis (Wu and Van 
Kaer, 2009). In general, NKT cell’s ability to suppress Th1 responses and skew 
towards Th2 is protective against autoimmune diseases. However, when this 
ability is mis-regulated such as in rheumatoid arthritis and primary biliary 
cirrhosis, NKT cells can exacerbate disease (Wu and Van Kaer, 2009). 
Conversely, the anti-tumour ability of NKT cells relies upon their ability to induce 
an inflammatory Th1 response. A number of advanced cancers reveal low 
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numbers of peripheral blood NKT cells whose functions are skewed toward Th2. 
Consistently, therapeutic ability to elicit NKT cell Th1 responses by αGalCer 
administration with or without specific tumor antigens, has shown greatly 
beneficial effects in tumor clearance by CD8 and NK cells (Dhodapkar et al., 
2003; Molling et al., 2005; Molling et al., 2007; Tahir et al., 2001). Thus, NKT 
cells make appealing targets for treatment of autoimmune diseases and cancer.  
What role do different NKT cell subsets play in various disease states? Why 
do certain infections/diseases induce Th1 response from NKT cells while others 
induce a Th2 response? How do we harness the ability of NKT cells to skew an 
immune response in favour of a protective role during specific diseases? A 
better understanding of NKT cell development, during which NKT cell subsets 
acquire and commit to all these functions, is therefore necessary to address the 
above questions and to develop/tailor NKT cell based immunotherapies. 
 
LINEAGE COMMITTMENT 
As with conventional T cells, NKT cells begin their developmental journey in 
the thymus (Coles and Raulet, 2000; Hammond et al., 1998; Pellicci et al., 
2002). In mice, NKT cells are detected only by the 3rd postnatal day (Benlagha 
et al., 2005; Hammond et al., 1998). A number of studies have addressed 
whether NKT cells develop from an independent or common precursor pool, the 
same as conventional T cells. Transfer experiments revealed that NKT cells 
develop from CD4+CD8+ double positive (DP) thymocytes (Gapin et al., 2001). 
Mice deficient in RORγ, a retinoic acid orphan receptor, which is needed for DP 
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thymocytes to survive long enough to make distal TCR re-arrangements, 
including the Vα14-to-Jα18 rearrangement, lack NKT cells (Bezbradica et al., 
2005; Egawa et al., 2005). It is the distal Vα14-to-Jα18 TCR rearrangement that 
commits DP thymocytes to the NKT cell lineage. Therefore, NKT cells develop 
from a common T cell precursor pool and go through the same early 
developmental stages as conventional T cells. Because of the shared early 
thymic developmental stages, NKT cells and T cells require the same ontogenic 
cues that drive development through those stages: these include IL-7Rα, 
common γ-chain, Jak3 (Janus kinase-3), pre-TCRα, and ZAP (ζ chain-
associated protein)-70 signaling (Fig. 1-3) (Boesteanu et al., 1997; Eberl et al., 
1999a; Iwabuchi et al., 2001; Peschon et al., 1994; Thomis et al., 1995).  
Deletion of specific transcription factors at the DP stage greatly impairs 
NKT cell development. Similar to RORγt, HEB—a basic helix-loop-helix E 
protein, is required for the survival of DP thymocytes thereby allowing for distal 
TCR rearrangements (D'Cruz et al., 2010), and hence, like RORγt is critically 
required for NKT lineage development (Fig. 1-3, Table 1-3). Likewise, a 
deficiency in c-Myb, a nuclear DNA binding protein, results in the loss of NKT 
cell development. This too is associated with impaired TCR rearrangement and 
also with impaired expression of SLAM and SAP molecules, important 
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Figure 1-3. NKT cell developmental stages and signaling requirements 
NKT cell lineage commitment occurs with HEB-RORγt-dependent survival for 
expression of the semi-invariant TCR at the DP stage. Hence, both NKT cells 
and conventional CD4 and CD8 T cells require the same factors to progress from 
the CD3NEGCD4NEGCD8NEG triple negative (TN) to DP thymocyte stage. Positive 
selection by DP thymocytes displaying CD1d-self-lipid complexes and SLAM-
SLAM interactions at stage 0/1 induce survival. TCR-induced calcineurin-NFAT-
Egr2 and Ras-Egr2 induce expression of PLZF, necessary for the NKT cell 
memory-like phenotype. At this stage, TCR-induced PKCθ-NFκB signalling is 
critical for lineage maintenance (e.g., Bcl-xL) and effector differentiation (e.g. 
Csf2). Ontogenetic progression at this stage is further regulated by SAP-Fyn 
signalling axes culminating in GATA3 and T-bet expression, which are 
transcription factors essential for the elaboration of IL-4 and IFN-γ for which this 
lineage is best known (stages 1 and 2). Finally, stage 3 NKT cells require ITK 
and VDR induction of T-bet for terminal maturation. Additionally, NKT cells 
require IL-15 for proliferation in the periphery. Dashed arrows, intermediates not 
known; thick arrow, over activation. 
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Table 1-3. NKT cell developmental factors  
 
Factors Type Necessary for Refs 
 
Pre-selection 
 
RORγt TF Survival (Bcl-xL) and distal 
TCR re-arrangements  
(Bezbradica et al., 
2005; Egawa et 
al., 2005) 
HEB TF Induction of RORγt (D'Cruz et al., 
2010) 
c-Myb TF Survival and TCR re-
arrangement, regulates 
CD1d, SLAM, SAP 
expression (extrinsic) 
(Hu et al., 2010; 
Yuan et al., 2010) 
miR-150 microRNA May regulate expression 
level of c-Myb 
(Zheng et al., 
2012) 
Bcl11b TF Lipid processing and 
presentation (extrinsic) 
(Albu et al., 2007; 
Albu et al., 2011) 
Developmental Stage 0 
 
AP-1 (Fra-
2) 
TF Selection (Lawson et al., 
2009) 
Runx1 TF Selection (Egawa et al., 
2005) 
c-Myc TF Proliferation (Dose et al., 2006; 
Mycko et al., 2009) 
TOX TF Early development (Aliahmad and 
Kaye, 2008) 
SAP STM SLAM signalling (Chung et al., 
2005; Nichols et 
al., 2005; Pasquier 
et al., 2005) 
Fyn STM SLAM-SAP signalling (Eberl et al., 
1999b; Gadue et 
al., 1999) 
Lck STM TCR signalling (Eberl et al., 
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1999a) 
Zap70 STM TCR signalling (Iwabuchi et al., 
2001) 
Ras STM	   Selection (Hu et al., 2011; 
Shen et al., 2011a) 
CD1d CSM NKT cell selection  (Bendelac, 1995; 
Xu et al., 2003) 
Developmental Stage 1 
 
Egr2 TF	   Survival, TCR signalling 
through Ras-Erk and NFAT  
(Lazarevic et al., 
2009; Seiler et al., 
2012) 
NF-κB1 TF	   Survival and function, TCR 
signalling 
(Stanic et al., 
2004a) 
PLZF TF	   Memory phenotype and 
maturation 
(Kovalovsky et al., 
2008; Savage et 
al., 2008) 
RelB TF	   Survival (Elewaut et al., 
2003b) 
Dock2 STM	   Immunological synapse 
formation 
(Kunisaki et al., 
2006) 
IKK2 STM	   Inhibits IκB (NFκB inhibitor) (Schmidt-Supprian 
et al., 2004) 
NIK STM	   RelB signalling (Elewaut et al., 
2003b) 
PKCθ STM	   TCR signalling to NFκB (Schmidt-Supprian 
et al., 2004; Stanic 
et al., 2004b) 
Bcl-10 STM	   TCR signalling to NFκB (Schmidt-Supprian 
et al., 2004) 
CYLD STM Regulates NFκB signalling 
and IL7Rα expression 
(Lee et al., 2010) 
SLAMF1, 
SLAMF6 
CSM	   Selection  (Griewank et al., 
2007) 
TGF-βR CSM	   Proliferation/expansion  (Doisne et al., 
2009a) 
Dicer Endoribo- miRNA expression (Fedeli et al., 
2009; Zhou et al., 
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nuclease 2009) 
Developmental Stage 2 
 
GATA-3 TF	   Generation of CD4+ NKT 
cells, may induce TH-POK 
(Kim et al., 2006) 
TH-POK TF Generation of CD4+ NKT 
cells 
(Engel et al., 2010) 
RelA TF	   Regulates expansion and 
maturation through IL-7 and 
IL-15 
(Vallabhapurapu et 
al., 2008) 
Developmental Stage 3 
 
Ets-1 TF	   Development (only NK1.1+ 
analysed) 
(Walunas et al., 
2000) 
MEF TF	   Development (only NK1.1+ 
analysed) 
(Lacorazza et al., 
2002) 
Elf-1 TF Development and function (Choi et al., 2011) 
T-bet TF CD122 expression, 
maturation & function 
(Matsuda et al., 
2006; Townsend et 
al., 2004) 
IRF1 STM	   Regulates thymic IL-15 
levels (extrinsic) 
(Ohteki et al., 
1998) 
ITK STM	   Induction of T-bet (Felices and Berg, 
2008) 
CD28 CSM	   Expression of T-bet and 
CD122 
(Zheng et al., 
2008) 
ICOS CSM	   Expression of T-bet and 
CD122 
(Akbari et al., 
2008) 
TGF-βR CSM Expansion at early stage 
and maintenance of T-bet 
and CD122 at St3 
(Doisne et al., 
2009a) 
Osteopontin glycoprotein Maturation and function (Diao et al., 2008) 
WASp adaptor  Role unclear (Astrakhan et al., 
2009; Locci et al., 
2009) 
VDR TF T-bet expression (Yu and Cantorna, 
2008, 2011; Yue et 
al., 2011) 
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Effector differentiation 
 
GM-CSF cytokine Cytokine secretion (Bezbradica et al., 
2006a) 
T-bet TF TH1 cytokine production (Matsuda et al., 
2007; Matsuda et 
al., 2006; 
Townsend et al., 
2004) 
GATA-3 TF TH2 cytokine production, 
may induce TH-POK 
(Kim et al., 2006) 
TH-POK TF TH2 cytokine production (Engel et al., 2010) 
Emigration & peripheral homeostasis 
 
S1P1 CSM Thymic emigration (Allende et al., 
2008) 
LT-αβ cytokine Thymic emigration (Franki et al., 
2006) 
CXCR6 CSM Migration of NK1.1+ NKT 
cells in liver 
(Germanov et al., 
2008; Monticelli et 
al., 2009) 
ID2 TF Survival (Bcl-2 & Bcl-xL) and 
migration of NK1.1+ NKT 
cells in liver by CXCR6 
expression 
(Boos et al., 2007; 
Cannarile et al., 
2006; Monticelli et 
al., 2009) 
IL-7 cytokine Minor role compared to IL-
15 
(Matsuda et al., 
2002) 
LFA-1 CSM Regulates migration/re-
circulation of hepatic NKT 
cells 
(Emoto et al., 
1999; Ohteki et al., 
1999) 
PLZF TF Modulates expression of 
LFA-1 
(Thomas et al., 
2011) 
IL-15 cytokine Proliferation (Matsuda et al., 
2002; Ranson et 
al., 2003) 
TF= transcription factor 
STM = signal transduction molecule 
CSM = cell surface molecule 
	   31	  
co-regulators in NKT cell selection (Fig. 1-3, Table 1-3) (Hu et al., 2010; Yuan et 
al., 2010). Targeting of c-Myb gene expression may be mediated by microRNA-
150 (miRNA-150) as deficiency in this small regulatory RNA prevents NKT cell 
development and maturation (Table 1-3) (Zheng et al., 2012). While RORγt, HEB, 
and c-Myb are required for NKTCR rearrangement, deficiency in Runx1 –runt 
related transcription factor 1, results in a block at the earliest known NKT cell 
commitment stage suggesting a possible role for Runx1 in positive selection or 
lineage expansion (Table 1-3) (Egawa et al., 2005). The above factors are 
necessary to reach lineage commitment of Vα14Jα18 NKT cells, which begins 
with positive selection by CD1d-positive double-positive thymocytes (Table 1-3). 
From this step on, NKT cells diverge from the T cell lineage and therefore we 
begin to uncover unique NKT cell specific developmental cues.  
 
POSITIVE AND NEGATIVE SELECTION 
Low-to-intermediate affinity self recognition and removal of potentially auto-
reactive T cells is the purpose of the positive and negative selection processes 
during thymocyte development. Avidity of the TCR-antigen interaction is the 
main determinant of these processes. Positive selection occurs when developing 
DP thymocytes encounter self peptide-MHC that induces low to intermediate 
reactivity allowing further development and differentiation to single positive 
thymocytes. In contrast, negative selection results in elimination of developing 
thymocytes, which are highly reactive to self peptide-MHC. Similar to 
conventional T cells, NKT cells are thought to undergo both positive and 
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negative selection, even though genetic evidence for the latter process was 
lacking. Furthermore, the extent to which each of these processes plays a role in 
shaping the NKT cell repertoire is less well understood. Both of these questions 
will be addressed as a part of this study. 
Self peptide-MHC expressed on thymic epithelial cells are critical for 
positive selection of conventional T cells. However, NKT cells are unique in their 
requirement for self glycolipid-CD1d expression on DP thymocytes for positive 
selection to occur. There are several lines of genetic evidence to support this 
conclusion. Absence of CD1d on double positive thymocytes within bone 
marrow chimeric mice results in a lack of NKT cells (Bendelac, 1995). If CD1d is 
re-introduced into CD1d-deficient mice by a pLCK driven transgene, NKT cell 
development resumes (Schumann et al., 2005; Xu et al., 2003). Molecules such 
as adapter protein (AP)-3 (Cernadas et al., 2003; Elewaut et al., 2003a) and lipid 
transfer proteins saposins (Kang and Cresswell, 2004), which are necessary for 
appropriate loading of endogenous glycolipids into CD1d within endosome, are 
also necessary for NKT cell development. Trafficking of CD1d through the 
intracellular endosomal and lysosomal pathways are guided by AP-3 (Sugita et 
al., 2002), indicating that CD1d presentation of a self-glycolipid is required for 
positive selection of NKT cells. Additionally, signalling lymphocytic activation 
molecule (SLAM) receptors slamf1 and slamf6, which are necessary co-
stimulators in NKT cell selection, are expressed by cortical thymocytes and not 
thymic epithelia (Griewank et al., 2007). Thus, DP thymocytes supply critical 
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developmental signals to NKT cells through CD1d-NKTCR and SLAM-SLAM 
interactions (Fig. 1-3, Table 1-3).  
 Identifying the selecting ligand is critical to understanding NKT cell 
biology because positive selection is thought to bias the NKT cell TCRβ usage. 
Most NKT cells express TCRs containing Vβ8.2, 7 and 2 (Bendelac et al., 2007). 
Expression of a Vα14Jα18 transgene in CD1d-deficient mice reveals a broad 
TCR Vβ cell repertoire (Wei et al., 2006). Thus, the restriction is not due to the 
inability of the α-chain to pair with particular Vβs. Additionally, only TCRs 
containing Vβ7, 8.2 and 2 were capable of responding to stimulation with a 
putative endogenous selecting ligand iGb3 (Wei et al., 2006). Thus, the NKTCR 
bias is thought to be the result of positive selection. Whether one or more lipid 
ligands play a role in NKT cell positive selection and what affect they have on 
the NKTCR repertoire remains to be determined.  
Several lines of somewhat indirect evidence indicate that NKT cells 
undergo negative selection. Neonatal mice injected intraperitoneally with high 
affinity antigen, αGalCer, at days 3—14 lose NKT cells in a dose dependent 
manner (Pellicci et al., 2003). Similarly, addition of αGalCer to fetal thymic organ 
culture (FTOC) also results in loss of NKT cells (Chun et al., 2003; Pellicci et al., 
2003). Conversely, intrathymic injection or addition of αGalCer to adult mice and 
older thymocyte cultures respectively, does not affect already selected NKT cells 
numbers (Pellicci et al., 2003). Since older thymi contain more mature NKT cells 
these data indicate that if negative selection does occur during NKT cell 
development it is at an early stage. Conclusions from this evidence are 
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confounded by the fact that while αGalCer is a potent agonist; it is not an 
endogenous lipid encountered by NKT cells during development. Additional 
supportive evidence indicates that transgenic over-expression of CD1d by 
thymic dendritic cells abrogates NKT cell development. Conversely, lack of 
CD1d expression by thymic dendritic cells results in development of hyper-
responsive NKT cells (Chun et al., 2003; Schumann et al., 2005). The 
aforementioned studies indicate that negative selection occurs in NKT cells. The 
genetic evidence for existence of negative selection as well as the extent to 
which negative selection plays a role in shaping the NKT cell repertoire is the 
focus of my studies that are described in Chapter II.  
 
DIFFERENTIATION & MATURATION 
A number of divergent signalling requirements for NKT development (Fig. 1-
3; Table 1-3) highlight the branch point in which NKT cells begin their unique 
ontogenic program. Upon commitment, immature NKT cells undergo robust 
proliferation and further differentiation. NKT cell precursors (CD24HICD69+CD44-
NK1NEG; stage-0: ST0) emerge from DP thymocytes soon after expression of the 
semi-invariant TCR (Bendelac et al., 2007). Precursor ST0 cells proliferate 
extensively in a c-Myc-dependent manner (Dose et al., 2009; Mycko et al., 2009) 
and undergo positive selection through homotypic interactions of SLAM 
molecules and heterotypic interactions between the semi-invariant TCR and 
CD1d molecules expressed by DP thymocytes (Bendelac et al., 2007; Godfrey 
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et al., 2010). These interactions are necessary for a number of signalling 
pathways critical for NKT cell development.  
As previously mentioned, SLAM family members, Slamf1 and Slamf6 
(Griewank et al., 2007) are critical for positive selection of developing NKT cells. 
Signals initiated by interaction of SLAM receptors are transduced by a 
mechanism involving the SAP and Fyn signalling module (Chung et al., 2005; 
Eberl et al., 1999b; Gadue et al., 1999; Nichols et al., 2005; Pasquier et al., 
2005). While SAP deficiency results in a severe loss of NKT cells, a lack of Fyn 
displays a less dramatic effect on NKT cell development, thus indicating that 
SLAM-SAP can mediate signals though Fyn-dependent and -independent 
mechanisms. In conventional T cells SLAM-SAP signals are necessary for 
cooperating with TCR signals in the induction of NFκB signalling (Cannons et 
al., 2004). NKT cell development is dependent upon cell intrinsic NFκB 
signalling (Elewaut et al., 2003b; Sivakumar et al., 2003; Stanic et al., 2004a), 
raising the question as to whether the SLAM/SAP signals are required for this 
induction of NFκB. Over expression of constitutively active IKKβ, essential for 
NFκB activation, was unable to rescue NKT cell development in SAP deficient 
mice (Cen et al., 2009), even though the uncontrolled/overt NFκB activation 
might not quite recapitulate the situation seen during positive selection in vivo. 
Thus, the signalling pathway downstream of SLAM-SAP remains to be defined 
(Fig. 1-3). 
TCR stimulation initiates a number of signalling pathways critical for proper 
NKT cells development: PKCθ-NFκB, Ras-Erk, and calcineurin-NFAT (Fig. 1-3) 
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(Das et al., 2010). While the NFκB family of transcription factors modestly 
affects conventional T cell development, they play important roles during NKT 
cell development at multiple stages (Table 1-3). Disruption of NFκB signalling 
results in a significant impairment of NKT cell development at the earliest 
precursor stage (Sivakumar et al., 2003; Stanic et al., 2004a). This impairment is 
due to a lack of induction of lineage-specific survival factor(s) of the Bcl-2 family. 
Hence, the forced expression of a Bcl-xL transgene can rescue NKT cell 
development in mice in which NFκB signal induction is disrupted (Stanic et al., 
2004a). Interestingly, loss of upstream signal transduction molecule PKCθ 
resulted in a milder defect in NKT cell development (Schmidt-Supprian et al., 
2004; Stanic et al., 2004b), indicating that multiple pathways are required for the 
activation of NFκB during NKT cell ontogeny (Fig. 1-3). On the other hand, lack 
of NFκB signal strength regulation as seen in mice deficient for CYLD –a 
deubiquitinating enzyme and negative regulator of NFκB, results in the loss of 
NKT cells through overt apoptosis (Lee et al., 2010) Similarly, absence of 
diacylglycerol (DAG) kinase α and ζ –a negative regulator of DAG, causes 
severe defects in NKT development as a result of overt NFκB and Ras-Erk 
activation (Shen et al., 2011b). Thus, both too much and too little NFκB 
activation is detrimental to NKT cell development indicating importance of very 
tight regulation of NFκB signalling in selection of appropriate NKT cells.    
Infelicitous calcium signalling which leads to Ca2+-calcineurin-NFAT 
represents another pathway involved in NKT cell development. TCR signalling 
results in the activation of calcineurin through Ca2+ influx and the release of 
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intracellular calcium stores. Absence of calcineurin B1 results in a significant 
loss of NKT cells (Fig. 1-3, Table 1-3) (Lazarevic et al., 2009). Likewise, loss of 
Egr-2 –a transcription factor and a target of calcineurin-NFAT, results in a 
developmental block after positive selection at ST0 to ST1 as a result of 
increased cell death (Lazarevic et al., 2009). Egr-2 is a transcription factor that 
can be induced by both NFAT and Ras signalling pathways. A previous report 
indicated that Ras signalling does not play a role in NKT cell development (Fig. 
1-3, Table 1-3) (Alberola-Ila et al., 1996). However, two recent studies have 
indicated otherwise. Mice expressing a dominant negative Ras displayed a 
dramatic loss of NKT cells (Hu et al., 2011). Additionally, RasGrp1-activator of 
Ras, was required for proper NKT cell development (Shen et al., 2011a). Thus, 
Ras and NFAT signalling may both play a role in the induction of Egr-2 (Fig. 1-
3). 
While many pathways seem to be important to allow for proper NKT cell 
survival and lineage expansion, a long term goal of many studies has been to 
identify a master regulator of NKT cell development. One such study identified 
the broad complex tramtrack bric-a-brac-zinc finger (BTB-ZF; also known as 
promyelocytic leukaemia zinc finger or Zbtb16) transcription factor PLZF 
(Kovalovsky et al., 2008; Savage et al., 2008). PLZF-deficient mice are impaired 
in NKT cell development and residual NKT cells that develop do not exhibit a 
memory-like phenotype. Transgenic expression of PLZF in thymocytes 
conferred a memory-like phenotype to conventional T cells similar to that of wild 
type NKT cells (Raberger et al., 2008; Savage et al., 2008). Interesting however, 
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PLZFtg T cells do not acquire the expression of NK cell markers, suggesting that 
not all aspects of NKT cell lineage can be imprinted by this one factor. Ras 
induced Erg-2 was recently shown to be a regulator of PLZF expression by NKT 
cells (Fig. 1-3, Table 1-3) (Seiler et al., 2012). Furthermore, recent studies reveal 
a role for PLZF in other cell types such as NKT cell-like Vγ1.1+Vδ6.3+ T cells, 
which also express a memory-like phenotype (Alonzo et al., 2010; Kreslavsky et 
al., 2009). These data indicate that although PLZF is an important regulator of 
NKT cell development it is not, at least when acting alone, the single and 
sufficient lineage specific master regulator.   
 NKT cells develop in the thymus and attain markers typical of NK and 
activated/memory T cells as they mature (Fig. 1-3) (Godfrey et al., 2010). For 
further development and functional differentiation into ST1 
(CD24NEGCD44NEGNK1.1NEG), ST2 (CD24NEGCD44+NK1.1NEG) and ST3 
(CD24NEGCD44+NK1.1+) NKT cells require regulation by a number of instructive 
signals. At ST2 and ST3, NKT cells also acquire memory T cell markers (CD44HI, 
CD62LLO, CCR7NEG) as well as NK cell markers (NKG2D, Ly49 and NK1.1) and 
cytolytic function (granzyme B and perforin) (Bendelac et al., 2007; Godfrey and 
Berzins, 2007). During differentiation, NKT cells acquire the ability to produce IL-
4 (ST1), IL-4 and IFN-γ (ST1 and ST2) or IL-4LO and IFN-γHI (ST3) in response to 
TCR stimulation (Benlagha et al., 2002; Gadue and Stein, 2002). It is at the final 
maturation stage (ST2 TO ST3 transition) that T-cell-specific T-box transcription 
factor (T-bet) plays an indispensable role. T-bet deficiency results in a 
developmental block at ST2 (Fig. 1-3, Table 1-3) (Matsuda et al., 2006; 
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Townsend et al., 2004). In the absence of T-bet, NKT cells fail to proliferate due 
to a lack of CD122 expression and consequent inability to respond to IL-15 
stimulation (Townsend et al., 2004). Furthermore, T-bet deficient NKT cells fail 
to activate the necessary functional NK-like properties so typical of mature NKT 
cells, for example the ability to produce IFN-γ (Matsuda et al., 2007; Matsuda et 
al., 2006). The integral role that T-bet plays during the final stages of NKT cell 
development can be seen in the similar NKT cell developmental defects found in 
the absence of various molecules/pathways which regulate T-bet expression: IL-
2 inducible tyrosine kinase (ITK) (Felices and Berg, 2008), transforming growth 
factor-β receptor (TGF-βR) (Doisne et al., 2009b), vitamin D receptor (VDR) (Yu 
and Cantorna, 2008), and inducible T cell costimulatory (ICOS) (Akbari et al., 
2008) (Fig. 1-3, Table 1-3). In addition to T-bet, GATA binding protein 3 (Gata-3) 
plays an important role in some aspects of functional development of NKT cells 
(Kim et al., 2006). Gata-3, (which is well know and the master regulator of Th2 
functions in conventional T cells) acts possibly together with its downstream 
target Th-inducing POZ/Kruppel-like factor (ThPOK) within NKT cells to control 
the production of TH2 cytokines (Fig. 1-3, Table 1-3) (Engel et al., 2010). While 
production of cytokines is regulated by transcription factors like T-bet, Gata-3 
and ThPOK, secretion of these cytokines by NKT cells is regulated by CSF-2 
(Fig. 1-3, Table 1-3). CSF-2 deficient mice are capable of producing, packaging, 
and transporting cytokines to the NKT cell-dendritic cell synapse but are unable 
to release the secretory vesicles (Bezbradica et al., 2006a). Thus, acquisition of 
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the ability to secrete cytokines is an important step for the development of 
functional NKT cells. 
NKT cells developmentally regulate the expression of CD4 as well. NKT 
cells emerge from the DP positive stage as those that express CD4. As these 
NKT cells differentiate, a portion down regulate CD4 expression and become 
double negative (CD8-CD4-). Two transcription factors have been identified as 
key players in the development of CD4+ NKT cells: Gata-3 and ThPOK. Gata-3 
is essential at numerous stages of T cell development: early thymocyte 
differentiation, the development of conventional CD4+ T cells, and differentiation 
of CD4+ T cells to a Th2 phenotype (Hernandez-Hoyos et al., 2003; Pai et al., 
2003). Likewise, it is also required for the development of CD4+ NKT cells and it 
plays an ill-defined role in hepatic NKT cell survival and TCR-induced activation 
of NKT cells (Table 1-3) (Cen et al., 2009; Kim et al., 2006; Wang et al., 2006). 
Loss of the transcription factor Th-POK results in a normal number of NKT cells, 
but they completely lack CD4 expression and are functionally impaired (Table 1-
3). Together, these data suggest that Gata-3 and ThPOK may function in a 
similar pathway (Engel et al., 2010). As discussed previously, CD4 expression 
has been used in the identification of new functional NKT cell subsets. Thus, 
identification of developmental regulators of CD4+ NKT cells is an important area 
of future research. 
One important feature that emerges from these studies is that NKT cells 
use more than one master regulator, found within distinct conventional lineages 
(CD8 T cells, CD4 T cells, NK cells, innate cells) to acquire many functions that 
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these lineages can perform and to generate a lymphocyte with an extraordinary 
functional potential. How and when this potential is controlled and regulated is 
currently unclear.  
 
THYMIC EMIGRATION AND HOMING OF NKT CELLS 
While a substantial fraction of ST2 cells remain in the thymus and mature to 
ST3, a small fraction egresses from the thymus and migrates into the spleen and 
liver whereupon further maturation occurs (Benlagha et al., 2002; Berzins et al., 
2006; Pellicci et al., 2002). Migration to these peripheral sites depends on 
CXCR6 (Geissmann et al., 2005), while continued development and 
maintenance in the liver require LFA-1 (Ohteki et al., 1999) and Id2 (Monticelli et 
al., 2009) (Table 1-3). Even though mature thymic and splenic NKT cells are 
phenotypically similar, they behave as distinct functional populations at these 
sites because the developmental cues and perhaps the agonistic ligands are 
distinct at different sites (Berzins et al., 2006; McNab et al., 2005; McNab et al., 
2007). Thus, unlike conventional T lymphocytes, which undergo complete 
ontogenetic maturation in the thymus but commit to effector differentiation only 
upon antigen recognition in the periphery, NKT cells complete both these 
processes both within and outside the thymus.  
 
NKT CELL MAINTENANCE AND HOMEOSTASIS 
Upon lineage commitment and the emergence of ST0 NKT precursors and 
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through subsequent stages of differentiation and maturation, thymic and 
peripheral NKT cells are maintained by complex, yet poorly understood 
homeostatic mechanisms involving a vast array of molecules. These molecules 
function either to promote survival or proliferation of NKT cells. NFκB (Stanic et 
al., 2004a), calcineurin (Lazarevic et al., 2009), Egr-2 (Lazarevic et al., 2009) 
and Id2 (Monticelli et al., 2009) mediate survival of NKT cells through the 
induction of Bcl-xL and/or Bcl-2 (Table 1-3). c-Myc is critical to proliferation of 
NKT cells during early ontogeny (Table 1-3) (Dose et al., 2009; Mycko et al., 
2009). Peripheral NKT cells, on the other hand, require IL-15 for homeostatic 
proliferation (Table 1-3) (Matsuda et al., 2002). A number of studies support the 
essential role of IL-15. Loss of interferon regulatory factor (IRF)-1, which 
regulates IL-15 gene expression, results in a loss of NKT cells (Ohteki et al., 
1998). Additionally, defects in receptors involved in IL-15 signalling such as 
CD122 (Ohteki et al., 1997) and IL-15Rα (Chang et al., 2011a; Lodolce et al., 
1998) exhibit impaired NKT cell homeostasis. Similarly, RelA regulates IL-15Rα 
expression and loss of RelA leads to defective IL-15 and IL-7-induced 
proliferation of NKT cells (Vallabhapurapu et al., 2008). While IL-15 is required 
for homeostatic proliferation in the periphery, NKT cell proliferation in the thymus 
appears intact in IL-15-deficient (IL-150) mice (Matsuda et al., 2002). Yet, the 
thymic NKT cell developmental defect in IL-150 mice is quite severe and arrests 
NKT cell ontogeny at ST2, with leaky progression to ST3 (Fig. 1-3) (Matsuda et 
al., 2002) thus implicating additional roles for IL-15 in NKT cell development. 
The extent to which IL-15 plays a role in NKT cell thymic ontogeny, and whether 
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IL-15 is essential for NKT cell survival, proliferation and/or functional maturation 
in the thymus or periphery is the focus of my studies described in Chapter III.  
 
OUTSTANDING QUESTIONS 
NKT cells are an important immunoregulatory cell type that can function both 
to enhance and suppress an immune response. They play roles in a vast 
number of disease states, i.e., infections, allergy, autoimmune disease, tumour 
immunity, and allograft survival. The innate and memory like properties of NKT 
cells allow them to respond quickly and vigorously to produce 
immunomodulatory cytokines, thus, making them ideal targets for the design of 
immunotherapies. Controlling the type and intensity of the immune response is 
crucial to any immunotherapy. Both the subtype of NKT cell responding and the 
conditions of activation regulate these features. Because NKT cells acquire their 
functional properties during development, to allow for rapid and ‘ready-to-go’ 
responses, it is critically important to have a clear understanding of the NKT cell 
developmental program/signalling networks involved in shaping their functional 
response. Using genetically deficient mice, numerous transcription factors and 
other signalling molecules have been identified as important regulators of NKT 
cell development. Yet for many of these, their precise mechanism of action and 
how their activity is induced and regulated remain unclear. Thus, the central 
goal of my thesis research was to delineate signals critical to shaping the 
functional NKT cell repertoire. To address this, two outstanding questions were 
defined: 
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1) What is the role of negative selection in sculpting a functional NKT cell 
repertoire? 
2) What is the role of interleukin (IL)-15 in NKT cell effector differentiation 
and homeostasis? 
 
What is the role of negative selection in sculpting a functional NKT cell 
repertoire? 
Central tolerance of conventional T cells is mediated by the process of 
negative selection. Since NKT cells have characteristics of activated 
conventional T cells and they react to self-lipids, the question arises as to 
whether they are subjected to negative selection. The Nur77 family of nuclear 
orphan hormone receptors mediates negative selection in conventional T cells 
(Calnan et al., 1995; Cheng et al., 1997; Zhou et al., 1996). Nur77 expression is 
temporarily controlled in developing T cells, because it functions by translocating 
to the cytoplasm upon induction where it targets Bcl-2 at the mitochondria. 
Binding of Bcl-2 by Nur77 induces conformational changes in Bcl-2 and converts 
its function from anti-apoptotic to pro-apoptotic, thereby inducing cell death 
(Kolluri et al., 2008; Thompson et al., 2010; Thompson and Winoto, 2008). 
Previous studies from our group had revealed that a small population of the 
earliest stage of immature NKT cells expressed Nur77 (Stanic et al., 2004a). This 
subset was further expanded in NFκB signalling deficient mice whose NKT cells 
are arrested at earliest immature stage due to failure to survive during positive 
selection. Thus, data imply that Nur77 is expressed in NKT cells and, like in T 
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cells, may mediate negative selection of developing NKT cells. Whether NKT 
cells undergo Nur77 mediated negative selection and what role it plays in 
shaping the NKT cells repertoire is addressed in Chapter II. 
 
What is the role of IL-15 in NKT cell effector differentiation and 
homeostasis? 
The pleiotropic cytokine, IL-15 regulates the development and 
maintenance of several subsets of innate lymphocytes, including γδ T, CD8αα T, 
and NK cells (Ma et al., 2006). IL-15 is also vital to proper NKT cell development 
as seen by defective development of thymic and peripheral NKT cells in IL-15 
deficient mice (Matsuda et al., 2002). Of note, while the peripheral defect is due 
to impaired homeostatic proliferation, thymic proliferation appears intact 
(Matsuda et al., 2002). Yet, IL-15 deficient mice develop a severe blockade in 
NKT cell ontogeny at ST2, with leaky progression to ST3 (Matsuda et al., 2002). 
Furthermore, IL-15 signals the ontogeny, effector differentiation and Mcl-1-
dependent survival of an  NKT-related lymphocytic lineage, NK cells (Huntington 
et al., 2007). Thus, IL-15 may play roles in both survival and functional 
maturation of thymic NKT cells during final stages, i.e., when they begin to 
acquire typical NK-like behavior. On the other hand, the developmental block 
may be due to impaired ST3 survival and not a deficiency of maturation signals. 
What role do IL-15 signals play during thymic NKT cell ontogeny? Is IL-15 
essential for NKT cell functional maturation in the periphery? These questions 
will be addressed in Chapter III. 
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CHAPTER II 
 
NUR77 MEDIATES NEGATIVE SELECTION IN NKT CELLS  
 
ABSTRACT 
Semi-invariant NKT cells are innate-like lymphocytes whose functions are 
regulated by CD1d-restricted lipid agonists. NKT cells express an invariant TCR 
α-chain that pairs with a limited number of β-chains. The diversity in β-chains is 
encoded by rearrangements between Vβ and the Jβ2 cluster and relatively rarely 
the Jβ1 cluster. There are two views to the events that sculpt this semi-invariant 
NKTCR repertoire: One view holds that positive selection alone is sufficient to 
shape this repertoire, whilst the other purports that both positive and negative 
selection together sculpt the NKT cell repertoire. Indirect evidence supports both 
views. By directly addressing whether negative selection plays a role in sculpting 
the NKT cell repertoire, we found that no NKT cells developed in mice in which 
negative selection was induced by over expressing Nur77 within thymocytes 
even when the rearranged NKTCR α-chain gene was introgressed into these 
mice. Conversely, Nur77ΔNtg mice expressing a dominant negative mutant, 
which blocks negative selection, develop NKT cells but lower numbers. The NKT 
cells were further enriched to the wild type levels by introgression of the 
rearranged NKTCR α-chain gene into these mice. Strikingly, although β-chain 
usage remained the same, CDR3β in Nu77ΔNtg mice was encoded by 
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rearrangements to the Jβ1 cluster and relatively rarely to the Jβ2 cluster. The 
altered CDR3β had only a modest impact on reactivity to currently known lipid 
agonists. Moreover, introgression of Nur77ΔN into mice expressing the tail-
deleted CD1d mutant, which fails to positively select NKT cells, did not rescue 
NKT development in these mice. These data suggest that positive selection of 
NKT cells most likely precedes negative selection and that both together sculpt 
the NKT cell repertoire.   
 
INTRODUCTION 
The process of negative selection, in which highly self-reactive T cells are 
removed from the T cell repertoire, mediates central tolerance of T cells. Since 
NKT cells have characteristics of activated conventional T cells and they react to 
self-lipids, the question arises as to whether they are subjected to negative 
selection. Multiple lines of evidence suggest that NKT cells undergo negative 
selection (Chun et al., 2003; Pellicci et al., 2003; Schumann et al., 2005) but the 
extent to which it plays a role in shaping the NKT cell repertoire remains to be 
determined.  
In conventional T cells, Nur77 and other members of the Nur77 family of 
nuclear orphan hormone receptors mediate negative selection (Calnan et al., 
1995; Cheng et al., 1997; Zhou et al., 1996). Nur77 is a transcription factor 
composed of three domains: a N-terminal trans-activation domain, a Zn finger 
DNA-binding domain and a C-terminal ligand-binding domain. Transgenic studies 
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revealed that over-expression of full length Nur77 early in thymocytes results in 
overt negative selection and near complete loss of T cells. Conversly, over-
expression of a dominant negative (ΔN) Nur77, which lacks the trans-activation 
domain, rescues conventional T cell development in a model of negative 
selection (Calnan et al., 1995; Zhou et al., 1996). A recent study has revealed the 
mechanism by which Nur77 induces apoptosis in thymocytes undergoing 
negative selection. Upon induction, Nur77 translocates to the cytoplasm where it 
targets Bcl-2 at the mitochondria. Binding of Bcl-2 by Nur77 induces 
conformational changes of Bcl-2 converting its function from anti-apoptotic to pro-
apoptotic (Thompson and Winoto, 2008). Since a small population of immature 
NKT cells was shown to express Nur77, we decided to address whether NKT 
cells undergo Nur77 mediated negative selection and what role it plays in 
shaping the NKT cells repertoire.  
 
RESULTS  
NKT cell development is altered in Nur77tg mice 
Previously, we reported that a small population of NKT cells that were 
blocked at an early stage of development (ST0/ST1) expressed Nur77 (Stanic et 
al., 2004a). Nur77 family of transcription factors has been shown to mediate 
negative selection of conventional T cells. A tractable genetic model to study 
negative selection and its role in shaping the NKTCR repertoire is currently 
lacking. To address this issue, the previously reported Nur77 transgenic (tg) 
mouse model (Calnan et al., 1995), used to study negative selection in 
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conventional T cells was revisited. Re-evaluation of thymi and spleens by flow 
cytometry confirmed the loss of CD4+ and CD8+ T cell development within 
Nur77tg mice (Fig. 2-1A,B). The percentage of total CD3ε+ as well as CD4+ and 
CD8+ single positive populations were much lower in both thymus and spleen of 
Nur77tg mice compared to C57BL/6 while the percentage of thymic CD4+CD8+ 
DP cells remained unaltered (Fig. 2-1A). However, analysis of cell numbers 
revealed a near complete loss of DP thymocytes (reflecting an overall smaller 
size of the thymus in these mice), as well as a loss of CD4+ and CD8+ T cell 
populations in both thymus and spleen (Fig. 2-1B). These data indicate that the 
mouse model for overt negative selection (Nur77tg) is functioning as previously 
reported (Calnan et al., 1995). 
 Next, NKT cell development within Nur77tg mice was assessed by flow 
cytometry. Examination of NKT cell frequency (Fig. 2-2A) and absolute numbers 
(Fig. 2-2B) revealed a near complete loss of NKT cells within Nur77tg mice. NKT 
cell development is critically dependent upon positive selection by CD1d positive, 
DP thymocytes. Nur77tg mice have greatly reduced total numbers of DP 
thymocytes (Fig. 2-1A,B). Thus, the absence of NKT cells in Nur77tg mice may 
be a result of either Nur77-mediated negative selection, lack of the canonical 
Vα14-to-Jα18 gene rearrangement or the inability of DP thymocytes to induce 
positive selection of NKT cells. To test the last possibility, equal numbers of DP 
thymocytes from C57BL/6 or Nur77tg mice were used to stimulate three Vα14+ 
(N37-1H5a, N38.3C3, and N38-2C12) and one Vα14- (N37-1A12) hybridomas. 
Vα14+ NKT cell hybridomas are extremely sensitive to self antigen(s) displayed  
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Figure 2-1. Nur77 transgenic (tg) mice as models for negative selection 
 (A) Thymic and splenic CD4+ and CD8+ T cells from C57BL/6, Nur77tg and 
Nur77ΔNtg mice were identified as CD4+ or CD8+ cells within total thymocytes or 
electronically gated B220-CD3ε+ splenocytes. Numbers are % of CD4+ or CD8+ T 
cells among total leukocytes. Data are representative of 3 independent 
experiments; n= 5 mice.  
(B) Absolute numbers of CD4+ or CD8+ cells in the thymus and spleen of 
C57BL/6, and Nur77tg mice were calculated from % cells in A and total 
thymocytes or splenocytes recovered from the respective lymphoid organs. Data 
are representative of 3 independent experiments showing mean+sem; n as in A. 
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by CD1d molecules expressed by DP thymocytes. After overnight stimulation, the 
ability of Nur77tg DP thymocytes to activate NKT cell hybridomas was measured 
by ELISA for secreted IL-2 in the supernatant (Fig. 2-2C). Although the reactivity 
varied between hybridoma lines, both the C57BL/6 and Nur77tg DP thymocytes 
stimulated the Vα14+ hybridomas equally well (Fig. 2-2C). These data indicate 
that CD1d molecules expressed by Nur77tg DP thymocytes have the potential to 
positively select NKT cells. This result then left remaining two possibilities open 
for testing: that NKT cell deficiency in Nur77tg mice was due to negative selection 
and/or due to the lack of the canonical Vα14-to-Jα18 rearrangement.  
 
Nur77 overexpression induces apoptosis of developing NKT cells and can 
not be rescued by expression of rearranged Vα14 Jα18 TCR    
If Nur77 mediates negative selection within NKT cells via induction of cell 
death, then introgression of survival factors may rescue NKT cell development in 
Nur77tg mice. A previous study showed that negative selection of conventional T 
cells in Nur77tg mice can not be rescued by Bcl2 transgenesis (Rajpal et al., 
2003) as Nur77 and the related Nor1 molecules bind the anti-apoptotic Bcl-2, and 
convert it into the pro-apoptotic factor (Thompson et al., 2010; Thompson and 
Winoto, 2008). We therefore, introgressed the pLck-Bclxl transgene into Nur77tg 
mice. Enforced Bcl-xL over expression within early thymocytes rescued DP 
thymocytes from death and consequently the development of both conventional 
T cells and NKT cells (Fig. 2-3A and 2-3B) suggesting apoptosis as the potential 
underlying mechanism for NKT cell phenotype in Nur77tg mice. 
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Figure 2-2. Nur77 affects the development of NKT cells  
 (A) Thymic, splenic and hepatic NKT cells from C57BL/6, and Nur77tg mice were 
identified as CD3ε
+
tetramer
+
 cells within electronically gated CD8
LO thymocytes 
or B220
LO
 splenocytes and liver mononuclear cells. Numbers are % of NKT cells 
among total leukocytes within each organ. Data are representative of 3 
independent experiments, n=6.  
(B) Absolute numbers of NKT cells in the thymus and spleen of C57BL/6, and 
Nur77tg mice were calculated from % NKT cells in A and total thymocytes or 
splenocytes recovered from the respective lymphoid organs. Data are 
representative of 3 independent experiments showing n as in A. (C) The 
indicated hybridoma lines were incubated overnight with either C57BL/6 or 
Nur77tg double positive thymocytes or without stimulator cells (N.S.). Using 
ELISA, IL-2 secreted into the supernatant was measured. Data are 
representative of 2 independent experiments, n=6. 
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Figure 2-3. Overexpression of Bcl-xl restores NKT cell development in 
Nur77tg mice 
(A) Thymic NKT cells from C57BL/6 (n=2), Bcl-xLtg (n=2), Nur77tg (n=2), and 
Nur77tg;Bcl-xLtg (n=5) mice were identified as CD3ε+tetramer+ cells within 
electronically gated CD8lo thymocytes. Numbers are % of NKT cells among total 
leukocytes. Absolute NKT cell numbers (right panel) were calculated as in Fig 3-
2A.  
(B) Splenic and hepatic NKT cells from mice were identified as CD3ε+tetramer+ 
cells within electronically gated B220lo splenocytes. Numbers are % of NKT cells 
among total leukocytes within each organ. Absolute NKT cell numbers were 
calculated as in Fig 3-2A. Data are representative of 2 independent experiments 
showing. n, as in A.   
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Since there was only partial rescue of NKT cell development within 
Nur77tg;Bcl-xLtg mice (Fig. 2-3), it is possible that Nur77tg DP thymocytes poorly 
rearrange distal Vα14-to-Jα18 gene segments, due to their premature apoptosis 
thereby resulting in low NKT cell precursors and total numbers. To test this, in a 
pilot experiment, DP thymocytes were sorted from C57BL/6, Nur77tg, and Jα180 
(NKT deficient) thymi and their RNA was analysed by RT-PCR for the canonical 
Vα14 to Jα18 rearrangement. The specificity of the reaction was ascertained by 
RT-PCR for Vα3 to Jα18 rearrangement. The data revealed that in contrast to 
C57BL/6 DP thymocytes, those from Nur77tg mice had not rearranged the 
canonical Vα14 and Jα18 gene segments (Fig. 2-4A), as expected from 
previously described animal models with similarly high DP thymocyte apoptosis 
(e.g., RORγt-/- and HEB-/-). None of the strains tested showed Vα3 to Jα18 
rearrangement (Fig. 2-4A), which was used as negative control. To confirm and 
quantify Vα14-to-Jα18 re-arrangement, qRT-PCR analysis was performed on 
RNA isolated from CD3ε+ T cell-enriched C57BL/6, Nur77tg, and Vα14tg (from 
rearranged Vα14Jα18 TCR transgenic mice (Bendelac, 1996)) thymocytes and 
splenocytes. Compared to C57BL/6, Nur77tg CD3ε+ T cell-enriched thymocytes 
and splenocytes contained significantly lower amount of Vα14Jα18 transcript 
(Fig. 2-4B). In contrast, but as expected, Vα14tg CD3ε+ T cell-enriched 
thymocytes and splenocytes contained very high levels of Vα14Jα18 transcript 
(Fig. 2-4B). These results suggest that a low initial pool of NKT cell precursors in 
DP thymocytes may have led to decreased numbers of NKT cells in Nur77tg 
mice.  
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Figure 2-4. Absence of Vα14Jα18 transcript in Nur77 transgenic T cells 
(A) RT-PCR assessment of Vα3 to-Jα18 and Vα14-to-Jα18 rearrangements 
within Nur77tg and Jα180 thymocytes compared to C57BL/6 thymocytes. Data 
are representative of 1 experiment.  
(B) Quantitative RT-PCR for Vα14Jα18 transcript within CD3ε
+
 cells magnetically 
enriched from Nur77tg and Vα14tg thymocytes, and splenocytes. 
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Based on the above speculation, we reasoned that forced expression of a 
rearranged Vα14Jα18 transgene, which bypasses the requirement for 
endogenous TCR rearrangement, should rescue NKT cell development, if there 
was no contribution of overt negative selection to Nur77tg NKT cell phenotype. 
Therefore, a rearranged Vα14Jα18 TCR transgene (Vα14tg) was introgressed 
into the Nur77tg strain. The resulting mice were assessed for T cell and NKT cell 
development. Developing thymocytes expressed higher levels of CD3ε within 
both Vα14tg and Nur77tg;Vα14tg mice perhaps due to forced over expression of 
the TCR transgene (Fig. 2-5A). Nonetheless, as expected both Nur77tg and 
Nur77tg;Vα14tg mice had fewer conventional T cells in the spleen compared to 
C57BL/6 mice (Fig. 2-5A) and their numbers should not be affected by 
introgression of the NKT cell specific TCR transgene. Hence, the absolute 
number of T cells in both the thymus and spleen were much lower in both Nur77tg 
and Nur77tg;Vα14tg mice (Fig.2-5A) and those few T cells that developed were 
either skewed towards CD4 or did not express either CD4 or CD8 (Fig. 2-5B). 
Assessment of NKT cell development revealed that they were poorly represented 
in Nur77tg;Vα14tg mice compared to the Vα14tg controls (Fig. 2-6A and 2-6B). 
While Vα14tg;Nur77tg mice have apparent higher frequency of NKT cells 
compared to C57BL/6 (which has intact conventional T and DP T cell 
compartment), a more appropriate way to compare these two strains with 
unequal thymic cellular composition was to compare the absolute numbers of 
cells, rather than frequencies, and those numbers revealed significantly reduced 
thymic and splenic NKT compartment in Vα14tg;Nur77tg compared to that in both 
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Figure 2-5. Nur77 negatively selects T cells  
(A) Thymic, splenic and hepatic CD3ε+ cells from C57BL/6, Nur77tg, Vα14tg and 
Nur77tg;Vα14tg. Numbers are % of CD3ε+ T cells among total leukocytes. Data 
are representative of 1 experiment, n=2. Absolute numbers of T cells in the 
thymus and spleen were calculated from % T cells and total cell count. 
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Figure 2-5 continued. Nur77 negatively selects T cells  
(B) Thymic, splenic and hepatic CD4+ and CD8+ T cells from C57BL/6, Nur77tg, 
Vα14tg and Nur77tg;Vα14tg mice were identified as CD4+ or CD8+ cells within 
electronically gated B220- CD3ε+ thymocytes or splenocytes. Numbers are % of 
CD4+ or CD8+ T cells among total leukocytes. Absolute numbers of T cells in the 
thymus and spleen were calculated from % T cells and total cell count. n=2.  
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Figure 2-6. Nur77 negatively selects Vα14tg NKT cells  
(A) Thymic, splenic and hepatic NKT cells from C57BL/6, Nur77tg, Vα14tg and 
Nur77tg;Vα14tg mice were identified as CD3ε
+
tetramer
+
 cells within electronically 
gated CD8
LO thymocytes or B220
LO
 splenocytes and liver mononuclear cells. 
Numbers are % of NKT cells among total leukocytes within each organ. n=2.  
(B) Absolute numbers of NKT cells in the thymus and spleen were calculated 
from % NKT cells in A and total cell count.  n as in A.  
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Figure 2-6, continued. Nur77 negatively selects of Vα14tg NKT cells  
(C) NKT cell developmental stages in C57BL/6, Nur77tg, Vα14tg and 
Nur77tg;Vα14tg mice were identified as CD44NEGNK1.1NEG ST1, CD44+NK1.1NEG 
ST2, or CD44+NK1.1+ ST3 in the thymus or as NK1.1NEGtetramer+ or 
NK1.1+tetramer+ within the splenic and hepatic MNCs. Numbers are % of cells 
among total NKT cells. n=2.  
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C57BL/6 and Vα14tg mice (Fig. 2-6B). To determine how far the NKT cells that 
were detected in Nur77tg;Vα14tg mice had progressed through development, the 
expression pattern of CD44 and NK1.1 markers were investigated. The data 
revealed that the thymic Vα14tg;Nur77tg NKT cells were blocked at the very 
immature CD44NEGNK1.1NEG stage and contained lower frequency of 
CD44HINK1.1+ NKT cells when compared to C57BL/6 and Vα14tg mice (Fig. 2-
6C). Taken together, the results described above suggest that regardless of 
NKTCR rearrangement and despite Vα14Jα18 transgenic TCR expression in 
Nur77tg;Vα14tg mice, Nur77 is still capable of inducing negative selection during 
early development of NKT cells.  
 
Dominant negative Nur77 mouse: a model for T cell negative selection  
Previous reports demonstrated that thymocyte-specific expression of the 
dominant negative Nur77 transgene (Nur77ΔNtg) blocks negative selection of 
conventional T cells (Calnan et al., 1995; Zhou et al., 1996). Since Nur77 plays a 
role in negative selection of NKT cells (Fig 2-2), this model of impaired negative 
selection was investigated. Mice were generated that express proximal-Lck 
promotor-enhancer driven Nur77ΔN transgene by the Vanderbilt Transgenic 
Mouse Shared Resource. This was accomplished by microinjection of an 
expression plasmid construct [generously provided by Dr. A. Winoto of UC 
Berkley (Fig. 2-7A) (Calnan et al., 1995)] into fertilized oocytes isolated from 
C57BL/6 mice. Upon breeding and PCR screening for germline transmission, 
three founder lines were identified. Functional redundancy between Nur77 family 
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Figure 2-7. Nur77 transgenic (tg) mice as models for negative selection 
(A) Map of transgene constructs both driven by the Lck-proximal promoter. The 
wild-type Nur77 construct contains full length Nur77 cDNA made up of the 
transactivation domain (TAD), the zinc finger DNA binding domain (Tyznik et al., 
2008), and c-terminal domain (CT). The dominant negative (ΔN) Nur77 construct 
lacks the TAD. Nur77tg mice and the Nur77ΔN construct were generous gifts 
from Dr. A. Winoto.  
(B) Transcript expression levels within thymocytes and splenocytes from 3 
founder lines of Nur77ΔNtg mice was assessed by real-time qPCR. β-actin was 
used as the internal control for normalization. Data from 1 experiment; each 
qPCR was performed in triplicate. 
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members Nur77 and Nor-1 was previously shown (Cheng et al., 1997). Hence, 
the conventional Nur770 mice can not be used as appropriate model and 
furthermore, Nur77ΔN transgene must be expressed at high enough levels to 
inhibit function of both family members. Therefore, transgene expression in 
thymic and splenic T cells was determined in the three Nur77ΔNtg founder lines 
by real-time qRT-PCR. Founder line #2 was determined to have the highest 
expression of Nur77ΔN (Fig. 2-7B). This line was used for all experiments 
described herein.   
Evaluation of thymi and spleens confirmed the development of CD4+ and 
CD8+ T cell within Nur77ΔNtg mice (Fig. 2-8). Both the frequency (Fig. 2-8A) and 
absolute number (Fig. 2-8B) of T cells in Nur77ΔNtg mice were similar to C57BL/6 
levels. As expected the frequency and absolute number of conventional T cells 
were low in Nur77tg mice as described above and in the previous studies (Calnan 
et al., 1995).  
Next, to ascertain whether the Nur77ΔN transgene does indeed inhibit 
negative selection, the Nur77ΔN transgene was introgressed into a mouse model 
of negative selection, the TCR-HYtg mouse. TCR-HYtg male C57BL/6 mice do not 
develop CD8+ T cells due to overt negative selection of HY specific T cells upon 
recognition of their cognate male minor histocompatibility antigen pHY presented 
by the H2Db (Kisielow et al., 1988). Flow cytometric analysis of blood revealed 
rescue of T cell development within Nur77ΔNtg;TCR-HYtg C57BL/6 male mice 
(Fig. 2-8C). These data indicate that in this mouse model, Nur77ΔN 
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Figure 2-8. Nur77 transgenic (tg) mice as models for negative selection 
 (A) Thymic, splenic and hepatic NKT cells from C57BL/6, Nur77tg, and 
Nur77ΔNtg mice were identified as CD3ε
+
tetramer
+
 cells within electronically 
gated CD8
LO thymocytes or B220
LO
 splenocytes and liver mononuclear cells. 
Numbers are % of NKT cells among total leukocytes within each organ. Data are 
representative of 3 independent experiments, n=6.  
(B) Absolute numbers of NKT cells in the thymus and spleen of C57BL/6, 
Nur77tg, and Nur77ΔNtg mice were calculated from % NKT cells in A and total 
thymocytes or splenocytes recovered from the respective lymphoid organs. Data 
are representative of 3 independent experiments showing n as in A. 
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Figure 2-8, continued. Nur77 transgenic (tg) mice as models for negative 
selection  
(C) Blood from male C57BL/6 (n= 3), Nur77ΔNtg (n= 3), TCR-HYtg (n= 4), and 
Nur77ΔNtg;TCR-HYtg (n= 9) mice was stained for presence of T cells (CD3ε+) and 
TCR-Hy (Vβ8+) transgene. Top row indicates T cells within total leukocytes. 
Bottom row indicates TCR-HY transgene (Vβ8+) expression within electronically 
gated CD3ε+ leukocytes, when present. Numbers in top row are % of total 
lymphocytes and the bottom row are % of CD3ε+ leukocytes. Data are 
representative of 3 independent experiments. 
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functions as previously reported (Zhou et al., 1996) and, consequently, blocks 
negative selection of CD8+ T cells. 
 
NKT cells develop and mature in Nur77ΔNtg mice 
Since Nur77ΔN blocked negative selection of transgenic CD8+ T cells, we 
wanted to examine whether the mutant transcription factor could also block 
negative selection of NKT cells within Nur77ΔNtg mice. Should negative selection 
occur during NKT cell development, upon blocking negative selection one would 
expect one of few outcomes: the most obvious assumption would be an increase 
in NKT cell frequency and number due to increased survival of these 
lymphocytes. This was a rather unlikely outcome as levels of conventional CD4 
and CD8 T cells, which also undergo Nur77-mediated negative selection, are not 
increased in these mice either (Fig 2-8), perhaps reflecting some other general 
mechanism dictating overt population size in lymphoid organs. Indeed, our data  
revealed that thymic CD4, CD8 and NKT cell frequency (Fig. 2-8 and 2-9A) and 
absolute number (Fig. 2-9B) were close to similar in Nur77ΔNtg mice and 
C57BL/6 mice. Splenic NKT cells were about half reduced in the mutant mice 
compared to C57BL/6 animals (Fig. 2-9A and 2-9B) suggesting potential 
additional aspects of NKT cell population control in peripheral organs. Moreover, 
similar to C57BL/6 NKT cells, Nur77ΔNtg NKT cells that develop were mature 
because they had attained CD44HINK1.1+ phenotype (Fig. 2-9C). The reduced 
peripheral Nur77ΔNtg NKT cell number may also be a consequence of the
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Figure 2-9. Nur77 affects the development of NKT cells  
 (A) Thymic, splenic and hepatic NKT cells from C57BL/6, Nur77tg, and 
Nur77ΔNtg mice were identified as CD3ε
+
tetramer
+
 cells within electronically 
gated CD8
LO thymocytes or B220
LO
 splenocytes and liver mononuclear cells. 
Numbers are % of NKT cells among total leukocytes within each organ. Data are 
representative of 3 independent experiments, n=6.  
(B) Absolute numbers of NKT cells in the thymus and spleen of C57BL/6, 
Nur77tg, and Nur77ΔNtg mice were calculated from % NKT cells in A and total 
thymocytes or splenocytes recovered from the respective lymphoid organs. n as 
in A.  
(C) NKT cell developmental stages in C57BL/6 and Nur77tg;Vα14tg mice were 
identified as CD44NEGNK1.1NEG ST1, CD44+NK1.1NEG ST2, or CD44+NK1.1+ ST3 in 
the thymus or as NK1.1NEGtetramer+ or NK1.1+tetramer+ within the splenic and 
hepatic MNCs. Data are showing n as in A.  
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 transgene interfering with the NKT cell developmental program in an as yet 
unknown manner.  
 
Positive selection precedes Nur-77-mediated negative selection during NKT 
cell development 
Developing conventional T cells initially undergo the process of positive 
selection within the cortex of the thymus. Before completing their development, 
those that are positively selected then undergo negative selection upon migrating 
to cortico-medullary boundary to eliminate highly self-reactive T cell clones. NKT 
cells undergo positive selection in the thymus by interacting with CD1d molecules 
expressed by DP thymocytes (Bendelac, 1995; Xu et al., 2003). This process is 
dependent upon proper endosomal CD1d trafficking and lipid presentation 
because NKT cells poorly, if at all develop in CD1d tail-deleted (TD) mice. Mutant 
CD1d-TD molecules lack the cytoplasmic tail; consequently, they do not recycle 
efficiently through the endo-lysosomal compartment. This recycling is essential 
for CD1d-restricted presentation of lipid ligand(s) that mediate positive selection 
of NKT cells (Chiu et al., 2002). Since our data indicate that NKT cells undergo 
negative selection, we queried which process occurs first, positive or negative 
selection. To address this question, the CD1d-TD knock-in strain was bred to the 
Nur77ΔNtg strain. We reasoned that if negative selection occurs first, NKT cell 
number would increase in CD1d-TDKI;Nur77ΔNtg mice compared to either parent 
strain. Alternatively, if negative selection occurs after positive selection, the new 
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strain should look identical to CD1d-TDKI as developing NKT cells would be 
arrested at the failed positive selection step just like seen in CD1d-TDKI. The data 
supported the latter scenario i.e., NKT cell frequency and absolute number were 
much lower in CD1d-TDKI;Nur77ΔNtg mice when compared to Nur77ΔNtg mice 
and more closely resembled those of NKT cells in CD1d-TDKI mice (Fig. 2-10). 
These data indicate that positive selection of NKT cells precedes their negative 
selection. Because it was reported that biased usage of Vβ chains in NKTCR is 
shaped during positive selection, these data suggest a hypothesis, to be tested 
below, in which positive selection plays a dominant role in grossly shaping the 
NKT cell repertoire. 
 
Block of negative selection in Nur77ΔNtg mice has a modest effect on 
positively selected αGalCer reactive NKTCR repertoire  
NKT cells express a restricted TCR Vβ repertoire composed of Vβ8.2, 7, 2, 
6,10, and 14. This restriction is not due to the inability of the α-chain to pair with 
particular Vβ as Vα14Jα18tg;CD1d-deficient mice contain a broad TCR Vβ cell 
repertoire (Bendelac et al., 2007). Additionally, only TCRs containing Vβ7, 8.2 
and 2 were capable of responding to stimulation with a putative endogenous 
selecting ligand iGb3 (Wei et al., 2006). Thus, the NKTCR bias is thought to be 
the result of positive selection. What role negative selection plays in shaping the 
NKT cell repertoire is currently ill defined despite the fact that there is evidence to 
indicate this (Chun et al., 2003; Pellicci et al., 2003). A serologic analysis using 
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Figure 2-10. Positive selection precedes negative selection in NKT cells  
(A) Thymic, splenic and hepatic NKT cells from C57BL/6 (n=7), Nur77ΔNtg (n=4), 
CD1dTD (n=3), and Nur77ΔNtg;CD1dTD (n=7) mice were identified as 
CD3ε
+
tetramer
+
 cells within electronically gated CD8
LO thymocytes or B220
LO
 
splenocytes and liver mononuclear cells. Numbers are % of NKT cells among 
total leukocytes within each organ. Data are representative of 3 independent 
experiments.  
(B) Absolute numbers of NKT cells in the thymus and spleen were calculated 
from % NKT cells in A and total thymocytes or splenocytes recovered from the 
respective lymphoid organs. Data showing n as in A. 
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Vβ-specific mAbs revealed that Vβ usage in C57BL/6 and Nur77ΔNtg thymic NKT 
cells were not significantly altered (Fig. 2-11A). A similar analysis of splenic NKT 
cells in the two strains showed only minor differences (Fig. 2-11A) thus 
supporting dominant role of positive selection in restricting overall Vβ usage by 
NKT cells.  
The TCR repertoire is shaped not only by the particular pairing of α- and β- 
chains but also by V(D)J rearrangements that confers extreme diversity to the 
complementary determining region 3 (CDR3) within the two TCR chains. 
Negative selection within NKT cells may not alter Vβ chain usage but may alter 
the length and frequency of CDR3β expressed by Nur77ΔNtg NKT cells. The 
nature of CDR3β has been shown to influence lipid ligand recognition by NKT 
cells even though this part of the TCR makes very little direct contact with the 
CD1d-lipid complex (Li et al., 2010; Scott-Browne et al., 2007). To assess CDR3 
diversity within C57BL/6 and Nur77ΔNtg NKT cells, TCRs were sequenced from 
purified NKT cells. Preliminary data show no overlapping sequences in both 
strains (Table 2-1), even though the exact level of overlap (or its absence) will be 
tested in the repeat experiment to ensure the reproducibility of the technology in 
the animals of the same genotype. Regardless, Nur77ΔNtg NKT cells contained 
generally higher percentage of re-arrangements between Vβ-to-Jβ1-cluster when 
compared to C57BL/6, which predominantly utilized Jβ2-cluster to code for 
CDR3β (Fig. 2-11B). This bias also rules out the randomness in our sequence 
analysis. The Jβ-cluster bias was more evident in NKTCRs made up of Vβ6 than  
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Figure 2-11. Nur77 plays a minor role in modeling the NKTCR repertoire 
(A) TCR Vβ usage by thymic and splenic NKT cells from C57BL/6 and Nur77ΔNtg 
mice was determined by flow cytometry. Shown are the percents of NKT cells 
expressing the indicated Vβs. Data are representative of 5 independent 
experiments showing n=5. 
(B) Ratio of Nur77ΔNtg to C57BL/6 percentage of Jβ expression based on 
sequences in Table 3-1.  
 	   73	  
 
Table 2-1. NKTCR CDR3 sequences 
C57BL/6 TCR Vβ8 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1, CDR2, CDR3] 
Productive (P), Stop 
codon (S), Out of frame 
(O) 
ASSD  TNSDYT TRBJ1-2*01 [5.6.10] P 
ASSD  TNSDYT TRBJ1-2*01 [5.6.10] P 
1 
ASSD  TNSDYT TRBJ1-2*01 [5.6.10] P 
2 ASGD LGGR EDTQY TRBJ2-5*01 [5.6.13] P 
3 ASG GTGS AETLY TRBJ2-3*01 [5.6.12] P 
4 ASG GLGAL SAETLY TRBJ2-3*01 [5.6.14] P 
5 ASGD  DTGQLY TRBJ2-2*01 [5.6.10] P 
6 ASGD V GNTLY TRBJ1-3*01 [5.6.10] P 
7 ASGD AES SYEQY TRBJ2-7*01 [5.6.12] P 
8 AS ALPGTGG DEQY TRBJ2-7*01 [5.6.13] P 
9 ASGD QGA DAEQF TRBJ2-1*01 [5.6.12] P 
10 AS TGTG NTEVF TRBJ1-1*01 [5.6.11] P 
11 ASGD AIGA SAETLY TRBJ2-3*01 [5.6.14] P 
12 ASG AS SDYT TRBJ1-2*01 [5.6.9] P 
13    TRBJ2-1*01 [5.6.X] O 
14 ASGD RL NQDTQY TRBJ2-5*01 [5.6.12] P 
15 ASGD *LGG# #DTQY TRBJ2-5*01 [5.6.X] S,O 
16 ASGD AAGGG YEQY TRBJ2-7*01 [5.6.13] P 
17 ASGD AGGA NSDYT TRBJ1-2*01 [5.6.13] P 
18 ASGD ELGI YEQY TRBJ2-7*01 [5.6.12] P 
19 AS GA DTQY TRBJ2-5*01 [5.6.8] P 
20 ASS GDRG TEVF TRBJ1-1*01 [5.6.11] P 
21 ASGD DWGG SQNTLY TRBJ2-4*01 [5.6.14] P 
22 ASG V SNTEVF TRBJ1-1*01 [5.6.10] P 
23 ASGD AGTGG SQNTLY TRBJ2-4*01 [5.6.15] P 
24 AS SGTD NNQAPL TRBJ1-5*01 [5.6.12] P 
25 ASGD AGTSYE QY TRBJ2-5*01 [5.6.12] P 
26 ASGE RA QNTLY TRBJ2-4*01 [5.6.11] P 
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Nur77ΔN tg TCR Vβ8 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1.CDR2.CDR3] 
Productive (P), Stop codon (S), Out 
of frame (O) 
ASG  SQNTLY TRBJ2-4*01 [5.6.9] P (no D segment) 1 
ASG  SQNTLY TRBJ2-4*01 [5.6.9] P (no D segment) 
2 ASSD VRGA AETLY TRBJ2-3*01 [5.6.13] P 
3 ASGD AQ AYEQY TRBJ2-7*01 [5.6.11] P 
4 ASGD GTGGN NYAEQF TRBJ2-1*01 [5.6.15] P 
5 ASGD VGG NSPLY TRBJ1-6*01 [5.6.12] P 
6 ASGD AGE DTGQLY TRBJ2-2*01 [5.6.13] P 
7 ASSD AAGTG# YEQY TRBJ2-7*01 [5.6.X] S, O 
8 ASGD AGES SYEQY TRBJ2-7*01 [5.6.13] P 
9 ASGE QGNX APL TRBJ1-5*01 [5.6.11] P 
10 ASG PGQ TNTEVF TRBJ1-1*01 [5.6.12] P 
11 ASGD RDV NTEVF TRBJ1-1*01 [5.6.12] P 
12 ASR GTS SNERLF TRBJ1-4*02 [5.6.12] P 
13 ASSD ASTGV NQDTQY TRBJ2-5*02 [5.6.15] P 
14 ASGD ADI QDTQY TRBJ2-5*01 [5.6.12] P 
15 ASGD  NTEVF TRBJ1-1*01 [5.6.9] P 
16 ASSD N YEQY TRBJ2-7*01 [5.6.9] P 
17 ASSD RGG NQAPL TRBJ1-5*01 [5.6.12] P 
18 ASGD AGGPV# QF TRBJ2-1*01 [5.6.X] S, O 
19 ASGD  NTEVF TRBJ1-1*01 [5.6.9] P 
20 ASR  DTQY TRBJ2-5*01 [5.6.7] P 
21 ASGD AGQGG# NYAEQF TRBJ2-1*01 [5.6.X] S, O 
22 ASSE MGG EQY TRBJ2-7*01 [5.6.10] P 
23 AS SDAWGL AEQF TRBJ2-1*01 [5.6.12] P 
24 ASG GT SQNTLY TRBJ2-4*01 [5.6.11] P 
25 ASG QGG AETLY TRBJ2-3*01 [5.6.11] P 
26 ASGD SGGD QNTLY TRBJ2-4*01 [5.6.13] P 
27 ASGD AGT ANSDYT TRBJ1-2*01 [5.6.13] P 
28 ASGD AGQGG #NYAEQF TRBJ2-1*01 [5.6.X] S, O 
29 ASGD LTGGD YEQY TRBJ2-7*01 [5.6.13] P 
30 ASG T TNTEVF TRBJ1-1*01 [5.6.10] P 
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C57BL/6 TCR Vβ6 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1.CDR2.CDR3] 
Productive (P), Stop codon (S), 
Out of frame (O) 
ASS PLGQA QNTLY TRBJ2-4*01 [5.6.13] P 
ASS PLGQA QNTLY TRBJ2-4*01 [5.6.13] P 
ASS PLGQA QNTLY TRBJ2-4*01 [5.6.13] P 
1 
ASS PLGQA QNTLY TRBJ2-4*01 [5.6.13] P 
ASS RFGS SAETLY TRBJ2-3*01 [5.6.13] P 2 
ASS RFGS SAETLY TRBJ2-3*01 [5.6.13] P 
3 ASSI RTGG YAEQF TRBJ2-1*01 [5.6.13] P 
4 ASSI S YAEQF TRBJ2-1*01 [5.6.10] P 
5 ASSI WG# SYEQY TRBJ2-7*01 [5.6.X] S, O 
6  ARGTG DTEVF TRBJ1-1*01 [5.6.10] P 
7 AS IPGLGGRG EQY TRBJ2-7*01 [5.6.13] P 
8 ASSI MGR YEQY TRBJ2-7*01 [5.6.11] P 
9 ASSM GLG# SYEQY TRBJ2-7*01 [5.6.X] S, O 
10 ASX XSXXHT LY TRBJ1-3*01 [5.6.11] S 
11 ASSI DRS SYEQY TRBJ2-7*01 [5.6.12] P 
12 ASS PRQ DSDYT TRBJ1-2*01 [5.6.11] P 
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Nur77ΔN tg TCR Vβ6 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1.CDR2.CDR3] 
Productive (P), Stop codon (S), Out 
of frame (O) 
ASSI TGGA DSDYT TRBJ1-2*01 [5.6.13] P 
ASSI TGGA DSDYT TRBJ1-2*01 [5.6.13] P 
ASSI TGGA DSDYT TRBJ1-2*01 [5.6.13] P 
1 
ASS TGGA DSDYT TRBJ1-2*01 [5.6.13] P 
ASS RDRGKG NTEVF TRBJ1-1*01 [5.6.14] P 
ASS RDRGKG NTEVF TRBJ1-1*01 [5.6.14] P 
ASS RDRGKG NTEVF TRBJ1-1*01 [5.6.14] P 
2 
ASS RDRGKG NTEVF TRBJ1-1*01 [5.6.14] P 
ASS RGR EVF TRBJ1-1*01 [5.6.9] P 
ASS RGR EVF TRBJ1-1*01 [5.6.9] P 
3 
ASS RGR EVF TRBJ1-1*01 [5.6.9] P 
ASS PLG AETLY TRBJ2-3*01 [5.6.11] P 4 
ASS PLG AETLY TRBJ2-3*01 [5.6.11] P 
5 ASSI PA#  TRBJ2-3*01 [5.6.X] O (PHE 118 not identified) 
6 ASSI VQ SQNTLY TRBJ2-4*01 [5.6.12] P 
7 ASSM RD# #NERLF TRBJ1-4*02 [5.6.X] O 
8 ASS TLQA NSDYT TRBJ1-2*01 [5.6.12] P 
9 ASR DRGR DSDYT TRBJ1-2*01 [5.6.12] P 
10 ASSI PES NSDYT TRBJ1-2*01 [5.6.12] P 
11 AS AGTGPS  TRBJ1-6*01 [5.6.8] P 
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C57BL/6 TCR Vβ2 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1.CDR2.CDR3] 
Productive (P), Stop codon (S), Out of 
frame (O) 
TCSA DWG EQY TRBJ2-7*01 [6.6.10] P 
TCSA DWG EQY TRBJ2-7*01 [6.6.10] P 
TCSA DWG EQY TRBJ2-7*01 [6.6.10] P 
1 
TCSA DWG EQY TRBJ2-7*01 [6.6.10] P 
2 TCSAD R DQDTQY TRBJ2-5*01 [6.6.12] P 
3 TCSAE WV EQY TRBJ2-7*01 6.6.10] P 
4 TCSA AGIQ DTQY TRBJ2-5*01 [6.6.12] P 
5 TCSAD GGV YEQY TRBJ2-7*01 [6.6.12] P 
6 TCSAD GGLGGH NYAEQF TRBJ2-1*01 [6.6.17] P 
7 TCSAD GVG NERLF TRBJ1-4*02 [6.6.13] P 
8 TCSAD GRGL DTQY TRBJ2-5*01 [6.6.13] P 
9 TCSA A GAETLY TRBJ2-3*01 [6.6.11] P 
10 TCR GTGG KNTLY TRBJ2-4*01 [6.6.12] P 
11 TCSA LDWGVS SAETLY TRBJ2-3*01 [6.6.16] P 
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Nur77ΔN tg TCR Vβ2 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1.CDR2.CDR3] 
Productive (P), Stop codon (S), 
Out of frame (O) 
TCSAD QG TLY TRBJ2-3*01 [6.6.10] P 1 
TCSAD QG TLY TRBJ2-3*01 [6.6.10] P 
2 TCSAD RLG SAETLY TRBJ2-3*01 [6.6.14] P 
3 TCS GTG NTEVF TRBJ1-1*01 [6.6.11] P 
4 TCSA DRG DTEVF TRBJ1-1*01 [6.6.12] P 
5 TCS DIRE EVF TRBJ1-1*01 [6.6.10] P 
6 TCSAD HG SQNTLY TRBJ2-4*01 [6.6.13] P 
7 TCSA RDF SAETLY TRBJ2-3*01 [6.6.13] P 
8 TCS PDRGS SAETLY TRBJ2-3*01 [6.6.14] P 
9  PAVQINWGA# EQY TRBJ2-7*01 [6.6.X] S, O 
10 TCS GD SQNTLY TRBJ2-4*01 [6.6.11] P 
11 TCSAD LG QDTQY TRBJ2-5*01 [6.6.12] P 
12 TCSAD S NERLF TRBJ1-4*02 [6.6.11] P 
13 TCSAE TVW EQY TRBJ2-7*01 [6.6.11] P 
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C57BL/6 TCR Vβ7 
Group Vβ N/D/N Jβ 
 
Jβ-
nomenclature 
CDR length 
[CDR1.CDR2.CDR3] 
Productive (P), Stop codon (S), 
Out of frame (O) 
ASSL GH SNERLF TRBJ1-4*02 [5.6.12] P 1 
ASSL GH SNERLF TRBJ1-4*01 [5.6.12] P 
2 AS H TNTGQLY TRBJ2-2*01 [5.6.10] P 
3 ASSLS R SQNTLY TRBJ2-4*01 [5.6.12] P 
4 ASS XQGXX AEQF TRBJ2-1*01 [5.6.12] P 
5 A TQG SAETLY TRBJ2-3*01 [5.6.10] P 
6 ASSL TGD ANTGQLY TRBJ2-2*01 [5.6.14] P 
7 AR TGP ANTGQLY TRBJ2-2*01 [5.6.12] P 
8 ASS SPTG ANTGQLY TRBJ2-2*01 [5.6.14] P 
9 AS H TNTGQLY TRBJ2-2*01 [5.6.10] P 
10 ASS TGQGG NTLY TRBJ2-4*01 [5.6.12] P 
11 ASS XXGGK AETLY TRBJ2-3*01 [5.6.13] P 
12 ASSL  DTQY TRBJ2-5*01 [5.6.8] P (no D segment) 
13 ASSL AGTG DERLF TRBJ1-4*02 [5.6.13] P 
14 ASSLS YGG GAETLY TRBJ2-3*01 [5.6.14] P 
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the high affinity Vβ7 and Vβ2. Thus, highly self reactive NKTCR containing Jβ1 
may be negatively selected in wild type mice while they survive in Nur77ΔNtg. 
These data indicate that Nur77 plays a minor role in shaping the αGalCer 
reactive NKT cell repertoire. 
 
C57BL/6 and Nur77ΔNtg NKT cells react differently to a variety of lipid 
agonists 
The purpose of negative selection is to remove highly self-reactive T cells 
from the repertoire to prevent potential autoimmune responses. Therefore, 
whether Nur77ΔNtg NKT cells show altered reactivity to currently known self lipid 
agonists was determined. Since conventional T cells also express the Nur77ΔNtg, 
it was important to rule out any reactivity that may be contributed by conventional 
T cells in the functional assays. Thus, Nur77ΔNtg mice were made deficient for 
NKT cells by crossing them with Jα180 mice (Fig. 2-13A). Splenocytes stimulated 
in vitro with different amounts of the known potent NKT cell agonist αGalCer 
resulted in similar or slightly reduced IFN-γ secreted into the culture supernatants 
when Nur77ΔNtg splenocytes were compared to C57BL/6 cells (Fig. 2-12B). The 
slight reduction in response may be due to the reduced overall numbers of NKT 
cells within Nur77ΔNtg spleens. Additionally, IFN-γ was not found in the culture 
supernatant when Nur77ΔNtg;Jα180 splenocytes stimulated as above, suggesting 
that the IFN-γ response to αGalCer stimulation in vitro is NKT cell dependent.   
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Figure 2-12. Defective Nur77 expression alters in vitro NKT cell response to 
antigens  
(A) Splenic NKT cells from C57BL/6 (n=7), Nur77ΔNtg (n=11), and 
Nur77ΔNtg;Jα180 (n=6) mice were identified as CD3ε+tetramer+ cells within 
electronically gated CD8LO thymocytes or B220LO splenocytes. Numbers are % of 
NKT cells among total mononuclear leukocytes within each organ. Total 
splenocytes from mice in A were cultured 5 days with titrated amounts αGalCer 
(B). Using ELISA, IFN-γ secreted into the supernatant was measured. Data are 
representative of 4 independent experiments; n as in A.  
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Figure 2-12, continued. Defective Nur77 expression alters in vitro NKT cell 
response to antigens  
Total splenocytes from mice in A were cultured 5 days with indicated lipids.  
(C) Using ELISA, IFN-γ secreted into the supernatant was measured. Data are 
representative of 4 independent experiments; n as in A.  
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Since αGalCer is an extremely potent NKT cell antigen, any variation in 
reactivity might be difficult to detect due to the robustness of the response. 
Therefore, we reasoned that weaker NKT cell lipid agonists might allow a better 
assessment of NKT cell responses in Nur77ΔNtg mice. Thus, a panel of lipids 
composed of an αGalCer variant (OCH), a known microbial glycolipid ligand 
(αGalDAG), the putative selecting antigen (iGb3), and a number of self lipids 
(sulfatide, PtdCho, PtdIno, and PtdEtN) were used in preliminary experiments to 
stimulate C57BL/6 and Nur77ΔNtg NKT cells in vitro (Fig. 2-12C). αGalCer and 
OCH elicited slightly lower IFN-γ response from Nur77ΔNtg splenocytes when 
compared to C57BL/6 cells (Fig. 3-12C). Nonetheless, the weaker agonists such 
as iGb3 and αGalDAG elicited higher IFN-γ response from Nur77ΔNtg 
splenocytes when compared to C57BL/6 cells (Fig. 2-12C) despite the reduced 
numbers of NKT cells in Nur77ΔNtg splenocytes (Fig. 2-9). Additionally, the self-
lipid PtdCho elicited a slightly increased IFN-γ response within Nur77ΔNtg but not 
C57BL/6 cultures (Fig. 2-12C). Thus, negative selection of NKT cells does 
moderately impact reactivity to self lipid agonists. One caveat of this analysis is 
that it uses all known NKT cell agonists and those were discovered by studying 
already selected NKT cell repertoire of wild type mice. Hence, it would be 
interesting to test in the future the more unbiased panel of cellular lipids using 
either splenocytes of the NKT cell clones generated from Nur77ΔNtg mice to 
identify any previously unanticipated NKT cell specificities.  
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An NKT cell response can be assessed both by measuring the robustness 
of secreted cytokines and by following the kinetics of cytokine response. Upon in 
vivo stimulation with αGalCer, NKT cells rapidly secrete IL-4, which peaks within 
2 hours, followed by IFN-γ and the down regulation of the TCR (Bendelac et al., 
2007). Therefore, in vivo splenic and hepatic NKT cell responses in C57BL/6 and 
Nur77ΔNtg mice were assessed at 2 and 4 hours post αGalCer injection. TCR 
down-regulation was delayed beyond 4 hours in hepatic NKT cells of Nur77ΔNtg 
mice whereas splenic NKTCR down regulation was the same in both strains (Fig. 
2-13A). Robust IFN-γ response was elicited from both splenic and hepatic NKT 
cells at 2 hours in C57BL/6 and Nur77ΔNtg mice (Fig. 2-13B). At 4 hours, IFN-γ 
response begins to wane in livers of the C57BL/6 mice but still remains on-going 
in liver of Nur77ΔNtg (Fig.2-13B). IL-4 response was the same in both strains in 
both organs (Fig.2-13B). These functional data indicate that Nur77ΔN expression 
affects hepatic NKT cell function. Whether this reflects altered NKTCR repertoire 
or intrinsic role of Nur77 in hepatic NKT cells requires further investigation.  
 
DISCUSSION 
Here we provide evidence for the role of Nur77 in mediating negative selection 
during NKT cell development. First, overexpression of Nur77 results in the 
massive apoptosis of NKT cells as well as CD4, CD8 and DP thymocytes, all of 
which could be rescued by overexpression of the anti-apoptotic protein Bcl-xL.  
 
 
 	   85	  
 
 
 
 
 
 
 
 
Figure 2-13. Comparable in vivo functional NKT cell response in C57BL/6 
and Nur77 defective mice 
C57BL/6 (n=4) and Nur77ΔNtg (n=4) mice were injected i.p. with 5 µg αGalCer 
(open) or vehicle (shaded). After 2 and 4 hrs, splenic and hepatic NKT 
(B220
LO
CD3ε
+
tetramer
+
) cells were electronically gated (A).  
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Figure 2-13, continued. Comparable in vivo functional NKT cell response in 
C57BL/6 and Nur77 defective mice 
(B) Intracellular IL-4 and IFN-γ expression within gated NKT cells in A. Numbers 
refer to ΔMFI and % of NKT cells. Data are representative of 2 independent 
experiments.  
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Second, positive selection precedes negative selection in NKT cells and hence 
play dominant role in shaping NKT cell Vβ repertoire. Inhibition of Nur77-
mediated negative selection, results in the alteration of CDR3β sequences in 
NKTCR and reveals increased TCR Jβ1-cluster usage over Jβ2-cluster, which is 
predominantly used by C57BL/6 NKT cells. Preliminary analyses revealed that 
this subtle alteration in NKTCR does not affect recognition of high affinity NKT 
antigens but does increase reactivity to the weaker self-lipid ligands. From these 
data we propose that Nur77 induces negative selection of NKT cells during 
thymic development, and that negative selection, together with positive selection, 
sculpts the NKT cell repertoire and, thereby, impacts their function.  
In this study we re-generated two previously described mouse models used 
to over-induce (Nur77tg) or to suppress (Nur77ΔNtg) negative selection of 
developing thymocytes (Calnan et al., 1995). As was seen with conventional T 
cells, we discovered dramatic loss of NKT cells in Nur77tg mice. We investigated 
three possible mechanisms to explain the loss of NKT cells in these mice: a 
defect in positive selection owing to decreased DP thymocytes, which mediate 
this process; a DP thymocyte intrinsic impairment in the rearrangement of the 
canonical Vβ14-to-Jβ18 segments; and a defect in NKT cell survival. Two 
experiments ruled out the role of a DP cell defect in the loss of NKT cells. First, 
Nur77tg DP thymocytes were equally capable of stimulating NKT cell hybridomas, 
which are sensitive to the purported positively selecting endogenous lipid 
antigen, ruling out a defect in positive selection of NKT cells in Nur77tg mice. 
Second, we found that the DP thymocytes did not rearrange the canonical Vβ14-
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to-Jβ18 segments. Nonetheless, complementation of this defect by the 
introgression of a rearranged Vα14Jα18 transgene into Nur77tg mice failed to 
rescue NKT cell development. Hence, the lack of NKT cells in Nur77tg mice was 
not due to the inability of DP cells to make the necessary TCR rearrangements. 
Finally, introgression of the Bcl-xL transgene into Nur77tg mice partially rescued 
NKT cell development within Nur77tg mice, indicating a role of Nur77 in inducing 
NKT cell death. From these results we conclude that Nur77 mediates negative 
selection of NKT cells, just like it does in conventional CD4 and CD8 T cells.   
Mice in which negative selection was blocked (Nur77ΔNtg mice) developed 
NKT cells, but their number was somewhat reduced in the spleen and liver. One 
possible explanation for the low peripheral NKT cell number could be that 
negative selection may not play a major role in shaping the NKT cell ontogeny. 
This however, would be inconsistent with the data discussed above. Therefore, 
an alternative explanation might be an incomplete block of Nur77 function in the 
Nur77ΔNtg mouse line used in this study. Although this line expresses the highest 
level of Nur77ΔNtg among the three founder lines generated, other parts of Nur77 
that were not deleted in the dominant negative mutant might play a role in 
mediating negative selection. A number of studies have implicated the Nur77 
transactivation domain in mediating negative selection induced apoptosis (Kuang 
et al., 1999; Rajpal et al., 2003). Therefore, the deletion of this domain from 
Nur77, as in the Nur77ΔN transgene used in this study, should have blocked 
negative selection. However, one study has shown that the binding of Nur77 to 
Bcl-2 and the consequent conversion of the anti-apoptotic Bcl-2 to a proapoptotic 
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form requires the C-terminal ligand binding domain of Nur77 (Thompson et al., 
2010; Thompson and Winoto, 2008). The dominant negative Nur77 transgene 
encodes a protein that lacks the transactivation domain but contains the C-
terminal domain. It is unclear whether such a mutant would be able to convert the 
anti-apoptotic to pro-apoptotic Bcl-2, and whether this part of Nur77 function 
would or not require an intact transactivation domain. Based on these reports, we 
predict that the Nur77ΔN transgene, as it still contains the Bcl-2 binding C-
terminal domain may largely but not completely block all pathways leading to 
negative selection. This therefore, results in a milder phenotype such that some 
developing NKT cells continue to undergo negative selection. The role that the C-
terminal domain plays in negative selection of NKT cells and shaping the NKT 
cell repertoire will be an area for future research.   
When does positive and negative selection of NKT cells occur? Previous 
studies have suggested that during NKT cell development there is a defined 
period of susceptibility to negative selection. Both the addition of αGalCer to 
foetal thymic organ culture (FTOC) at later stages of culture and intrathymic 
injection of adult mice with αGalCer do not result in the depletion of NKT cells, 
raising the question as to which development stage do NKT cells undergo 
negative selection (Pellicci et al., 2003). Conventional T cells are sensitive to 
negative selection as long as they are in a semi-immature state (HSAHI). Previous 
reports have shown that an immature population of NKT cells that were HSAHI 
also expressed Nur77, suggesting that negative selection occurs during a very 
early stage of NKT cell development (Moran et al., 2011; Stanic et al., 2004a). In 
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agreement with this report is the finding that the residual NKT cells which 
develop in Nur77tg;Vα14tg are blocked at the immature CD44LOWNK1.1LOW ST1. 
This suggests that NKT cells undergo negative selection at very early stage in 
development. Additionally, analysis of CD1d-TDKI;Nur77ΔNtg revealed a complete 
absence of NKT cells despite a block of negative selection, indicating that 
positive selection (which is altered in CD1d-TDKI mice) occurs before negative 
selection within NKT cells.  
NKT cells have a very limited TCR Vβ repertoire. A number of studies have 
implicated positive selection as the sole process by which the NKT cell repertoire 
is selected (Mallevaey et al., 2009; Pellicci et al., 2009; Wei et al., 2006). The 
role of negative selection however, has been much less clear. Analysis of 
Nur77ΔNtg mice revealed that TCR Vβ usage in NKT cells is very similar to 
C57BL/6 mice. This is consistent with our data suggesting that positive selection 
precedes negative selection and with published data suggesting that positive 
selection actually shapes Vβ usage in NKT cells. A previous study has shown 
that the CDR2β loop in the NKTCR is responsible for CD1d/glycolipid recognition 
and in particular for strong recognition by Vβ8.2, Vβ7, and Vβ2 (Florence et al., 
2009; Gui et al., 2001; Mallevaey et al., 2009). Mallevaey et al. (2009) study also 
found that CDR3β could play a role in increasing or decreasing the affinity of 
NKTCR/CD1d/glycolipid interactions. Thus, we decided to look at whether 
Nur77ΔNtg NKT cells expressed altered CDR3β compared to C57BL/6. 
The junctions of V-D-J rearrangements codes for the CDR3β region of the 
TCR. Whereas C57BL/6 NKT cells predominately use the Jβ2-cluster for this 
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rearrangement, Nur77ΔNtg NKT cells retained the usage of Jβ1-cluster for this 
purpose. Though limited by a small sample size, the data here suggests that 
negative selection also impacts NKT cell repertoire, although apparently in a 
more subtle way than positive selection does. A major limitation to these studies 
is the assumption that NKT cells rescued from negative selection will also be 
reactive to tetrameric CD1d-αGalCer that was used to sort and analyse cells in 
these experiments. Future studies involving the use of tetramers of CD1d loaded 
with endogenous lipid ligands will be important for teasing out additional 
populations of NKT cells not detected with tetrameric CD1d-αGalCer.  
The role of negative selection is to remove highly self-reactive T cells from 
the repertoire. Thus, by blocking negative selection, one would expect to find 
altered antigen reactivity within the emerging T cell pool. In vitro stimulation 
studies revealed an increased response to αGalDAG and modestly increased, 
but nonetheless, significantly higher response to iGb3 and PtdCho by Nur77ΔNtg 
NKT cells when compared to C57BL/6 NKT cells. This increased reactivity is not 
the result of overt sensitivity of Nur77ΔNtg NKT cells to lipids caused by the 
expression of the mutant transcription factor, as reactivity to αGalCer and OCH 
was not increased when compared to C57BL/6 NKT cell response. In vivo 
stimulation resulted in persistent hepatic NKT cell response in Nur77ΔNtg mice 
compared to the response in C57BL/6 mice. Additional experiments will be 
required to determine if this is due to a delay in activation or reflects the 
prolonged responsive state of Nur77ΔNtg NKT cells.  
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Altered reactivity, especially increased response to a pathogen derived lipid 
antigen such as Borrelia burgdorferi-derived αGalDAG can have deleterious 
effects. The role of NKT cells in the immune system is generally one of protection 
from pathogens and autoimmune disease. However, NKT cells have also been 
found to have detrimental affects during immune responses to pathogens such 
as Salmonella enterica and Sendai virus (Tupin et al., 2007) and in exacerbating 
autoimmune diseases such as rheumatoid arthritis and primary biliary cirrhosis 
(Wu and Van Kaer, 2009). Thus, NKT cells’ potential to induce detrimental 
cytokine storm by rapidly and robustly secreting cytokines has to be kept in 
check. Therefore, negative selection is an important mechanism of central 
tolerance that is accomplished during NKT cell development.  
In conclusion, NKT cells undergo Nur77 mediated negative selection during 
development. While positive selection broadly shapes the NKT cell repertoire, 
negative selection fine-tunes this repertoire. A properly shaped repertoire is 
important for the necessary and appropriate immune responses initiated by NKT 
cells.  
 	   93	  
CHAPTER III 
 
IL-15 REGULATES HOMEOSTASIS AND TERMINAL MATURATION 
 OF NKT CELLS 
 
ABSTRACT 
Semi-invariant NKT cells are thymus-derived innate lymphocytes that 
modulate microbial and tumor immunity as well as autoimmune diseases. These 
immunoregulatory properties of NKT cells are acquired during their development. 
Much has been learnt regarding the molecular and cellular cues that promote 
NKT cell development, yet how these cells are maintained in the thymus and the 
periphery and how they acquire functional competence are incompletely 
understood. We found that IL-15 induced several Bcl-2 family survival factors in 
thymic and splenic NKT cells in vitro. Yet, IL15-mediated thymic and peripheral 
NKT cell survival critically depended on Bcl-xL expression. Additionally, IL-15 
regulated thymic developmental stage 2 (ST2) to ST3 lineage progression and 
terminal NKT cell differentiation. Global gene expression analyses and validation 
revealed that IL-15 regulated Tbx21 (T-bet) expression in thymic NKT cells. The 
loss of IL-15 also resulted in poor expression of key effector molecules such as 
IFN-γ, granzyme A and C as well as several NK cell receptors in NKT cells. 
Strikingly, the maturation of CD44+NK1- st2 precursors to st3 CD44+NK1+ NKT 
cells was essential for protecting mice from the lethal disease caused by 
Francisella tularensis. Taken together, our findings reveal a critical role for IL-15 
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in NKT cell survival, which is mediated by Bcl-xL, and effector differentiation, 
which is consistent with a role of T-bet in regulating terminal maturation, and 
protection from runaway inflammation caused by a lethal bacterial infection 
 
INTRODUCTION 
IL-15 is a pleiotropic cytokine that regulates the development and 
maintenance of several subsets of innate lymphocytes, including γδ T, CD8αα T, 
NK and NKT cells (Ma et al., 2006). Furthermore, IL-15 signals the ontogeny, 
effector differentiation and Mcl-1-dependent survival of NK cells (Huntington et 
al., 2007). Moreover, thymic and peripheral NKT cells develop poorly in IL-15-
deficient (IL-150) mice (Matsuda et al., 2002). In the periphery, this is due to 
impaired NKT cell homeostatic proliferation (Matsuda et al., 2002). In the thymus, 
NKT cell proliferation appears intact, yet IL-150 mice develop a severe blockade 
in NKT cell ontogeny at ST2, with leaky progression to ST3 (Matsuda et al., 2002). 
What role IL-15 signals play during thymic NKT cell ontogeny and whether IL-15 
is essential for NKT cell functional maturation in the periphery remain unknown.  
Here we provide evidence that thymic and peripheral NKT cell survival 
critically depends on IL-15. One important downstream target of IL-15 appears to 
be Bcl-xL. Furthermore, we describe a new function for IL-15 by which it regulates 
ST2 to ST3 lineage progression and terminal NKT cell maturation, which is 
consistent with a role of T-bet in regulating ST2 to ST3 transition and terminal 
differentiation. Strikingly, IL15-dependent terminal maturation was essential for 
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mice to survive Francisella tularensis subsp. novicida (Ft novicida) and F. 
tularensis subsp. holartica-derived live vaccine strain (LVS) infection.   
 
RESULTS  
IL-15 induces Bcl-2 family survival factors within thymic but not peripheral 
NKT cells 
Previous reports demonstrated that NKT cell frequency is significantly lower 
in mice lacking IL-15 compared to wild type mice due to altered NKT cell 
homeostasis within the thymus and spleen (Kennedy et al., 2000; Matsuda et al., 
2002). Whilst IL-15 regulates proliferation of splenic NKT cells, its role in 
homeostasis of the thymic subset has remained unclear (Matsuda et al., 2002). A 
re-evaluation confirmed that NKT cell frequency was altered in the absence of IL-
15 and, hence, their numbers were reduced in the thymus, spleen and liver (Fig. 
3-1A). Likewise, in vivo BrdU incorporation experiments revealed that splenic but 
not thymic NKT cell proliferation was impaired in IL-150 mice (Fig. 3-1B). These 
data indicate that, in addition to its role in cell proliferation, IL-15 plays another 
role(s) during thymic NKT cell ontogeny.  
Previous studies have suggested that IL-15 induces anti-apoptotic Bcl-2 
family members, including Bcl-2, Bcl-xL and Mcl-1, to prevent apoptosis and to 
regulate homeostasis in vivo (Ma et al., 2006). For example, IL-15 promotes the 
survival of NK cells by inducing the survival factor Mcl-1 (Huntington et al., 2007). 
An examination of the expression of the Bcl-2 family of survival factors by flow 
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Figure 3-1. Defective NKT cell development and maintenance in IL-150 mice 
(A) Thymic, splenic and hepatic NKT cells from C57BL/6 (n=13) and B6-IL-150 
(n=9) mice were identified as CD3ε+tetramer+ cells within electronically gated 
CD8LO thymic, B220LO splenic or liver mononuclear cells (MNCs). Numbers are 
% NKT cells among total leukocytes within each organ. Data are representative 
of 9 independent experiments.  
(B) C57BL/6 and IL-150 mice were injected i.p. with 2 mg BrdU daily for three 
consecutive days and sacrificed one day later. BrdU incorporation was 
determined by flow cytometry after extracellular lineage specific staining and 
intracellular labeling with anti-BrdU Alexa-647 mAb. Overlaid histograms are of 
NKT cells identified as in A from vehicle (shaded) or BrdU injected (open) mice. 
The histograms show the expression levels of BrdU within NK1.1NEG (left) and 
NK1.1+ (Gadola et al., 2006a) NKT cells within the thymus and spleen. Data are 
representative of 3 independent experiments; n=6.  
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Figure 3-1, continued: Defective NKT cell development and maintenance in 
IL-150 mice 
 (C&D) Thymic and splenic MNCs from C57BL/6 and B6-IL-150 mice were 
assessed for intracellular expression of Bcl-2, Bcl-xL (C) and Mcl-1 (D), detected 
with specific mAb within electronically gated B220LOCD3ε+tetramer+ cells. 
Numbers refer to the difference in mean fluorescence intensity (ΔMFI) between 
isotype control (shaded) and specific mAb (open) staining. Data are 
representative of 3 independent experiments; n=5. The flow data were acquired 
on two different instruments (FACSCalibur and LSR-II) in different experiments. 
Though the actual mean fluorescence intensity varied, the represented trend 
remained the same. Therefore, we have chosen to represent the ratio of 
expression between wild type and IL-150 NKT cells. The ratio of Bcl-2, Bcl-xL and 
Mcl-1 expression by IL-150 and wild type NKT cells is shown. A ratio of ~1 
indicates no difference in expression; a ratio <1 indicates lower expression in IL-
150 NKT cells. 
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cytometry revealed that intracellular Bcl-2 expression was dramatically reduced 
in IL-150 thymic and splenic NKT cells (Fig. 3-1C). Although not as dramatic, 
intracellular Bcl-xL and Mcl-1 expression levels were also reduced either in 
thymic (Bcl-xL) or in both thymic and splenic (Mcl-1) IL-150 NKT cells when 
compared with wild type NKT cells (Fig. 3-1C,D).  
To test whether IL-15 induces survival factors in NKT cells, wild type 
thymocytes and splenocytes were cultivated in the absence or presence of 
exogenous rhIL-15 for 5 days and Bcl-2, Bcl-xL and Mcl-1 expression in fresh or 
cultivated NKT cells (with or without rhIL-15) was evaluated using flow cytometry. 
Both fresh NKT cells and those cultivated without rhIL-15 were included as 
controls because expression of these survival factors changes during the 5d 
culture. The data revealed that IL-15 up-regulated the expression of Bcl-2 and 
Bcl-xL but not Mcl-1 in thymic NKT cells to levels above those expressed by 
freshly isolated NKT cells (Fig. 3-2A,B). Very few NKT cells cultivated without IL-
15 expressed the three survival factors and, hence, when compared to this 
control, IL-15 also appeared to induce Mcl-1 expression in thymic NKT cells (Fig. 
3-2B). IL-15 also modestly induced Bcl-2 and Bcl-xL expression within splenic 
NKT cells but not to the levels found in freshly isolated NKT cells; their 
expression was above control NKT cells cultured in medium without rhIL-15 (Fig. 
3-2A,B). These data indicate that IL-15 has the potential to induce or maintain 
the expression of survival factors of the Bcl-2 family in thymic or splenic NKT 
cells, respectively, and, hence, to support NKT cell survival during development.  
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Figure 3-2. IL-15 up-regulates expression of the survival factors Bcl-2, Bcl-
xL, and Mcl-1 within thymic and splenic NKT cells 
Thymic and splenic MNCs from C57BL/6 mice were cultivated in vitro in the 
absence or presence of 100 ng/mL of rhIL-15. After 5 days, intracellular 
expression of (A) Bcl-2, Bcl-xL and (B) Mcl-1 was detected with specific mAb 
within electronically gated B220LOCD3ε+tetramer+ cells. Numbers refer to the 
difference in mean fluorescence intensity (ΔMFI) between isotype control 
(shaded) and specific mAb (open). Data are representative of 3 independent 
experiments, n=5. As for Figure 1, the flow data were acquired on two different 
instruments in different experiments. Hence, the ratio of IL-15-induced Bcl-2, Bcl-
xL and Mcl-1 expression NKT cells in comparison to un-stimulated, freshly 
isolated NKT cells is shown. A ratio of <1 indicates no induction; a ratio >1 
indicates IL-15-induced expression.   
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 Bcl-xL over expression in IL-150 mice supports NKT cell survival 
 
We took a genetic approach to further investigate the role of IL-15-induced 
genes in the survival of thymic and peripheral NKT cells. Thus, Bcl-2 and Bcl-xl 
transgenes were independently introgressed into IL-150 mice. Analysis of the 
resulting mice at age 6—8 wks, when thymic and splenic cellularity is similar 
between the different strains, revealed that enforced Bcl-xL but not Bcl-2 over 
expression rescued the frequency and absolute numbers of thymic, splenic and 
hepatic NKT cells in IL-150 mice (Fig. 2-3A,B).  
Because the Bcl2 (Igµ) and Bclxl (pLck) transgenes are under the control of 
different promoters (Chao et al., 1995; Strasser et al., 1991), we assessed the 
expression patterns of both transgenes within different thymocyte subsets. The 
data revealed that both transgenes were expressed as early as the CD4-8- 
double negative stage of development, through the DP stage, and within CD4 
and CD8 single positive thymocytes (Fig. 3-3C). Consistent with Bcl-2 expression 
during early thymocyte development, Bcl-2 transgene introgression into IL-7 
receptor-α null mice, which poorly if at all develop conventional T and NKT cells 
(Boesteanu et al., 1997; Peschon et al., 1994), rescued the development of both 
lineages (Fig. 3-3D). Therefore, the failure of Bcl-2 over expression to restore 
NKT cell numbers in IL-150 mice was not due to the lack of proper transgene 
expression or functionality, but most likely due to the fact that Bcl-2 plays a minor 
role when compared to Bcl-xL in conveying IL-15 signals for NKT cell survival. 
Together, the above data indicate that IL-15 relays specific, Bcl-xL-dependent 
survival signals during NKT cell ontogeny.  
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Figure 3-3. Bcl-xL over expression restores NKT cell development in IL-150 
mice  
(A) Thymic, splenic and hepatic NKT cells from C57BL/6 (n=8), B6-IL-150 (n=10), 
B6-IL-150;Bcl-2tg (n=6), and B6-IL-150;Bcl-xLtg (n=16) mice were identified as 
CD3ε+tetramer+ cells within electronically gated CD8LO thymic, B220LO splenic or
 
liver MNCs. Numbers are % NKT cells among total leukocytes.  
(B) Absolute numbers of NKT cells in the thymus and spleen of C57BL/6, B6-IL-
150, B6-IL-150;Bcl-2tg, and B6-IL-150;Bcl-xLtg mice were calculated from % NKT 
cells in A and total cell count. Data are representative of 6 independent 
experiments showing n, as in A. p value was calculated by one-way ANOVA with 
Tukey's post-test.  
(C) Intracellular expression of the hBcl-xL and hBcl-2 transgene within DN, DP, 
CD4+CD8NEG and CD8+CD4+ thymocytes of B6.C-Bcl-xLtg (right panels) and B6-
Bcl-2tg (left panels) mice. Over-laid histograms represent isotype control (shaded) 
and specific mAb (open). Data are representative of 3 independent experiments; 
n=5. 
 	   102	  
 
   
 
 
 
 
 
 
Figure 3-3, continued: Bcl-xL over expression restores NKT cell 
development in IL-150 mice  
(D) Thymic and splenic NKT cells from IL-7Rα+/- (n=3), IL-7Rα0 (n=3), IL-
7Rα0;Bcl-2tg (n=3) and IL-7Rα0;Bcl-xLtg (n=2) mice were identified as 
CD3ε+tetramer+ cells within electronically gated CD8LO thymocytes or B220LO 
splenocytes and liver MNCs. Numbers are % NKT cells among total leukocytes. 
Absolute NKT cell number was calculated from % NKT cells and total MNC 
number. Data are representative of 2 independent experiments. Note that 
because IL-7Rα0 thymic size is small due to low cellularity, % NKT cells appears 
artificially high despite extremely low NKT cell numbers. P value was calculated 
by one-way ANOVA with Tukey's post-test.  
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Figure 3-3, continued: Bcl-xL over expression restores NKT cell 
development in IL-150 mice  
(E) Intracellular expression of the hBcl-xL and hBcl-2 transgenes within NKT and 
NK cells of B6.C-Bcl-xLtg and B6-Bcl-2tg mice. Overlaid histograms represent 
isotype control (shaded) and specific mAb (open) staining. Data are 
representative of 2 independent experiments; n as in C. 
(F) Splenic and hepatic NK and NKT cells from C57BL/6 (n=6), B6-IL-150 (n=7), 
B6-IL-150;Bcl-2tg (n=4), and B6-IL-150;Bcl-xLtg (n=10) mice were identified as 
NK1.1+tetramerNEG and NK1.1+tetramer+ cells, respectively, within electronically 
gated B220LO splenic or hepatic MNCs. Data are representative of 4 independent 
experiments.  
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A previous study reported that IL-15-induced Mcl-1 specifically supported 
NK cell survival in vivo and in vitro (Huntington et al., 2007) and that over 
expression of Bcl-2 in mice lacking IL-2Rβ—the common β-chain of IL-2 and IL-
15 receptors—or in IL-150 mice repopulates NK cells in vivo (Minagawa et al., 
2002; Nakazato et al., 2007). Because NKT and NK cells are closely related 
innate lymphocyte lineages and because both lineages use IL-15 for survival, we 
ascertained whether IL-15 induces survival of the two cell types by similar 
mechanism(s). This question was addressed because Bcl-2 and Bcl-xL 
transgenes were expressed in NK cells from B6-Bcl-2tg and C-Bcl-xLtg mice (Fig. 
3-3E). We found that, as previously reported (Minagawa et al., 2002; Nakazato et 
al., 2007), Bcl-2 partially rescued hepatic but not splenic NK cells. Nonetheless, 
Bcl-xL over expression rescued NKT but not hepatic or splenic NK cells in IL-150 
mice (Fig. 3-3F), which is consistent with the reported model in which NK cells 
predominantly utilize Mcl-1 for IL-15-induced survival (Huntington et al., 2007). 
Thus, IL-15 appears to regulate survival of distinct lineages in a unique, cell type-
specific manner, with Bcl-xL serving as an IL-15-induced survival factor for NKT 
cells. 
Because Bcl-xL is required for DP thymocyte survival and Vα14 to Jα18 
rearrangement (Bezbradica et al., 2005), it is possible that IL-150 DP thymocytes 
poorly rearrange these distal gene segments, thereby resulting in low NKT cell 
numbers. To test this, Vα14 to Jα18 rearrangement within DP thymocytes flow 
sorted from wild type, IL-150, Jα180 and CD1dTD—which rearrange Vα14 to 
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Jα18 gene segments but are deficient in positive selection of NKT cells (Chiu et 
al., 2002) —mice was quantified. No defect in the canonical Vα14 to Jα18 
rearrangement was seen in IL-150 DP thymocytes (Fig. 3-4). Likewise, the more 
distal Vα8 to Jα5 rearrangement was also unaffected in IL-150 DP thymocytes as 
gauged by non-quantitative PCR (Fig. 3-4B). Interestingly, however, ~1.5-fold 
higher Vα14 to Jα18 rearrangement was observed in DP thymocytes of IL-
150;Bcl-xLtg mice (Fig. 3-4A), which was statistically insignificant. This result 
suggests that any increase in the initial pool of NKT cell precursors in DP 
thymocytes of IL-150;Bcl-xLtg mice less likely led to increased numbers of NKT 
cells in these mice.  
 
IL-15 regulates terminal maturation of NKT cells 
Because IL-15 deficiency reduced the numbers of thymic CD44+NK1.1- ST2 
and CD44+NK1.1+ ST3 NKT cells, and because forced Bcl-xL over expression in 
IL-150 mice rescued total thymic and peripheral NKT cell numbers (Fig. 3-3), 
whether IL-15 has additional roles in NKT cell ontogeny was ascertained. 
Therefore, we determined whether IL-15 regulates terminal maturation of 
developing NKT cells as well, particularly at ST3 where NKT cells acquire most of 
their NK cell-like effector functions. Thus, the phenotype of IL-150;Bcl-xLtg NKT 
cells was compared to wild type and IL-150 NKT cells. Surprisingly, akin to IL-150 
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Figure 3-4. Normal TCRα rearrangement in IL-150 mice  
(A) Vα14-to-Jα18 rearrangement within DP thymocytes flow sorted from the 
indicated strains was assessed by real-time qPCR represented as mean+sd of 2 
independent experiments. β-actin was used as the internal control for 
normalization. p value calculated by two-tailed, unpaired T-test indicated that 
Vα14-to-Jα18 rearrangement in C57BL/6, B6-IL-150 and B6-IL-150;Bcl-xLtg DP 
thymocytes was significant only when compared to that in B6-J180 DP cells. The 
~1.5-fold increased Vα14-to-Jα18 rearrangement seen in B6-IL-150;Bcl-xLtg DP 
thymocytes compared to the others was statistically insignificant (p <0.0997.  
(B) RT-PCR assessment of Vα8-to-Jα5 and Vα14-to-Jα18 rearrangements. Data 
are representative of 2 experiments.  
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NKT cells, phenotypic ST2 to ST3 transition, as measured by acquisition of the 
NK1.1 surface marker was still partially impaired in IL-150;Bcl-xLtg mice (Fig. 3-
5A,B), despite near wild type numbers of NKT cells in these mice. Additional 
phenotypic analyses revealed that expression patterns of few other mature NKT 
cell markers such as NKG2D, Ly6C, CD69, and Ly49C/I reflected those of thymic 
NKT cells that were blocked at ST2 (Fig. 3-5C) as these markers are 
predominantly expressed by NK1.1+ NKT cells (see Fig. 3-6A). Of those markers, 
the expression of Ly6C was also altered in hepatic, but not splenic NKT cells in 
IL-150 and IL-150;Bcl-xLtg mice (Fig. 3-5C). Thus, IL-15 is required not only for 
lineage survival but also for terminal maturation of NKT cells, especially of the 
thymic subset. Furthermore, the differential requirement for IL-15 in terminal 
differentiation (e.g., acquisition of Ly6C, NK1.1) of some (thymic and/or hepatic) 
but not all (splenic) NKT cells suggests that distinct signals instruct NKT cell 
maturation in distinct lymphoid organs.  
 
IL-15 regulates multiple gene expression changes during ST2 to ST3 NKT 
cell transition  
To define the mechanism by which IL-15 regulates terminal maturation of 
thymic NKT cells, microarray experiments were performed. For this, wild type 
and IL-150 thymic NKT cells were flow sorted, and the derived RNA was 
subjected to hybridisation to a mouse microarray chip containing 60,000 genes; 
hybridisation was performed in duplicate (IL-150) or triplicate (wild type). The 
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Figure 3-5. IL-15 regulates terminal maturation of NKT cells  
(A) NKT cell developmental stages in C57BL/6 (n=9), B6-IL-150 (n=6), and B6-IL-
150;Bcl-xLtg (n=13) mice were identified as CD44NEGNK1.1NEG ST1, 
CD44+NK1.1NEG ST2, or CD44+NK1.1+ ST3 in the thymus or as 
NK1.1NEGtetramer+ or NK1.1+tetramer+ within the splenic and hepatic MNCs. 
Numbers are % of cells among total NKT cells. Data are representative of 6 
independent experiments.  
(B) Absolute numbers of thymic NKT cells within ST1, ST2 and ST3 were 
calculated as in Fig. 3D. Data are representative of 6 independent experiments 
showing the n, same as in A. p value was calculated by one-way ANOVA with 
Tukey's post-test.  
 	   109	  
 
 
 
 
 
 
 
Figure 3-5 continued: IL-15 regulates terminal maturation of NKT cells 
(C) Expression of lineage-specific markers by thymic, splenic, and hepatic NKT 
cells from C57BL/6 (n=6), B6-IL-15
0
 (n=6), and B6-IL-15
0
;Bcl-xL
tg 
(n=6) mice as 
determined by flow cytometry after staining with specific mAb. Data are 
representative of 3 independent experiments.  
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 microarray data are available at GEO 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=dtgxpkoosiokmpm&acc=); 
accession number: GSE32568. Select genes differentially expressed (minimally 
log2 fold change >+1.5/<-1.5 and nominal P-value <0.001) in wild type and IL-150 
NKT cells (Fig 3-6A) were then validated by quantitative (q), real-time PCR. We 
found that Tbx21 (T-bet) was up-regulated in wild type NKT cells compared to IL-
150 NKT cells (Fig. 3-6A,B). This finding is consistent with the previously reported 
IL-15-induced Tbx21-encoded T-bet expression in NKT cells in vitro (Townsend 
et al., 2004). Furthermore, multiple Tbx21-regulated genes —such as Ifng, Gzma 
(granzyme A), Gzmc, Hopx (homeobox domain only containing protein x), and 
several NK cell receptor genes: Klra3 (NKG2E), Klrb1c (NK1.1), Klrc1 
(NKG2A/B), and Klrk1 (NKG2D) (Matsuda et al., 2006; Townsend et al., 2004)— 
were up-regulated in wild type thymic NKT cells, which predominantly consists of 
ST3 NKT cells (Fig 3-6B). Consistent with the lack of intracellular Bcl-2 in IL-150 
NKT cells (Fig. 3-1C), the Bcl2 gene was poorly expressed in these cells (Fig. 3-
6B). Conversely, Zbtb16 (PLZF), Tcf7 (TCF1) and Rorc (RORγt) genes, all 
signatures of ST1 and ST2 NKT cells were up-regulated in IL-150 thymic NKT cells 
(Fig. 3-6C), consistent with developmental arrest at ST2. Because T-bet is a 
critical regulator of differentiation in other lineages with cytotoxic properties (CTL 
and NK cells), our results are consistent with a role of Tbx21 in regulating ST2 to 
ST3 transition.  
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Figure 3-6. IL-15 induces Tbx21 and T-bet-regulated genes in developing 
NKT cells 
A. Cluster analysis of all genes differentially expressed in C57BL/6 (n=3) and IL-
150 (n=2) NKT cells a microarray experiment. Differential expression was defined 
as those genes that showed log2 fold change >1.5/<-1.5 with a nominal p value 
<0.001. The microarray data can be accessed at 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token= dtgxpkoosiokmpm&acc= 
using the accession number GSE32568.  
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Figure 3-6 continued: IL-15 induces Tbx21 and T-bet-regulated genes in 
developing NKT cells  
B&C. Select differentially expressed genes identified in A were validated by 
qPCR using RNA isolated from flow sorted C57BL/6 and B6-IL-150 mice. Genes 
up-regulated in B6-derived thymic NKT cells (B) and genes up-regulated in B6-
IL-150-derived NKT cells (C) are shown. β-actin was used to normalise 
expression levels. Data represent mean+sd of 2 independent experiments; each 
qPCR was performed in duplicate for an n value of 4 to calculate the p value by 
unpaired T test.   
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IL-15 regulates functional maturation of NKT cells 
 
Terminally mature NKT cells produce the highest amounts of effector 
cytokines. Because phenotypically this subset of NKT cells appears impaired in 
IL-150 and IL-150;Bcl-xLtg mice, we determined whether they were functionally 
competent. For this purpose, the potent NKT cell ligand αGalCer (Kawano et al., 
1997) was administered i.p. into IL-15+/-, IL-150 and IL-150;Bcl-xLtg mice and 4 hrs 
later, intracellular and serum IL-4 and IFN-γ responses were monitored. 
Compared to IL-15+/- mice, significantly fewer splenic and hepatic NKT cells from 
IL-150 and IL-150;Bcl-xLtg mice expressed intracellular IL-4 and IFN-γ in response 
to in vivo stimulation (Fig. 3-7A,B). Furthermore, NKT cells that expressed IL-4 
(splenic) and IFN-γ (splenic and hepatic) in IL-150 and IL-150;Bcl-xLtg mice, 
expressed these cytokines at significantly lower levels compared to those in IL-
15+/- mice (Fig. 3-7A,B). Consistent with this expression pattern, the serum IFN-γ 
and IL-4 responses were also poor in IL-150 and IL-150;Bcl-xLtg mice compared to 
their IL-15+/- counterparts (Fig. 3-7C,D). Thus, IL-15 signalling is required for fully 
competent NKT cell responses in vivo.   
IFN-γ and IL-4 responses by NKT cells require transcriptional regulation by 
T-bet and Gata-3 (Cen et al., 2009; Wang et al., 2006). T-bet is also required for 
the terminal maturation of thymic NKT cells, as T-bet deficiency blocked NKT cell 
ontogeny at the ST2 to ST3 transition (Townsend et al., 2004), similar to that seen 
with IL-15 deficiency (Fig. 3-5). Because Tbx21 expression is reduced in IL-150 
NKT cells and IL-15 induces Tbx21 expression in NK cells in vitro (Townsend et 
al., 2004), we investigated whether impaired NKT cell function in IL-150 and
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Figure 3-7. IL-15 regulates functional maturation of NKT cells  
A&B. C57BL/6 (n=6), B6-IL-150 (n=6), and B6-IL-150;Bcl-xLtg (n=12) mice were 
injected i.p. with 5 µg αGalCer (open) or vehicle (shaded). After 4 hrs, splenic (A) 
and hepatic (B) B220LOCD3ε+tetramer+ cells were electronically gated and 
intracellular IL-4 and IFN-γ expression was monitored. Numbers refer to ΔMFI. 
Data are representative of 4 independent experiments.  
C&D. Using ELISA, serum IFN-γ (C) and IL-4 (D) responses to in vivo NKT cell 
stimulation in the above experiment were measured. p value was calculated by 
one-way ANOVA with Tukey's post-test.  
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Figure 3-7 continued: IL-15 regulates functional maturation of NKT cells 
E&F. Thymic and splenic MNCs from C57BL/6 and B6-IL-150 mice were 
analyzed for intracellular T-bet (E) and Gata-3 (F) expression within electronically 
gated CD8LOCD3ε+tetramer0 thymocytes or B220LOCD3ε+tetramer+ splenocytes. 
Numbers refer to the ΔMFI between isotype control (shaded) and specific mAb 
(open). Data are representative of 2 independent experiments; n=5.  
(G) The ratio of T-bet and Gata-3 expression by IL-150 and wild type NKT cells is 
shown. A ratio of ~1 (e.g., Gata-3) indicates no difference in expression; a ratio 
<1 (e.g., T-bet) indicates lower expression in IL-150 NKT cells.   
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 IL-150;Bcl-xLtg mice was due to altered levels of T-bet and Gata-3 expression. 
For this, thymic and splenic NK1.1- and NK1.1+ NKT cells from wild type and IL-
150 mice were probed for intracellular expression of T-bet and Gata-3. We found 
that the level of T-bet expression was reduced by 30% (splenic) to 50% (thymic) 
in IL-150 compared to wild type NKT cells (Fig. 3-7E,G). Additionally, a slightly 
reduced percentage of thymic, but not splenic, NKT cells expressed T-bet in IL-
150 mice. Similarly, intracellular Gata-3 expression was ~15—20% lower in 
thymic and splenic NK1.1- NKT cells but about similar in NK1.1+ NKT cells of IL-
150 mice compared to their wild type counterparts (Fig. 3-7F,G), consistent with 
somewhat more preserved IL-4 production in IL-150 NKT cells when compared to 
IFN-γ response. In wild type NKT cells, Gata-3 expression level was constant, 
whilst T-bet levels increased with ST3 differentiation (Fig. 3-7G). Hence, the 
reduced T-bet expression (Fig. 3-7E) in IL-150 mice is consistent with reduced 
ST3 NKT cells in these mice. Thus, IL-15 signals are partially required for T-bet 
and Gata-3 expression in NKT cells and, possibly, for the robust IFN-γ and IL-4 
cytokine responses seen in wild type but not in IL-150 and IL-150;Bcl-xLtg mice.   
 
IL15-dependent NKT cell effector maturation is essential to survive lethal F. 
tularensis infection   
If, as shown above, IL-15 deficiency results in a block in the development of 
functional NKT cells, IL-150 mice should be more susceptible to microbial 
infection that depends on NKT cells for protection. Francisella tularensis (Ft) 
subspecies tularensis—the causative agent of lethal tularaemia in humans—is a 
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Gram-negative bacterium that is easily bio-weaponized. IFN-γ and TNF-α are 
critical for protective, sterilizing immunity against Ft. Previously, the human live 
vaccine strain (LVS) derived from Ft spp. holarctica was shown to stimulate IFN-γ 
from CD3+NK1.1+ NKT cells (Fuller et al., 2006). Significantly, in pilot 
experiments, we found that both Ft novicida and LVS activated NKT cells and 
induced intracellular IFN-γ expression (Gilchuk,P., Spencer,C.T. and Joyce, S. 
unpublished data).  
IL-150 mice inoculated with either Ft novicida or LVS did indeed show a 
survival defect compared with wild type animals (Fig. 3-8A). As IL-15 deficiency 
also suppresses the development of NK cells—a major component of the innate 
response against microbes—Jα180 mice, which specifically lack NKT but not NK 
cells, were similarly inoculated with these bacteria. IL-150 mice yielded an almost 
identical survival curve as Jα180 animals, suggesting that the susceptibility of IL-
150 mice to Ft novicida and LVS was due to the lack of functional NKT cells. 
 Infection of mice with other pathogens, such as Sphingomonas and 
Ehrlichia, results in a NKT cell-dependent release of cytokines including IFN-γ 
and protection from death (Kinjo et al., 2005; Mattner et al., 2005). To determine 
the role of NKT cells in protecting mice against lethal Ft novicida and LVS 
infection, the serum levels of three proinflammatory cytokines previously known 
to be critical for the control of Ft infection—IFN-γ, TNF-α and IL-6—was 
determined. We found that many more Jα180 and IL-150 mice secreted copious 
amounts of proinflammatory cytokines such as IFN-γ, TNF-α and IL-6 (Fig. 3-8B). 
This finding is consistent with the increased susceptibility of many more Jα180 
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Figure 3-8. NKT cells are essential for tempering lethal disease caused by 
Francisella infection  
(A) Kaplan-Meier plots detail the survival of C57BL/6 (n=14—15), B6-Jα180 
(n=13—15) and B6-IL-150 (n=7—10) inoculated with 1 LD50 Ft spp. novicida (left) 
or LVS (Gadola et al.). Significance values were calculated by Mantel-Cox 
comparison of individual survival curves (*p<0.04; **p<0.004).  
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Figure 3-8, continued: NKT cells are essential for tempering lethal disease 
caused by Francisella infection 
(B) Serum cytokine levels were measured by CBA assay and plotted according 
to whether the animals survived (solid symbols) or succumbed (open symbols) to 
the infection.   
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and IL-150 mice to infection when compared to wild type controls (Fig 3-8). 
Conversely, more wild type mice succeeded in tempering this cytokine storm and 
consequently survived the infection (Fig. 3-8). Taken together these data suggest 
that mice lacking NKT cells (Jα180) or even just lacking the terminally 
differentiated st3 NKT cells (IL-150) are unable to control runaway inflammation 
and, hence, succumb to Ft novicida and LVS infection.    
 
DISCUSSION   
We describe three unique features of IL-15 that are essential for functional 
NKT cell development: One, it induces survival of thymic and peripheral NKT 
cells by regulating Bcl-xL and Bcl-2 expression. Two, IL-15 regulates T-bet 
expression and signals ST3 NKT cell induction and differentiation. And three, it 
regulates effector differentiation that is consistent with the role of T-bet in this 
process. Fully differentiated functional NKT cells are essential for tempering 
runaway inflammation caused by F. tularensis infection. Thus, IL-15 plays a 
central role in NKT cell development and function.   
It appears as though NKT cells narrowly escape death at each stage of their 
development: Immediately after positive selection they turn-on Nur77 expression  
in ST0 NKT cells (Moran et al., 2011), perhaps owing to high avidity interactions 
with their cognate ligand, viz., CD1d-self lipid complexes, addressed in Chapter 
II. In T cells, the transcription factor Nur77, in addition to inducing an apoptotic 
program, when targeted to the mitochondrion binds to the otherwise anti-
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apoptotic factor Bcl-2, and by changing its conformation, converts it into a pro-
apoptotic protein (Thompson et al., 2010). Therefore, onward development of 
NKT cells perhaps requires survival signal(s) to protect the lineage from death. 
We have identified one such survival signal to be IL-15. It induces both Bcl-2 and 
Bcl-xL within thymic NKT cells in vitro. Yet, only genetic overexpression of Bcl-xL 
but not Bcl-2 confers survival potential to ST1 and ST2, but not ST3, NKT cells. 
These data are consistent with a previous report showing that enforced Bcl-2 
expression does not rescue NKT cell development in IL-15Rβ-null mice 
(Minagawa et al., 2002). A recent report suggested that forced Bcl-2 
overexpression or introgression of Bim-deficiency modestly rescues NKT cell 
development in the IL-15-presenting IL-15Rα-null mice (Chang et al., 2011a). 
The differences in survival mechanisms in these three animal models currently 
remain unknown.   
The global gene expression analysis of wild type and IL-15-deficient NKT 
cells, as well as our published data (Stanic et al., 2004a), indicate that ST3 but 
not ST0—2 NKT cells express high levels of Bcl-2. Hence, it is possible that Bcl-2 
functions as an important survival factor only upon commitment and development 
into ST3 NKT cells. Because the ST3 NKT cells are absent in IL-15-, IL-15Rα- and 
IL-15Rβ-null mice, another factor must be necessary to support NKT cell survival 
up to this stage. Our data suggest Bcl-xL provides that function. The failure of 
transgenic Bcl-2 to do so in this study perhaps reflects the need for an IL-15-
induced, ST3-specific accessory factor to execute its function.  
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Previous studies have demonstrated that thymic and peripheral NKT cells 
represent distinct functional subsets (Berzins et al., 2006; McNab et al., 2005; 
McNab et al., 2007). The factor(s) that impacts differentiation of these two 
subsets remained incompletely defined. We found that most thymic NKT cells in 
IL-150;Bcl-xLtg mice were blocked at the ST2-to-ST3 ontogenetic transition and 
lacked activation/memory marker expression as were IL-150 NKT cells. In striking 
contrast, splenic and hepatic NKT cells in IL-150 and IL-150;Bcl-xLtg mice 
underwent almost complete phenotypic maturation, suggesting that 
developmental cues in the thymus and periphery are somewhat distinct. In 
contrast, gene expression analyses indicated reduced T-bet expression in both 
thymic and splenic NKT cells of IL-150 mice. T-bet was previously shown to 
regulate the ST2-to-ST3 NKT ontogenetic transition (Matsuda et al., 2006; 
Townsend et al., 2004). Thus, reduced T-bet expression is consistent with the 
ST2-to-ST3 developmental block in IL-150 NKT cells. Furthermore, low levels of T-
bet may in part explain the poor expression of NK cell receptors as well as the 
deficiency in ST3-specific IFN-γ response in IL-150 mice. Taken together, we 
conclude that IL-15 differentially impacts central and peripheral NKT cell 
maturation in vivo.  
It is noteworthy that T-bet belongs to a group of transcription factors whose 
functions are regulated not only by their presence or absence but also by 
absolute levels. An example of such regulation is seen in effector CD8 T cell fate 
determination via graded expression of T-bet (Joshi et al., 2007). Differentiation 
into effector and memory CD8 T cell fates was dictated by the levels of T-bet, 
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where high T-bet expression induced an effector cell fate, whilst lower T-bet level 
directed cells into the memory pool. Such a model would in principle be 
consistent with a past report (Chang et al., 2011a) and ours suggesting that 
partially reduced levels of T-bet expression in IL-150 mice could indeed 
significantly impair the NKT cell differentiation programme. Finally, because T-bet 
regulates expression of IL-15/IL-2Rβ (CD122) on NKT cells (this report and 
Matsuda et al., 2006), and therefore IL-15 responsiveness, the two factors (IL-15 
and T-bet) generate a positive feedback regulatory loop. The property of all such 
loops is that small changes in gene expression are amplified by self-sustained 
and self-amplified system oscillation. Therefore, we predict that the reduced but 
not the complete absence of T-bet observed in IL-150 NKT cells may be sufficient 
to prevent complete effector differentiation.   
The importance of NKT cell function(s) is implicated in multiple infectious 
diseases. However, their role is poorly defined. Because NKT cells acquire most 
of their NK cell-like properties at the last ST3 stage of their differentiation, and 
because IL-15 seems to regulate acquisition of these properties, we speculated 
that IL-15-encoded NKT cell functions are important in controlling in vivo 
responses to infections. IL-150 mice, which have deficits in NKT cell effector 
differentiation, provide a model to ascertain how NKT cells regulate immunity to 
infectious diseases. This study revealed that protection from the mouse and 
human pathogen Ft novicida and LVS, respectively, critically depended on NKT 
cells in general and on IL-15-regulated NKT cell functions in particular. Thus, 
many more IL-150 mice than wild type mice succumbed to both F. tularensis 
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infections owing to defective NKT cell effector differentiation. Further analyses 
revealed that all the mice that succumbed to F. tularensis infection also secreted 
very high proinflammatory serum cytokines. Because the bacterial load in the 
lung and liver of IL-150 mice was not higher than wild type animals (Spencer, 
C.T., and Joyce, S., unpublished data), we conclude that NKT cells play very little 
role in regulating bacterial clearance but play a critical role in tempering runaway 
inflammation caused by F. tularensis infection and/or increasing host tolerance to 
an on-going inflammation. This will be an exciting area for future investigations.  
In conclusion, IL-15 functions by supporting survival of developing NKT cells 
and perhaps by inducing Tbx21 expression as an ST3-specific differentiation 
factor in NKT cells. NKT cells share this feature with NK cells and T cells, and 
are expected to collaborate with these lineages in executing Tbx21-induced 
functions in vivo. Fully mature NKT cells function to temper runaway 
inflammation caused by certain bacterial infections that cause lethal disease in 
humans.  
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CHAPTER IV 
 
CONCLUSION AND FUTURE DIRECTIONS 
 
NKT cells develop in the thymus from common precursors that give rise to 
conventional T cells. Commitment to the NKT cell lineage occurs at the DP 
stage where their ontogenetic program diverges from that of conventional CD4 
and CD8 T cells (Bezbradica et al., 2005; Egawa et al., 2005). Soon after 
commitment, NKT cells are positively selected by interactions with DP 
thymocytes through the semi-invariant TCR and CD1d-self lipid ligand(s) 
(Bendelac et al., 1995; Xu et al., 2003). It is currently thought that positive 
selection alone sculpts the semi-invariant NKT cell repertoire. Nonetheless, 
several groups have reported that negative selection can also contribute to the 
development of a function NKT cell repertoire (Chun et al., 2003; Pellicci et al., 
2003). These conclusions were predicated on indirect experimental approaches 
to evaluate the role of positive and negative selection processes in sculpting the 
NKT cell repertoire. And as such, the question had remained whether NKT cell 
precursors underwent negative selection and what impact this process had on 
NKT cell biology. Shortly after the selection process, this lineage undergoes a 
series of progressive maturation steps that culminate in effector differentiation. 
The signals and how they are integrated during NKT cell effector differentiation 
had remained ill-defined. I have answered these two critical questions in NKT 
cell biology in an effort to advance the field.   
 	   126	  
To directly address whether NKT cells undergo negative selection, I re-
generated and then investigated a previously described mouse model in which 
thymocytes are forced to undergo negative selection. In this model, Nur77, 
which is induced transiently in wild type thymocytes undergoing negative 
selection, is expressed constitutively as a transgene within developing T cells 
such that signalling through the TCR results in apoptotic cell death (Calnan et 
al., 1995). I chose this model because a prior study from our group found that 
Nur77 was expressed in a subset of immature ST0 
(CD24HICD44NEGNK1.1NEG)/ST1 (CD44NEGNK1.1NEG) NKT cells which were 
particularly enriched in NF κB signalling deficient mice due to their failure to 
induce survival signal and therefore progress further through the ontogeny. As a 
consequence, the thymus, spleen and liver of these mice did not contain NKT 
cells (Stanic et al., 2004a). Investigations of many strains of mice that I 
generated during the course of this study revealed the role for Nur77 in negative 
selection of NKT cells. The most compelling evidence that NKT cells undergo 
negative selection came when I introgressed a fully rearranged Vα14Jα18 
transgene into the Nur77tg mouse. The doubly transgenic mice developed very 
few NKT cells compared to Vα14Jα18 TCR transgenic mice. Those few 
escapees NKT cells that developed in the doubly transgenic mice were arrested 
at the CD44NEGNK1.1NEG stage (ST0/1) although some had progressed to the 
CD44NEGNK1.1NEG (ST2) and relatively fewer to the CD44NEGNK1.1NEG (ST3) 
stages. 
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In additional studies using another mouse model in which thymocytes were 
protected from negative selection, I addressed the impact of negative selection 
on NKT cell biology. These studies involving the mutant Nur77ΔNtg mice 
revealed differences in NKTCR repertoire and function. Nonetheless, the 
observed differences were subtle and, hence, these findings did not conclusively 
reveal a significant impact of negative selection on NKT cell biology, at least not 
as tested using currently known NKT cell antigens. I propose that the unique, 
rearranged TCR β-chain genes be cloned from wild type and Nur77ΔNtg mice. 
When introduced into wild type mice, TCR β-chain genes isolated from 
Nur77ΔNtg mice would be expected to undergo negative selection; hence, NKT 
cells bearing the introduced TCR β-chain will not develop. In contrast, the same 
TCR β-chain when introduced into Nur77ΔNtg mice will generate NKT cells 
expressing that TCR. If they do, then the functional consequence of expressing 
the NKTCR that would otherwise be negatively selected in wild type mice can be 
interrogated. Such questions as,  
a. whether novel NKT cell agonists are recognized by the Nur77ΔNtg NKT cells; 
b.  whether the novel NKT cells confer protective advantage to microbial or 
parasitic pathogens; and  
c. whether the new mouse strain develops autoimmune diseases and, if so, 
which organs are affected?  
should be interrogated.  
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 The most significant advance I made is related to understanding what 
cytokine signals induce NKT cell effector differentiation and how these signals 
are integrated to instruct this process. Our group had previously demonstrated 
that IL-15-deficient mice poorly developed mature ST3 (CD44HINK1.1+) T cells in 
the thymus (Kennedy et al., 2000). Studies from other groups had indicated that 
IL-15-deficient peripheral, splenic and hepatic NKT cells had proliferative defects 
and, hence, affected NKT cell homeostasis in the peripheral lymphoid organs 
(Chang et al., 2011a; Matsuda et al., 2002; Ranson et al., 2003; Wu et al., 
2008). The role of IL-15 in the thymus had remained undefined, however. Thus I 
discovered that the introgression of the human Bcl-xL transgene into the IL-15-
null mice increased NKT cell frequency and number in the thymus and the 
periphery. This result indicated that IL-15 provides a survival signal to 
developing NKT cells. How this survival signal(s) is relayed within NKT cell, and 
who delivers it, currently remains undefined. The survival issue is an important 
question in NKT cell biology because both their selection and peripheral 
functions are driven by the recognition of self lipid ligands, which would normally 
in other cell lineages (B or T) result in elimination of auto-reactive clones. 
Reports from several groups, including ours, have indicated that NKT cells 
narrowly escape death at multiple stages reviewed by (Bendelac et al., 2007). 
Elucidating the underlying survival signalling processes will reveal how the 
immune system protects the host from autoimmune diseases while at the same 
time uses this border-line autoreactivity to defend it from infectious diseases and 
chronic inflammation.  
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Most interestingly however, the NKT cells that arose in IL-150;Bcl-xL mice 
were immature in that they were developmentally blocked between 
CD44HINK1.1NEG ST2 to CD44HINK1.1+ ST3 transition. This result indicated that IL-
15 played additional roles, beyond just survival, in NKT cell development. To 
understand the underlying ontogenetic defect, I investigated the gene 
expression program in wild type and IL-150 NKT cells. From this line of 
investigation, I discovered several key steps in NKT cell differentiation program. 
I found that the transcription factor gene Tbx21 was poorly expressed in IL-150 
NKT cells. This result was consistent with the reduced T-bet protein expression 
within peripheral IL-150 NKT cells. T-bet was previously shown to regulate NKT 
cell maturation; a deficiency in this transcription factor also blocked NKT cell 
development at ST2, i.e., at the same stage where NKT cell development was 
arrested in IL-15-null mice (Matsuda et al., 2007; Matsuda et al., 2006; 
Townsend et al., 2004). Furthermore, IL-15 null NKT cells poorly transcribed 
their Ifng locus, a locus that is transcriptionally regulated by T-bet. Consistent 
with this finding, IL-150 NKT cells poorly, if at all, responded to its cognate 
ligand, CD1d-αGalCer, in vivo. Gene expression analyses revealed defects in 
additional T-bet regulated genes that encode proteins that mediate NKT cell 
effector functions. These included Gzma, Gzmc, Hopx, and Krl(a,b,c,k) that were 
down regulated in IL-15-deficient NKT cells (Figure 4-1).  
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Figure 4-1. Gene regulatory network  
Model for gene regulatory network functioning during NKT cell maturation, based 
upon gene expression analysis. IL-15 induces Tbx21 expression and its 
downstream target genes Hopx, Ifng, Gzm(a,b,c), Klr(a,b,c,k) (solid lines). and 
may regulate proposed targets (dashed lines). During NKT cell development 
NKTCR mediated signals are important for the upregulation of genes such as 
Tcf7, Il17, Zbtb16, and Nur77. Yet expression of Zbtb16 is reduced in mature 
NKT cells and Tcf7 is known to repress expression of effector molecules 
(granzyme A and B, and Klrg1) found in mature NKT cells. While Tbet functions 
as activator of gene expression, it can work in combination with other factors as 
a repressor. Thus, we propose that Tbx21, which is critical for NKT cell 
maturation, may directly or indirectly repress expression of Tcf7 and Zbtb16. 
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On the other hand, transcription factors such as Tcf7 (encoding T cell factor 
7), Rorc (encoding RORγt) and Zbtb16 (encoding PLZF), which are expressed 
by immature ST0—ST2 NKT cells, were abundant in IL-15-null NKT cells and 
conversely were poorly expressed in wild type NKT cells, indicating perhaps the 
enrichment of these stages in developmentally arrested IL15-null NKT cells. 	  
These data confirmed that IL-15 signalling was critical for functional maturation 
of NKT cells. The IL-15 signal is thus integrated and relayed into the nucleus to 
induce Tbx21 expression (amongst other genes) whose product in turn 
regulated the expression of multiple genes encoding effector molecules 
including IFN-γ, granzyme B and NK cell receptors (Figure 4-1). 
 Finally, the data emerging from the global gene expression analysis as 
described above lent to a draft gene regulatory network that specifies 
ontogenetic progression and effector differentiation of NKT cells (Figure 4-1). 
This draft gene regulatory network provides a framework to direct further studies 
on NKT cell lineage progression and effector differentiation. Questions of 
significant interest include,  
a. Elucidation of the mechanism(s) underlying IL-15 signal integration and how 
it is relayed to the nucleus; especially whether this mechanism is distinct 
from conventional T cells and NK cells or similar to one or the other lineage.  
b. How are NKT cell lineage specific transcription factors switched on and off as 
development progresses from immature to mature stages: Does IL-15-
induced Tbx21 expression in combination with other transcription factor(s) or 
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switch off Zbtb16 expression with the help of repressor(s)? In this regard it is 
noteworthy that T-bet in combination with Bcl-6 can act as a repressor 
(Oestreich et al., 2011) in conventional T cells and is thought to regulate 
effector differentiation in CD4 T cells. Conversely, BLIMP-1 can repress 
Tbx21 thereby attenuating Th1 differentiation (Cimmino et al., 2008). 
Similarly, it is possible that T-bet represses Tcf-7 expression to induce the 
expression of effector genes as they mature to ST3 NKT cells as Tcf-7 is 
known to repress granzyme A and B, perforin and Klrg1 gene expression in 
CD8+ T cells (Zhou et al., 2010). 
 
SUMMARY 
During NKT cell ontogeny, the integration of numerous developmental 
signals dictate the subtype and function of the developing cells. This thesis 
explored the role of negative selection in sculpting a functional NKT cell 
repertoire; and the role of IL-15 in NKT cell effector differentiation and 
homeostasis. I found that NKT cells undergo Nur77 mediated negative selection 
during development. I found that positive selection precedes negative selection 
during NKT cell development, and hence plays a major role in shaping global 
NKT cell Vβ repertoire. This repertoire is then further fine-tuned, particularly 
within CDR region during negative selection presumably to eliminate highest 
auto-reactive clones. Additionally I found that IL-15 functions by supporting 
survival of developing thymic NKT cells and is necessary for complete maturation 
perhaps by inducing T-bet expression as a ST3-specific differentiation factor in 
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NKT cells. NKT cells play key roles in regulating immune responses in health and 
disease. What ligands NKT cells recognize and how they respond to those 
ligands is determined by the signals that shape the NKTCR repertoire and its 
functional maturation. Thus, my findings provide important new insights into NKT 
cell ontogeny and have implications for NKT cell mediated immune responses. 
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CHAPTER V 
 
MATERIALS AND METHODS 
 
Mice  
The mouse strains used in this study and their sources are listed in Table 4-1. 
B6-IL-150, B6.129-IL-7α0, B6-J180, B6-Vα14tg, B6.129-CD1dTD mice and B6-
Nur77tg (Bendelac et al., 1996; Boesteanu et al., 1997; Calnan et al., 1995; Chiu 
et al., 2002; Cui et al., 1997; Kennedy et al., 2000) were generous gifts from J. 
Peschon (Immunex), M. Taniguchi (RIKEN, Japan), A. Bendelac (U Chicago), 
and A. Winoto (UC Berkley), respectively. B6-IL-150 and B6.129-IL-7Rα0 mice 
were bred with B6-Eµ36-Bcl-2tg (Strasser et al., 1991) and C-Lck-Bcl-xLtg (Chao 
et al., 1995) mice. B6.C-IL-150;Bcl-xLtg mice were backcrossed to B6-IL-150 mice 
for 6 generations. C57BL/6 and B6-TCR-Hytg were purchased from the Jackson 
Laboratory (Bar Harbor, Maine) and Taconic respectively. B6-Nur77ΔNtg were 
generated by the Vanderbilt Transgenic Mouse facility, which injected Nur77ΔNtg 
plasmid DNA into B6 pronucleus generating transgenic founder mice. Founders 
were bred to C57BL/6 and 3 founder lines were identified with germline 
transmission. B6-Nur77ΔNtg mice were bred with Jα180 and TCR-Hytg mice. B6-
Nur77tg mice were bred with Vα14tg mice. All mouse crosses and experiments 
were performed under approved by Institutional Animal Care and Use Committee 
protocols. 
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Table 4-1. Mouse strains used in this study 
Mouse strain Source/Reference 
C57BL/6 The Jackson Laboratory 
B6.129-Jα180 (Cui et al., 1997) 
B6.129CD1dTD (Chiu et al., 2002) 
B6-Vα14tg (Bendelac et al., 1996)  
B6-Eµ36-Bcl-2tg The Jackson Laboratory 
C-Lck-Bcl-xLtg The Jackson Laboratory 
B6-IL-150 (Kennedy et al., 2000) 
B6.C-IL150;Eµ36-Bcl-2tg This study 
B6.C-IL150;Bcl-xLtg This study 
B6.129-IL-7Rα0 
(Boesteanu et al., 1997; Peschon et al., 
1994)  
B6.129-IL-7Rα0;Eµ36-Bcl-2tg This study 
B6.129-IL-7Rα0;Bcl-xLtg This study 
B6-Nur77tg (Calnan et al., 1995) 
B6-Nur77tg;Bcl-xLtg This study 
B6-Nur77ΔNtg;Vα14tg This study 
B6-Nur77ΔNtg This study  
B6-TCR-HYtg Taconic 
B6-Nur77ΔNtg;TCR-HYtg This study 
B6-Nur77ΔNtg;CD1dTDKI  This study 
B6-Nur77ΔNtg;Jα180 This study 
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Antibodies and Reagents   
All antibodies used for the identification of NKT cells were from BD Pharmingen 
as described (Bezbradica et al., 2006b). Anti-BrdU-Alexa-647 (PRB-1; 
Invitrogen), anti-human Bcl-xL-PE and IgG3 isotype control-PE (7B25 and B10; 
Southern Biotech), anti-mouse Bcl-2-PE (3F11) and Armenian hamster IgG1κ 
isotype control-PE (A19-3), anti-human Bcl-2-PE (6C8) and Armenian hamster 
IgG2λ isotype control-PE (Ha4/8), anti-Mcl-1 rabbit polyclonal (Rockland), 
chicken anti-rabbit-Alexa-647 (Invitrogen), anti-T-bet-Alexa-647 (eBio4B10; 
eBiosciences) and mouse IgG1 isotype control-Alexa-647 (P3; eBioscience), 
anti-Gata-3-Alexa-647 (L50-823) and mouse IgG1κ isotype control-Alexa-647 
(MOPC-21), anti-PLZF (D-9, Santa Cruz), mouse IgG1 isotype control 
(eBioscience), anti-mouse IgG-FITC (eBiosciences), and TCR Vβ Screening 
Panel-FITC (BD Pharmingen) antibodies were purchased. α-galactosylceramide 
(αGalCer; KRN7000) was generously provided by Kirin Brewery Company 
(Gunma, Japan) or purchased from Funakoshi Co. Ltd. (Tokyo, Japan). Mouse 
αGalCer-loaded CD1d monomers were obtained from the NIH Tetramer Facility 
(Emory University). Preparation of αGalCer-loaded CD1d tetramer from 
monomer and their use are described elsewhere (Bezbradica et al., 2006b).  
 
 
 
 	   137	  
Flow Cytometry   
Antibodies and staining procedures for the identification of NKT cells were as 
described elsewhere (Bezbradica et al., 2006b). NKT cells were identified as 
CD3ε+tetramer+ cells among B220LO splenocytes and hepatic mononuclear cells 
or CD8LO thymocytes. Four-color flow cytometry was performed with a 
FACSCalibur instrument (Becton-Dickinson) whilst seven-color flow cytometry 
was performed with a LSR-II instrument (Becton-Dickinson). Data were analyzed 
with FlowJo software (Treestar Inc.). Absolute NKT cell numbers were calculated 
from % tetramer+ cells and total number of cells recovered from each organ.  
 
Ex Vivo Stimulation of Thymocytes and Splenocytes with IL-15   
Thymocytes and splenocytes were stimulated in vitro with 100 ng/ml recombinant 
human (rh) IL-15 (Miltenyi) for 5 days. Cells were then collected and stained with 
specific mAb for intracellular expression of Bcl-2, Bcl-xL, and Mcl-1.  
 
Intracellular Flow Cytometry   
Cells were fixed and permeabilized with cytofix/cytoperm solution for intracellular 
staining or with cytofix/cytoperm plus (both from BD Pharmingen) for intra-
nuclear BrdU staining according to the manufacturer’s protocol. Staining for 
intracellular IFN-γ and IL-4 also used GolgiStop (BD Pharmingen). Staining for 
intracellular T-bet, Gata-3, and PLZF used “Foxp3 staining buffer kit” 
(eBioscience). Intra-cellular and intra-nuclear staining was performed according 
to the manufacturer’s protocol. 
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Thymocyte sorting 
Thymic NKT cells were enriched by magnetic sorting using a Pan-T cell isolation 
kit in combination with CD8 beads (Miltenyi) as instructed by the manufacturer. 
Enriched NKT cells from 5—10 mice were pooled and further purified by flow 
sorting CD3ε+tetramer+ cells (FACSAria; Becton-Dickinson). CD4 and CD8 
double positive (DP) thymocytes were flow sorted as above. Freshly purified NKT 
cells and DP thymocytes were >98% pure as judged by CD3ε+tetramer+ and 
CD4/CD8 specific staining (data not shown).  
 
RNA preparation, microarray hybridization and analyses 
Freshly purified NKT cells were washed and lysed by passage through a 
Qiashedder column (Qiagen). Total RNA was extracted per the manufacturer’s 
instructions (RNeasy, Qiagen). RNA yield was quantified spectrophotometrically 
(Nanodrop ND-1000) and aliquots electrophoresed to determine sample purity 
and concentration (Agilent 2100 Bioanalyzer). Microarray hybridizations were 
performed using One-colour hybridization on SurePrint G3 Mouse GE 60K 
Microarray (Agilent) by the Functional Genomics and Shared Resources Core 
(Vanderbilt University). Scanning was performed using a GenePix® 4000B 
Microarray Scanner (Molecular Devices). The resulting images were processed 
with Agilent Feature Extraction software to generate raw probe intensity data, 
which was subsequently normalised by the quantile method (Bolstad et al., 
2003). Differential expression analysis was carried out with an empirical Bayes 
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approach on linear model using limma package (Smyth, 2004, 2005). In this 
study, we defined differentially expressed genes as those whose log2 fold change 
values were > +1.5 or > -1.5 and whose nominal P-values were less than 0.001 
(Huang, 2011). Next we performed hierarchical clustering of the differentially 
expressed genes using the R AMAP Package (http://cran.r-
project.org/web/packages/amap/). The microarray data are available at GEO 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=dtgxpkoosiokmpm&acc=); 
accession number: GSE32568. 
 
Real time quantitative PCR 
RNA was reverse transcribed with MuLV RT Reverse Transcriptase (Applied 
Biosystems) according to manufacturer’s protocol. qPCR was performed in the 
presence of IQ RealTime Sybr Green PCR Supermix and target gene-specific 
primers (Table 5-2) in an iQ5 thermocycler (Biorad). qPCR for Nur77 and β-actin 
was performed in the presence Taqman Universal Mastermix II and Nur77 
(4331182) and β-actin (4331182) Taqman probe sets (Invitrogen) in an iQ5 
thermocycler (Biorad). Results were analyzed using iQ5 software. Data were first 
normalized against β-actin control. As the CT values are obtained as log2 values, 
the normalised delta CT values of wild type samples were subtracted from 
normalised delta CT values of IL150 or Nur77ΔNtg samples. The resulting log2 
delta delta CT values were transformed yielding relative expression, which 
enabled comparison between cells isolated from the two strains. For this, IL150  
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Table 5-2. qPCR primer pairs used to validate gene expression data 
Gene Forward primer Reverse primer 
T-bet CCGCGCGAGGACTACGCATT CTTGCCGCTCTGGTACCGCC 
HOPX CCACGCTGTGCCTCATCGCA GGCCTGGCTCCCTAGTCCGT 
NKG2E GCATCTGAAGGCCAGCAGGCA AGATCCATTCCTTTGGACAAAGAGC 
GZMA TGACTGCTGCCCACTGTAACG CGGCATCTGGTTCCTGGTTTCACA 
GZMC GTTGGTGGGAAGAAGATGTTCTGC GATGTTGTGAGCCCCCAGTGTGA 
NK1.1 GCCCACAAGACTGGCTTTTACACCGAG GTCTGAAGCACAGCTCTCAGGAGTCAC 
NKG2A CGAAGCAAAGGCACAGATCAATTCC GCTGACCTCTGCCCTTCCGAAG 
NKG2D AGCAAATGGCTCCTGGCAGTGG ACACCGCCCTTTTCATGCAGAT 
NKRP1A TGCCAGACATGAACTGGAAGTGGA TGGCAGATCCAACGGTTGTCTGA 
IL4RA ACCAGATGGAACTGTGGGCTGA AGCAGCCATTCGTCGGACACAT 
CD160 GGACCTACCAGTGCTGTGCCAGA TGGCTGAAGTCAGGGTGTGACC 
IFN-γ CCTTCTTCAGCAACAGCAAGGCGAA GCAACAGCTGGTGGACCACTCG 
Ly6c1 CCTCTGATGGATTCTGCATTGCTC GCTGCAACAGGAAGTCCTCTCCCT 
Bcl-2 CAGGGAGATGTCACCCCTGGTGG CAGAGTGATGCAGGCCCCGACC 
PLZF TGCGGTGCCCAGTTCTCAAAGG TGGGGAAGGTGCGGTTGCAC 
Tcf7 CCTGCGGATATAGACAGCACTTC TGTCCAGGTACACCAGATCCCA 
RORC GTGGAGTTTGCCAAGCGGCTTT CCTGCACATTCTGACTAGGACG 
IRF4 GAACGAGGAGAAGAGCGTCTTC GTAGGAGGATCTGGCTTGTCGA 
ACTB CATTGCTGACAGGATGCAGAAGG TGCTGGAAGGTGGACAGTGAGG 
Vα14-
Jα18 
AGGTCTTGTGTCCCTGACAG CAGGTATGACAATCAGCTGAGTCC 
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sample, called the Calibrator was set to 1, and relative expression calculated as 
fold change in gene expression in wild type cells relative to the Calibrator.  
 
TCRα re-arrangement  
cDNA was prepared from total RNA isolated from DP thymocytes. qPCR for 
Vα14 to Jα18 rearrangement was performed as described above using the 
following forward (F) and reverse (R) primers: Vα14F (5'-AGGTCTTGTGTCCCTG-
ACAG-3'), Jα18R (5'-CAGGTATGACAATCAGCTGAGTCC-3'), Vα8F (5'-TCACA-
GACAACAAGAGGACC-3'), and Jα5R (5'-AGTGAGCTGCCCCACAACCT-3'). 
PCR products were separated by agarose gel electrophoresis and visualized by 
ethidium bromide staining. Alternatively, RNA was obtained from C57BL/6, 
Nur77tg and Jα18ko thymocytes per the manufacturer’s instructions (RNeasy; 
Qiagen) and reverse transcribed using protocol described above. PCR reaction 
was performed using Vα3, Vα14 and Jα18 specific primers (Table 5-3) with 30 
amplification cycles. PCR products were separated by agarose gel 
electrophoresis and visualized by ethidium bromide staining. 
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Table 5-3. PCR primers for Vβ-gene specific amplification and sequencing 
Gene 
name Forward primer 
Vβ2 TACAGACCCCACAGTGACTTTGC 
Vβ6 CCCTCCAAACTATGAACAAGTGG 
Vβ7 GAACAGGCCTGGTGGACATGAAAG 
Vβ8 CAAAACACATGGAGGCTGCAGTCA 
Vβ9 CAGCCACTTTTGTGGATACTACGG 
Vβ10 TTCCTATTGGTACAAGCAAGACTCT 
Vβ11 GAGCAGAACCAACAAATGTGGTG 
Vβ13 AGATCTATGGGCTCCAGGCTCTTCTTCGTGCTC 
Vβ15 GTGGAACTTCCATGAGGATGGAGT 
Vβ17 AGATCTGAATGGATCCTAGACTTCTTTGCTGTGTG 
Cβ GGGTGGAGTCACATTTCTCAGATC 
Vα3 CCCAGTGGTTCAAGGAGTGA 
Vα14 AGGTCTTGTGTCCCTGACAG 
Jα18 CAGGTATGACAATCAGCTGAGTCC 
pJET1.2-
for CGACTCACTATAGGGAGAGCGGC 
pJET1.2-
rev AAGAACATCGATTTTCCATGGCAG 
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Statistics  
Comparisons of normally distributed continuous data were performed by one-way 
ANOVA with Tukey’s post test to determine significance. The significance of 
gene expression analyzed by qPCR was determined by unpaired T test. 
Statistical significance of Vα14-Jα18 rearrangement by qPCR was calculated by 
two-tailed, unpaired T-test. Comparisons were performed using GraphPad 
(Prism).    
 
Cytokine Responses   
Individual, age (6—10 weeks old)-matched mice were either injected i.p. with 5 
µg αGalCer or vehicle (0.1% Tween-20 in PBS). After 2, 4, or 6 hrs, serum, 
splenocytes and hepatic mononuclear cells were prepared. Cells were stained 
with anti-CD3ε mAb, tetramer and anti-IFN-γ or anti-IL-4 mAb and analyzed by 
flow cytometry.  
 
Ft novicida and LVS Growth and Mouse Infection 
Frozen aliquots of Ft novicida and LVS were inoculated in triplicate into 35 ml LB 
broth and grown for 12 hrs at 37°C with 250 rpm agitation. Cultures were pooled 
and the density determined to be 3x109 and 9x109 cfu/ml, respectively, for Ft 
novicida and LVS. Bacteria were serially diluted into sterile PBS and an aliquot 
was plated to calculate the injected dose. Mice were injected with 50 µl diluted 
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bacteria (~68,000 cfu Ft novicida or ~106 cfu LVS) i.d. on the right dorsal region. 
Blood collection was performed by retroorbital bleed (d0, 1, 3 and 5 post-
inoculation) or cardiac puncture for terminal bleeds. Animals were monitored 
daily for weight loss and multiple times daily for progression of disease. Animals 
losing more than 20% of their initial body weight were humanely euthanized. 
Kaplan-Meier plots detail the survival of animals following infection. The indicated 
significance values were calculated by Mantel-Cox comparison of individual 
survival curves. Serum cytokine levels were determined by cytokine bead array 
(CBA) assay using mouse Th1, Th2, Th17 cytokine kit (BD Bioscience) according 
to the manufacturer’s instructions. 
 
Hybridoma stimulation 
All Vα14+ mouse NKT hybridomas N38-3C3, N37-1H5a, N38-2C12, and Vα14- 
mouse hybridoma N37-1A12 have been described (Bezbradica et al., 2006b; 
Stanic et al., 2003). 5x105 sorted double positive thymocytes were cultured 
overnight with 5x104 hybridomas. Cell-free supernatant was harvested and IL-2 
secreted during co-culture was determined by ELISA. 
 
 Analysis of TCR CDR3β sequence diversity 
Freshly purified NKT cells obtained from C57BL/6 and Nur77DN mice were 
washed and lysed by passage through a Qiashedder column (Qiagen). Total 
RNA was extracted per the manufacturer’s instructions (RNeasy; Qiagen). RNA 
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yield was quantified spectrophotometrically (Nanodrop ND-1000). RNA was 
reverse transcribed with MuLV RT Reverse Transcriptase (Applied Biosystems) 
according to the manufacturer’s protocol. PCR was performed by using the cDNA 
template resulting from the above RT reaction using the V-gene specific forward 
primers and C-gene specific primer (Table 5-3). PCR products were separated 
by agarose gel electrophoresis, purified from gel and cloned into sequencing 
vector pJET1.2. Nucleotide sequences of TCR were determined by Sanger 
sequencing using pJET1.2 vector specific primers (Table 5-3). Analysis of TCR 
CDR3 structure, variable (V), diverse (D) and joining (J) segment usage and the 
functionality of the whole V-gene sequences was performed using IMGT/V-
QUEST program (www.imgt.org/IMGT_vquest/share/textes/). Sequencing was 
performed by the Vanderbilt DNA Sequencing Facility. 
 
Ex Vivo Stimulation of Splenocytes with Lipids 
Splenocytes were stimulated in vitro with titrating doses of αGalCer , 100 ng/ml 
OCH or 10 µg/ml of αGalDAG, iGb3, Sulfatide, PtdCho, PtdIno or PtdEtN for 5 
days. Sandwich ELISA was performed as described (Bezbradica et al., 2006b) to 
monitor supernatant IFNγ response. 
 
 	   146	  
REFERENCES 
 
Akbari, O., Stock, P., Meyer, E.H., Freeman, G.J., Sharpe, A.H., Umetsu, D.T., 
and DeKruyff, R.H. (2008). ICOS/ICOSL interaction is required for CD4+ 
invariant NKT cell function and homeostatic survival. J Immunol 180, 5448-
5456. 
 
Alberola-Ila, J., Hogquist, K.A., Swan, K.A., Bevan, M.J., and Perlmutter, R.M. 
(1996). Positive and negative selection invoke distinct signaling pathways. J 
Exp Med 184, 9-18. 
 
Albu, D.I., Feng, D., Bhattacharya, D., Jenkins, N.A., Copeland, N.G., Liu, P., 
and Avram, D. (2007). BCL11B is required for positive selection and survival of 
double-positive thymocytes. J Exp Med 204, 3003-3015. 
 
Albu, D.I., VanValkenburgh, J., Morin, N., Califano, D., Jenkins, N.A., Copeland, 
N.G., Liu, P., and Avram, D. (2011). Transcription factor Bcl11b controls 
selection of invariant natural killer T-cells by regulating glycolipid presentation 
in double-positive thymocytes. Proc Natl Acad Sci U S A 108, 6211-6216. 
 
Aliahmad, P., and Kaye, J. (2008). Development of all CD4 T lineages requires 
nuclear factor TOX. J Exp Med 205, 245-256. 
 
Allende, M.L., Zhou, D., Kalkofen, D.N., Benhamed, S., Tuymetova, G., 
Borowski, C., Bendelac, A., and Proia, R.L. (2008). S1P1 receptor expression 
regulates emergence of NKT cells in peripheral tissues. FASEB J 22, 307-315. 
 
Alonzo, E.S., Gottschalk, R.A., Das, J., Egawa, T., Hobbs, R.M., Pandolfi, P.P., 
Pereira, P., Nichols, K.E., Koretzky, G.A., Jordan, M.S., and Sant'Angelo, D.B. 
(2010). Development of promyelocytic zinc finger and ThPOK-expressing 
innate gamma delta T cells is controlled by strength of TCR signaling and Id3. 
J Immunol 184, 1268-1279. 
 
Arase, H., Arase, N., Nakagawa, K., Good, R.A., and Onoe, K. (1993). NK1.1+ 
CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol 23, 
307-310. 
 
Arase, H., Arase, N., Ogasawara, K., Good, R.A., and Onoe, K. (1992). An 
NK1.1+ CD4+8- single-positive thymocyte subpopulation that expresses a 
highly skewed T-cell antigen receptor V beta family. Proc Natl Acad Sci U S A 
89, 6506-6510. 
 
Arrenberg, P., Halder, R., Dai, Y., Maricic, I., and Kumar, V. (2010). 
Oligoclonality and innate-like features in the TCR repertoire of type II NKT 
 	   147	  
cells reactive to a beta-linked self-glycolipid. Proc Natl Acad Sci U S A 107, 
10984-10989. 
 
Astrakhan, A., Ochs, H.D., and Rawlings, D.J. (2009). Wiskott-Aldrich syndrome 
protein is required for homeostasis and function of invariant NKT cells. J 
Immunol 182, 7370-7380. 
 
Bain, G., Engel, I., Robanus Maandag, E.C., te Riele, H.P., Voland, J.R., Sharp, 
L.L., Chun, J., Huey, B., Pinkel, D., and Murre, C. (1997). E2A deficiency leads 
to abnormalities in alphabeta T-cell development and to rapid development of 
T-cell lymphomas. Mol Cell Biol 17, 4782-4791. 
 
Bendelac, A. (1995). Positive selection of mouse NK1+ T cells by CD1-
expressing cortical thymocytes. J Exp Med 182, 2091-2096. 
 
Bendelac, A., Hunziker, R.D., and Lantz, O. (1996). Increased interleukin 4 and 
immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J 
Exp Med 184, 1285-1293. 
 
Bendelac, A., Killeen, N., Littman, D.R., and Schwartz, R.H. (1994). A subset of 
CD4+ thymocytes selected by MHC class I molecules. Science 263, 1774-
1778. 
 
Bendelac, A., Lantz, O., Quimby, M.E., Yewdell, J.W., Bennink, J.R., and 
Brutkiewicz, R.R. (1995). CD1 recognition by mouse NK1+ T lymphocytes. 
Science 268, 863-865. 
 
Bendelac, A., Matzinger, P., Seder, R.A., Paul, W.E., and Schwartz, R.H. (1992). 
Activation events during thymic selection. J Exp Med 175, 731-742. 
 
Bendelac, A., Savage, P.B., and Teyton, L. (2007). The biology of NKT cells. 
Annu Rev Immunol 25, 297-336. 
 
Benlagha, K., Kyin, T., Beavis, A., Teyton, L., and Bendelac, A. (2002). A thymic 
precursor to the NK T cell lineage. Science 296, 553-555. 
 
Benlagha, K., Wei, D.G., Veiga, J., Teyton, L., and Bendelac, A. (2005). 
Characterization of the early stages of thymic NKT cell development. J Exp 
Med 202, 485-492. 
 
Berzins, S.P., McNab, F.W., Jones, C.M., Smyth, M.J., and Godfrey, D.I. (2006). 
Long-term retention of mature NK1.1+ NKT cells in the thymus. J Immunol 
176, 4059-4065. 
 
Bezbradica, J.S., Gordy, L.E., Stanic, A.K., Dragovic, S., Hill, T., Hawiger, J., 
Unutmaz, D., Van Kaer, L., and Joyce, S. (2006a). Granulocyte-macrophage 
 	   148	  
colony-stimulating factor regulates effector differentiation of invariant natural 
killer T cells during thymic ontogeny. Immunity 25, 487-497. 
 
Bezbradica, J.S., Hill, T., Stanic, A.K., Van Kaer, L., and Joyce, S. (2005). 
Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ 
stage of thymic ontogeny. Proc Natl Acad Sci U S A 102, 5114-5119. 
 
Bezbradica, J.S., Stanic, A.K., and Joyce, S. (2006b). Characterization and 
functional analysis of mouse invariant natural T (iNKT) cells. Curr Protoc 
Immunol Chapter 14, Unit 14 13. 
 
Bilenki, L., Wang, S., Yang, J., Fan, Y., Joyee, A.G., and Yang, X. (2005). NK T 
cell activation promotes Chlamydia trachomatis infection in vivo. J Immunol 
175, 3197-3206. 
 
Boesteanu, A., De Silva, A.D., Nakajima, H., Leonard, W.J., Peschon, J.J., and 
Joyce, S. (1997). Distinct roles for signals relayed through the common 
cytokine receptor γ chain and interleukin 7 receptor α chain in natural T cell 
development. J Exp Med 186, 331-336. 
 
Bolstad, B.M., Irizarry, R.A., Astrand, M., and Speed, T.P. (2003). A comparison 
of normalization methods for high density oligonucleotide array data based on 
variance and bias. Bioinformatics 19, 185-193. 
 
Boos, M.D., Yokota, Y., Eberl, G., and Kee, B.L. (2007). Mature natural killer cell 
and lymphoid tissue-inducing cell development requires Id2-mediated 
suppression of E protein activity. J Exp Med 204, 1119-1130. 
 
Borg, N.A., Kjer-Nielsen, L., McCluskey, J., and Rossjohn, J. (2007a). Structural 
insight into natural killer T cell receptor recognition of CD1d. Adv Exp Med Biol 
598, 20-34. 
 
Borg, N.A., Wun, K.S., Kjer-Nielsen, L., Wilce, M.C., Pellicci, D.G., Koh, R., 
Besra, G.S., Bharadwaj, M., Godfrey, D.I., McCluskey, J., and Rossjohn, J. 
(2007b). CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell 
receptor. Nature 448, 44-49. 
 
Brennan, P.J., Tatituri, R.V., Brigl, M., Kim, E.Y., Tuli, A., Sanderson, J.P., 
Gadola, S.D., Hsu, F.F., Besra, G.S., and Brenner, M.B. (2011). Invariant 
natural killer T cells recognize lipid self antigen induced by microbial danger 
signals. Nat Immunol 12, 1202-1211. 
 
Brigl, M., and Brenner, M.B. (2010). How invariant natural killer T cells respond to 
infection by recognizing microbial or endogenous lipid antigens. Semin 
Immunol 22, 79-86. 
 
 	   149	  
Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E., and Brenner, M.B. (2003). 
Mechanism of CD1d-restricted natural killer T cell activation during microbial 
infection. Nat Immunol 4, 1230-1237. 
 
Calnan, B.J., Szychowski, S., Chan, F.K., Cado, D., and Winoto, A. (1995). A 
role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-
induced negative selection. Immunity 3, 273-282. 
 
Cannarile, M.A., Lind, N.A., Rivera, R., Sheridan, A.D., Camfield, K.A., Wu, B.B., 
Cheung, K.P., Ding, Z., and Goldrath, A.W. (2006). Transcriptional regulator 
Id2 mediates CD8+ T cell immunity. Nat Immunol 7, 1317-1325. 
 
Cannons, J.L., Yu, L.J., Hill, B., Mijares, L.A., Dombroski, D., Nichols, K.E., 
Antonellis, A., Koretzky, G.A., Gardner, K., and Schwartzberg, P.L. (2004). 
SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-
kappaB1. Immunity 21, 693-706. 
 
Carnaud, C., Lee, D., Donnars, O., Park, S.H., Beavis, A., Koezuka, Y., and 
Bendelac, A. (1999). Cutting edge: Cross-talk between cells of the innate 
immune system: NKT cells rapidly activate NK cells. J Immunol 163, 4647-
4650. 
 
Cen, O., Ueda, A., Guzman, L., Jain, J., Bassiri, H., Nichols, K.E., and Stein, P.L. 
(2009). The adaptor molecule signaling lymphocytic activation molecule-
associated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 
14 transgenic NKT cells via effects on GATA-3 and T-bet expression. J 
Immunol 182, 1370-1378. 
 
Cernadas, M., Sugita, M., van der Wel, N., Cao, X., Gumperz, J.E., Maltsev, S., 
Besra, G.S., Behar, S.M., Peters, P.J., and Brenner, M.B. (2003). Lysosomal 
localization of murine CD1d mediated by AP-3 is necessary for NK T cell 
development. J Immunol 171, 4149-4155. 
 
Chang, C.L., Lai, Y.G., Hou, M.S., Huang, P.L., and Liao, N.S. (2011a). IL-15Rα 
of radiation-resistant cells Is necessary and sufficient for thymic invariant NKT 
cell survival and functional maturation. J Immunol 187, 1235-1242. 
 
Chang, P.P., Barral, P., Fitch, J., Pratama, A., Ma, C.S., Kallies, A., Hogan, J.J., 
Cerundolo, V., Tangye, S.G., Bittman, R., et al. (2012). Identification of Bcl-6-
dependent follicular helper NKT cells that provide cognate help for B cell 
responses. Nat Immunol 13, 35-43. 
 
Chang, W.S., Kim, J.Y., Kim, Y.J., Kim, Y.S., Lee, J.M., Azuma, M., Yagita, H., 
and Kang, C.Y. (2008). Cutting edge: Programmed death-1/programmed 
death ligand 1 interaction regulates the induction and maintenance of invariant 
NKT cell anergy. J Immunol 181, 6707-6710. 
 	   150	  
 
Chang, Y.J., Kim, H.Y., Albacker, L.A., Lee, H.H., Baumgarth, N., Akira, S., 
Savage, P.B., Endo, S., Yamamura, T., Maaskant, J., et al. (2011b). Influenza 
infection in suckling mice expands an NKT cell subset that protects against 
airway hyperreactivity. J Clin Invest 121, 57-69. 
 
Chao, D.T., Linette, G.P., Boise, L.H., White, L.S., Thompson, C.B., and 
Korsmeyer, S.J. (1995). Bcl-XL and Bcl-2 repress a common pathway of cell 
death. J Exp Med 182, 821-828. 
 
Cheng, L.E., Chan, F.K., Cado, D., and Winoto, A. (1997). Functional 
redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell 
apoptosis. EMBO J 16, 1865-1875. 
 
Chiba, A., Dascher, C.C., Besra, G.S., and Brenner, M.B. (2008). Rapid NKT cell 
responses are self-terminating during the course of microbial infection. J 
Immunol 181, 2292-2302. 
 
Chiu, Y.H., Jayawardena, J., Weiss, A., Lee, D., Park, S.H., Dautry-Varsat, A., 
and Bendelac, A. (1999). Distinct subsets of CD1d-restricted T cells recognize 
self-antigens loaded in different cellular compartments. J Exp Med 189, 103-
110. 
 
Chiu, Y.H., Park, S.H., Benlagha, K., Forestier, C., Jayawardena-Wolf, J., 
Savage, P.B., Teyton, L., and Bendelac, A. (2002). Multiple defects in antigen 
presentation and T cell development by mice expressing cytoplasmic tail-
truncated CD1d. Nat Immunol 3, 55-60. 
 
Choi, H.J., Geng, Y., Cho, H., Li, S., Giri, P.K., Felio, K., and Wang, C.R. (2011). 
Differential requirements for the Ets transcription factor Elf-1 in the 
development of NKT cells and NK cells. Blood 117, 1880-1887. 
 
Chun, T., Page, M.J., Gapin, L., Matsuda, J.L., Xu, H., Nguyen, H., Kang, H.S., 
Stanic, A.K., Joyce, S., Koltun, W.A., et al. (2003). CD1d-expressing dendritic 
cells but not thymic epithelial cells can mediate negative selection of NKT 
cells. J Exp Med 197, 907-918. 
 
Chung, B., Aoukaty, A., Dutz, J., Terhorst, C., and Tan, R. (2005). Signaling 
lymphocytic activation molecule-associated protein controls NKT cell functions. 
J Immunol 174, 3153-3157. 
 
Cimmino, L., Martins, G.A., Liao, J., Magnusdottir, E., Grunig, G., Perez, R.K., 
and Calame, K.L. (2008). Blimp-1 attenuates Th1 differentiation by repression 
of ifng, tbx21, and bcl6 gene expression. J Immunol 181, 2338-2347. 
 
 	   151	  
Coles, M.C., and Raulet, D.H. (2000). NK1.1+ T cells in the liver arise in the 
thymus and are selected by interactions with class I molecules on CD4+CD8+ 
cells. J Immunol 164, 2412-2418. 
 
Coquet, J.M., Chakravarti, S., Kyparissoudis, K., McNab, F.W., Pitt, L.A., 
McKenzie, B.S., Berzins, S.P., Smyth, M.J., and Godfrey, D.I. (2008). Diverse 
cytokine production by NKT cell subsets and identification of an IL-17-
producing CD4-NK1.1- NKT cell population. Proc Natl Acad Sci U S A 105, 
11287-11292. 
 
Crowe, N.Y., Coquet, J.M., Berzins, S.P., Kyparissoudis, K., Keating, R., Pellicci, 
D.G., Hayakawa, Y., Godfrey, D.I., and Smyth, M.J. (2005). Differential 
antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 202, 
1279-1288. 
 
Crowe, N.Y., Uldrich, A.P., Kyparissoudis, K., Hammond, K.J., Hayakawa, Y., 
Sidobre, S., Keating, R., Kronenberg, M., Smyth, M.J., and Godfrey, D.I. 
(2003). Glycolipid antigen drives rapid expansion and sustained cytokine 
production by NK T cells. J Immunol 171, 4020-4027. 
 
Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, 
H., Kanno, M., and Taniguchi, M. (1997). Requirement for Vα14 NKT cells in 
IL-12-mediated rejection of tumors. Science 278, 1623-1626. 
 
D'Cruz, L.M., Knell, J., Fujimoto, J.K., and Goldrath, A.W. (2010). An essential 
role for the transcription factor HEB in thymocyte survival, Tcra rearrangement 
and the development of natural killer T cells. Nat Immunol 11, 240-249. 
 
Das, R., Sant'Angelo, D.B., and Nichols, K.E. (2010). Transcriptional control of 
invariant NKT cell development. Immunol Rev 238, 195-215. 
 
De Silva, A.D., Park, J.J., Matsuki, N., Stanic, A.K., Brutkiewicz, R.R., Medof, 
M.E., and Joyce, S. (2002). Lipid protein interactions: the assembly of CD1d1 
with cellular phospholipids occurs in the endoplasmic reticulum. J Immunol 
168, 723-733. 
 
Devera, T.S., Shah, H.B., Lang, G.A., and Lang, M.L. (2008). Glycolipid-activated 
NKT cells support the induction of persistent plasma cell responses and 
antibody titers. Eur J Immunol 38, 1001-1011. 
 
Dhodapkar, M.V., Geller, M.D., Chang, D.H., Shimizu, K., Fujii, S., Dhodapkar, 
K.M., and Krasovsky, J. (2003). A reversible defect in natural killer T cell 
function characterizes the progression of premalignant to malignant multiple 
myeloma. J Exp Med 197, 1667-1676. 
 
 	   152	  
Diana, J., and Lehuen, A. (2009). NKT cells: friend or foe during viral infections? 
Eur J Immunol 39, 3283-3291. 
 
Diao, H., Iwabuchi, K., Li, L., Onoe, K., Van Kaer, L., Kon, S., Saito, Y., 
Morimoto, J., Denhardt, D.T., Rittling, S., and Uede, T. (2008). Osteopontin 
regulates development and function of invariant natural killer T cells. Proc Natl 
Acad Sci U S A 105, 15884-15889. 
 
Doisne, J.M., Bartholin, L., Yan, K.P., Garcia, C.N., Duarte, N., Le Luduec, J.B., 
Vincent, D., Cyprian, F., Horvat, B., Martel, S., et al. (2009a). iNKT cell 
development is orchestrated by different branches of TGF-beta signaling. J 
Exp Med 206, 1365-1378. 
 
Doisne, J.M., Becourt, C., Amniai, L., Duarte, N., Le Luduec, J.B., Eberl, G., and 
Benlagha, K. (2009b). Skin and peripheral lymph node invariant NKT cells are 
mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond 
preferentially under inflammatory conditions. J Immunol 183, 2142-2149. 
 
Dose, M., Khan, I., Guo, Z., Kovalovsky, D., Krueger, A., von Boehmer, H., 
Khazaie, K., and Gounari, F. (2006). c-Myc mediates pre-TCR-induced 
proliferation but not developmental progression. Blood 108, 2669-2677. 
 
Dose, M., Sleckman, B.P., Han, J., Bredemeyer, A.L., Bendelac, A., and 
Gounari, F. (2009). Intrathymic proliferation wave essential for Vα14+ natural 
killer T cell development depends on c-Myc. Proc Natl Acad Sci U S A 106, 
8641-8646. 
 
Duthie, M.S., Kahn, M., White, M., Kapur, R.P., and Kahn, S.J. (2005a). Both 
CD1d antigen presentation and interleukin-12 are required to activate natural 
killer T cells during Trypanosoma cruzi infection. Infect Immun 73, 1890-1894. 
 
Duthie, M.S., Kahn, M., White, M., Kapur, R.P., and Kahn, S.J. (2005b). Critical 
proinflammatory and anti-inflammatory functions of different subsets of CD1d-
restricted natural killer T cells during Trypanosoma cruzi infection. Infect 
Immun 73, 181-192. 
 
Eberl, G., Fehling, H.J., von Boehmer, H., and MacDonald, H.R. (1999a). 
Absolute requirement for the pre-T cell receptor alpha chain during NK1.1+ 
TCRalphabeta cell development. Eur J Immunol 29, 1966-1971. 
 
Eberl, G., Lowin-Kropf, B., and MacDonald, H.R. (1999b). NKT cell development 
is selectively impaired in Fyn- deficient mice. J Immunol (Cutting Edge) 163, 
4091-4094. 
 
 	   153	  
Eberl, G., and MacDonald, H.R. (1998). Rapid death and regeneration of NKT 
cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in 
NKT cell homeostasis. Immunity 9, 345-353. 
 
Eberl, G., and MacDonald, H.R. (2000). Selective induction of NK cell 
proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 30, 985-
992. 
 
Egawa, T., Eberl, G., Taniuchi, I., Benlagha, K., Geissmann, F., Hennighausen, 
L., Bendelac, A., and Littman, D.R. (2005). Genetic evidence supporting 
selection of the Valpha14i NKT cell lineage from double-positive thymocyte 
precursors. Immunity 22, 705-716. 
 
Elewaut, D., Lawton, A.P., Nagarajan, N.A., Maverakis, E., Khurana, A., Honing, 
S., Benedict, C.A., Sercarz, E., Bakke, O., Kronenberg, M., and Prigozy, T.I. 
(2003a). The adaptor protein AP-3 is required for CD1d-mediated antigen 
presentation of glycosphingolipids and development of Valpha14i NKT cells. J 
Exp Med 198, 1133-1146. 
 
Elewaut, D., Shaikh, R.B., Hammond, K.J., De Winter, H., Leishman, A.J., 
Sidobre, S., Turovskaya, O., Prigozy, T.I., Ma, L., Banks, T.A., et al. (2003b). 
NIK-dependent RelB activation defines a unique signaling pathway for the 
development of V alpha 14i NKT cells. J Exp Med 197, 1623-1633. 
 
Emoto, M., Mittrucker, H.W., Schmits, R., Mak, T.W., and Kaufmann, S.H. 
(1999). Critical role of leukocyte function-associated antigen-1 in liver 
accumulation of CD4+NKT cells. J Immunol 162, 5094-5098. 
 
Engel, I., Hammond, K., Sullivan, B.A., He, X., Taniuchi, I., Kappes, D., and 
Kronenberg, M. (2010). Co-receptor choice by V alpha14i NKT cells is driven 
by Th-POK expression rather than avoidance of CD8-mediated negative 
selection. J Exp Med 207, 1015-1029. 
 
Exley, M., Garcia, J., Balk, S.P., and Porcelli, S. (1997). Requirements for CD1d 
recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med 186, 
109-120. 
 
Exley, M.A., Lynch, L., Varghese, B., Nowak, M., Alatrakchi, N., and Balk, S.P. 
(2011). Developing understanding of the roles of CD1d-restricted T cell 
subsets in cancer: reversing tumor-induced defects. Clin Immunol 140, 184-
195. 
 
Faveeuw, C., Angeli, V., Fontaine, J., Maliszewski, C., Capron, A., Van Kaer, L., 
Moser, M., Capron, M., and Trottein, F. (2002). Antigen presentation by CD1d 
contributes to the amplification of Th2 responses to Schistosoma mansoni 
glycoconjugates in mice. J Immunol 169, 906-912. 
 	   154	  
 
Fedeli, M., Napolitano, A., Wong, M.P., Marcais, A., de Lalla, C., Colucci, F., 
Merkenschlager, M., Dellabona, P., and Casorati, G. (2009). Dicer-dependent 
microRNA pathway controls invariant NKT cell development. J Immunol 183, 
2506-2512. 
 
Felices, M., and Berg, L.J. (2008). The Tec kinases Itk and Rlk regulate NKT cell 
maturation, cytokine production, and survival. J Immunol 180, 3007-3018. 
 
Fischer, K., Scotet, E., Niemeyer, M., Koebernick, H., Zerrahn, J., Maillet, S., 
Hurwitz, R., Kursar, M., Bonneville, M., Kaufmann, S.H., and Schaible, U.E. 
(2004). Mycobacterial phosphatidylinositol mannoside is a natural antigen for 
CD1d-restricted T cells. Proc Natl Acad Sci U S A 101, 10685-10690. 
 
Florence, W.C., Xia, C., Gordy, L.E., Chen, W., Zhang, Y., Scott-Browne, J., 
Kinjo, Y., Yu, K.O., Keshipeddy, S., Pellicci, D.G., et al. (2009). Adaptability of 
the semi-invariant natural killer T-cell receptor towards structurally diverse 
CD1d-restricted ligands. EMBO J 28, 3579-3590. 
 
Fox, L.M., Cox, D.G., Lockridge, J.L., Wang, X., Chen, X., Scharf, L., Trott, D.L., 
Ndonye, R.M., Veerapen, N., Besra, G.S., et al. (2009). Recognition of lyso-
phospholipids by human natural killer T lymphocytes. PLoS Biol 7, e1000228. 
 
Franki, A.S., Van Beneden, K., Dewint, P., Hammond, K.J., Lambrecht, S., 
Leclercq, G., Kronenberg, M., Deforce, D., and Elewaut, D. (2006). A unique 
lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of 
V{alpha}14 invariant natural killer T cells. Proc Natl Acad Sci U S A 103, 9160-
9165. 
 
Fujii, S., Liu, K., Smith, C., Bonito, A.J., and Steinman, R.M. (2004). The linkage 
of innate to adaptive immunity via maturing dendritic cells in vivo requires 
CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J 
Exp Med 199, 1607-1618. 
 
Fujii, S., Shimizu, K., Smith, C., Bonifaz, L., and Steinman, R.M. (2003). 
Activation of natural killer T cells by alpha-galactosylceramide rapidly induces 
the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for 
combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp 
Med 198, 267-279. 
 
Fuller, C.L., Brittingham, K.C., Hepburn, M.J., Martin, J.W., Petitt, P.L., Pittman, 
P.R., and Bavari, S. (2006). Dominance of human innate immune responses in 
primary Francisella tularensis live vaccine strain vaccination. J Allergy Clin 
Immunol 117, 1186-1188. 
 
 	   155	  
Gadola, S.D., Koch, M., Marles-Wright, J., Lissin, N.M., Shepherd, D., Matulis, 
G., Harlos, K., Villiger, P.M., Stuart, D.I., Jakobsen, B.K., et al. (2006a). 
Structure and binding kinetics of three different human CD1d-alpha-
galactosylceramide-specific T cell receptors. J Exp Med 203, 699-710. 
 
Gadola, S.D., Silk, J.D., Jeans, A., Illarionov, P.A., Salio, M., Besra, G.S., Dwek, 
R., Butters, T.D., Platt, F.M., and Cerundolo, V. (2006b). Impaired selection of 
invariant natural killer T cells in diverse mouse models of glycosphingolipid 
lysosomal storage diseases. J Exp Med 203, 2293-2303. 
 
Gadue, P., Morton, N., and Stein, P.L. (1999). The Src family tyrosine kinase Fyn 
regulates natural killer T cell development. J Exp Med 190, 1189-1196. 
 
Gadue, P., and Stein, P.L. (2002). NK T cell precursors exhibit differential 
cytokine regulation and require Itk for efficient maturation. J Immunol 169, 
2397-2406. 
 
Gapin, L., Matsuda, J.L., Surh, C.D., and Kronenberg, M. (2001). NKT cells 
derive from double-positive thymocytes that are positively selected by CD1d. 
Nat Immunol 2, 971-978. 
 
Geissmann, F., Cameron, T.O., Sidobre, S., Manlongat, N., Kronenberg, M., 
Briskin, M.J., Dustin, M.L., and Littman, D.R. (2005). Intravascular immune 
surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3, 
e113. 
 
Germanov, E., Veinotte, L., Cullen, R., Chamberlain, E., Butcher, E.C., and 
Johnston, B. (2008). Critical role for the chemokine receptor CXCR6 in 
homeostasis and activation of CD1d-restricted NKT cells. J Immunol 181, 81-
91. 
 
Godfrey, D.I., and Berzins, S.P. (2007). Control points in NKT-cell development. 
Nat Rev Immunol 7, 505-518. 
 
Godfrey, D.I., Stankovic, S., and Baxter, A.G. (2010). Raising the NKT cell family. 
Nat Immunol 11, 197-206. 
 
Griewank, K., Borowski, C., Rietdijk, S., Wang, N., Julien, A., Wei, D.G., 
Mamchak, A.A., Terhorst, C., and Bendelac, A. (2007). Homotypic interactions 
mediated by Slamf1 and Slamf6 receptors control NKT cell lineage 
development. Immunity 27, 751-762. 
 
Grubor-Bauk, B., Arthur, J.L., and Mayrhofer, G. (2008). Importance of NKT cells 
in resistance to herpes simplex virus, fate of virus-infected neurons, and level 
of latency in mice. J Virol 82, 11073-11083. 
 
 	   156	  
Gui, M., Li, J., Wen, L.J., Hardy, R.R., and Hayakawa, K. (2001). TCR beta chain 
influences but does not solely control autoreactivity of V alpha 14J281T cells. J 
Immunol 167, 6239-6246. 
 
Gumperz, J.E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., 
Koezuka, Y., Porcelli, S.A., Cardell, S., Brenner, M.B., and Behar, S.M. (2000). 
Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-
221. 
 
Hammond, K., Cain, W., van Driel, I., and Godfrey, D. (1998). Three day 
neonatal thymectomy selectively depletes NK1.1+ T cells. Int Immunol 10, 
1491-1499. 
 
Harada, M., Seino, K., Wakao, H., Sakata, S., Ishizuka, Y., Ito, T., Kojo, S., 
Nakayama, T., and Taniguchi, M. (2004). Down-regulation of the invariant 
Valpha14 antigen receptor in NKT cells upon activation. Int Immunol 16, 241-
247. 
 
Hayakawa, K., Lin, B.T., and Hardy, R.R. (1992). Murine thymic CD4+ T cell 
subsets: a subset (Thy0) that secretes diverse cytokines and overexpresses 
the V beta 8 T cell receptor gene family. J Exp Med 176, 269-274. 
 
Hayakawa, Y., Berzins, S.P., Crowe, N.Y., Godfrey, D.I., and Smyth, M.J. (2004). 
Antigen-induced tolerance by intrathymic modulation of self-recognizing 
inhibitory receptors. Nat Immunol 5, 590-596. 
 
Hermans, I.F., Silk, J.D., Gileadi, U., Salio, M., Mathew, B., Ritter, G., Schmidt, 
R., Harris, A.L., Old, L., and Cerundolo, V. (2003). NKT cells enhance CD4+ 
and CD8+ T cell responses to soluble antigen in vivo through direct interaction 
with dendritic cells. J Immunol 171, 5140-5147. 
 
Hernandez-Hoyos, G., Anderson, M.K., Wang, C., Rothenberg, E.V., and 
Alberola-Ila, J. (2003). GATA-3 expression is controlled by TCR signals and 
regulates CD4/CD8 differentiation. Immunity 19, 83-94. 
 
Hu, T., Gimferrer, I., Simmons, A., Wiest, D., and Alberola-Ila, J. (2011). The 
Ras/MAPK pathway is required for generation of iNKT cells. PLoS One 6, 
e19890. 
 
Hu, T., Simmons, A., Yuan, J., Bender, T.P., and Alberola-Ila, J. (2010). The 
transcription factor c-Myb primes CD4+CD8+ immature thymocytes for 
selection into the iNKT lineage. Nat Immunol 11, 435-441. 
 
Huntington, N.D., Puthalakath, H., Gunn, P., Naik, E., Michalak, E.M., Smyth, 
M.J., Tabarias, H., Degli-Esposti, M.A., Dewson, G., Willis, S.N., et al. (2007). 
 	   157	  
Interleukin 15-mediated survival of natural killer cells is determined by 
interactions among Bim, Noxa and Mcl-1. Nat Immunol 8, 856-863. 
 
Ishikawa, H., Hisaeda, H., Taniguchi, M., Nakayama, T., Sakai, T., Maekawa, Y., 
Nakano, Y., Zhang, M., Zhang, T., Nishitani, M., et al. (2000). CD4(+) 
v(alpha)14 NKT cells play a crucial role in an early stage of protective 
immunity against infection with Leishmania major. Int Immunol 12, 1267-1274. 
 
Iwabuchi, K., Iwabuchi, C., Tone, S., Itoh, D., Tosa, N., Negishi, I., Ogasawara, 
K., Uede, T., and Onoe, K. (2001). Defective development of NK1.1+ T-cell 
antigen receptor alphabeta+ cells in zeta-associated protein 70 null mice with 
an accumulation of NK1.1+ CD3- NK-like cells in the thymus. Blood 97, 1765-
1775. 
 
Johnson, T.R., Hong, S., Van Kaer, L., Koezuka, Y., and Graham, B.S. (2002). 
NK T cells contribute to expansion of CD8(+) T cells and amplification of 
antiviral immune responses to respiratory syncytial virus. J Virol 76, 4294-
4303. 
 
Joshi, N.S., Cui, W., Chandele, A., Lee, H.K., Urso, D.R., Hagman, J., Gapin, L., 
and Kaech, S.M. (2007). Inflammation directs memory precursor and short-
lived effector CD8(+) T cell fates via the graded expression of T-bet 
transcription factor. Immunity 27, 281-295. 
 
Joyce, S., Girardi, E., and Zajonc, D.M. (2011). NKT cell ligand recognition logic: 
molecular basis for a synaptic duet and transmission of inflammatory effectors. 
J Immunol 187, 1081-1089. 
 
Joyce, S., Woods, A.S., Yewdell, J.W., Bennink, J.R., De Silva, A.D., Boesteanu, 
A., Balk, S.P., Cotter, R.J., and Brutkiewicz, R.R. (1998). Natural ligand of 
mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279, 1541-1544. 
 
Kang, S.J., and Cresswell, P. (2004). Saposins facilitate CD1d-restricted 
presentation of an exogenous lipid antigen to T cells. Nat Immunol 5, 175-181. 
 
Kawakami, K., Yamamoto, N., Kinjo, Y., Miyagi, K., Nakasone, C., Uezu, K., 
Kinjo, T., Nakayama, T., Taniguchi, M., and Saito, A. (2003). Critical role of 
Valpha14+ natural killer T cells in the innate phase of host protection against 
Streptococcus pneumoniae infection. Eur J Immunol 33, 3322-3330. 
 
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., 
Nakagawa, R., Sato, H., Kondo, E., et al. (1997). CD1d-restricted and TCR-
mediated activation of Vα14 NKT cells by glycosylceramides. Science 278, 
1626-1629. 
 
 	   158	  
Kennedy, M.K., Glaccum, M., Brown, S.N., Butz, E.A., Viney, J.L., Embers, M., 
Matsuki, N., Charrier, K., Sedger, L., Willis, C.R., et al. (2000). Reversible 
defects in natural killer and memory CD8 T cell lineages in interleukin 15-
deficient mice. J Exp Med 191, 771-780. 
 
Kim, E.Y., Battaile, J.T., Patel, A.C., You, Y., Agapov, E., Grayson, M.H., Benoit, 
L.A., Byers, D.E., Alevy, Y., Tucker, J., et al. (2008). Persistent activation of an 
innate immune response translates respiratory viral infection into chronic lung 
disease. Nat Med 14, 633-640. 
 
Kim, P.J., Pai, S.Y., Brigl, M., Besra, G.S., Gumperz, J., and Ho, I.C. (2006). 
GATA-3 regulates the development and function of invariant NKT cells. J 
Immunol 177, 6650-6659. 
 
King, I.L., Fortier, A., Tighe, M., Dibble, J., Watts, G.F., Veerapen, N., Haberman, 
A.M., Besra, G.S., Mohrs, M., Brenner, M.B., and Leadbetter, E.A. (2012). 
Invariant natural killer T cells direct B cell responses to cognate lipid antigen in 
an IL-21-dependent manner. Nat Immunol 13, 44-50. 
 
Kinjo, Y., Illarionov, P., Vela, J.L., Pei, B., Girardi, E., Li, X., Li, Y., Imamura, M., 
Kaneko, Y., Okawara, A., et al. (2011). Invariant natural killer T cells recognize 
glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 12, 966-974. 
 
Kinjo, Y., Tupin, E., Wu, D., Fujio, M., Garcia-Navarro, R., Benhnia, M.R., Zajonc, 
D.M., Ben-Menachem, G., Ainge, G.D., Painter, G.F., et al. (2006). Natural 
killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat 
Immunol 7, 978-986. 
 
Kinjo, Y., Wu, D., Kim, G., Xing, G.W., Poles, M.A., Ho, D.D., Tsuji, M., 
Kawahara, K., Wong, C.H., and Kronenberg, M. (2005). Recognition of 
bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525. 
 
Kisielow, P., Bluthmann, H., Staerz, U.D., Steinmetz, M., and von Boehmer, H. 
(1988). Tolerance in T-cell-receptor transgenic mice involves deletion of 
nonmature CD4+8+ thymocytes. Nature 333, 742-746. 
 
Kitamura, H., Iwakabe, K., Yahata, T., Nishimura, S., Ohta, A., Ohmi, Y., Sato, 
M., Takeda, K., Okumura, K., Van Kaer, L., et al. (1999). The natural killer T 
(NKT) cell ligand alpha-galactosylceramide demonstrates its 
immunopotentiating effect by inducing interleukin (IL)-12 production by 
dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189, 
1121-1128. 
 
Ko, S.Y., Ko, H.J., Chang, W.S., Park, S.H., Kweon, M.N., and Kang, C.Y. 
(2005). alpha-Galactosylceramide can act as a nasal vaccine adjuvant 
 	   159	  
inducing protective immune responses against viral infection and tumor. J 
Immunol 175, 3309-3317. 
 
Kobrynski, L.J., Sousa, A.O., Nahmias, A.J., and Lee, F.K. (2005). Cutting edge: 
antibody production to pneumococcal polysaccharides requires CD1 
molecules and CD8+ T cells. J Immunol 174, 1787-1790. 
 
Kolluri, S.K., Zhu, X., Zhou, X., Lin, B., Chen, Y., Sun, K., Tian, X., Town, J., 
Cao, X., Lin, F., et al. (2008). A short Nur77-derived peptide converts Bcl-2 
from a protector to a killer. Cancer Cell 14, 285-298. 
 
Kovalovsky, D., Uche, O.U., Eladad, S., Hobbs, R.M., Yi, W., Alonzo, E., Chua, 
K., Eidson, M., Kim, H.J., Im, J.S., et al. (2008). The BTB-zinc finger 
transcriptional regulator PLZF controls the development of invariant natural 
killer T cell effector functions. Nat Immunol 9, 1055-1064. 
 
Kreslavsky, T., Savage, A.K., Hobbs, R., Gounari, F., Bronson, R., Pereira, P., 
Pandolfi, P.P., Bendelac, A., and von Boehmer, H. (2009). TCR-inducible 
PLZF transcription factor required for innate phenotype of a subset of 
gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A 
106, 12453-12458. 
 
Kuang, A.A., Cado, D., and Winoto, A. (1999). Nur77 transcription activity 
correlates with its apoptotic function in vivo. Eur J Immunol 29, 3722-3728. 
 
Kumar, H., Belperron, A., Barthold, S.W., and Bockenstedt, L.K. (2000). Cutting 
edge: CD1d deficiency impairs murine host defense against the spirochete, 
Borrelia burgdorferi. J Immunol 165, 4797-4801. 
 
Kunisaki, Y., Tanaka, Y., Sanui, T., Inayoshi, A., Noda, M., Nakayama, T., 
Harada, M., Taniguchi, M., Sasazuki, T., and Fukui, Y. (2006). DOCK2 is 
required in T cell precursors for development of Valpha14 NK T cells. J 
Immunol 176, 4640-4645. 
 
La Cava, A., Van Kaer, L., and Fu Dong, S. (2006). CD4+CD25+ Tregs and NKT 
cells: regulators regulating regulators. Trends Immunol 27, 322-327. 
 
Lacorazza, H.D., Miyazaki, Y., Di Cristofano, A., Deblasio, A., Hedvat, C., Zhang, 
J., Cordon-Cardo, C., Mao, S., Pandolfi, P.P., and Nimer, S.D. (2002). The 
ETS protein MEF plays a critical role in perforin gene expression and the 
development of natural killer and NK-T cells. Immunity 17, 437-449. 
 
Lang, G.A., Exley, M.A., and Lang, M.L. (2006). The CD1d-binding glycolipid 
alpha-galactosylceramide enhances humoral immunity to T-dependent and T-
independent antigen in a CD1d-dependent manner. Immunology 119, 116-
125. 
 	   160	  
 
Lang, M.L. (2009). How do natural killer T cells help B cells? Expert Rev 
Vaccines 8, 1109-1121. 
 
Lantz, O., and Bendelac, A. (1994). An invariant T cell receptor alpha chain is 
used by a unique subset of major histocompatibility complex class I-specific 
CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180, 1097-1106. 
 
Lawson, V.J., Maurice, D., Silk, J.D., Cerundolo, V., and Weston, K. (2009). 
Aberrant selection and function of invariant NKT cells in the absence of AP-1 
transcription factor Fra-2. J Immunol 183, 2575-2584. 
 
Lazarevic, V., Zullo, A.J., Schweitzer, M.N., Staton, T.L., Gallo, E.M., Crabtree, 
G.R., and Glimcher, L.H. (2009). The gene encoding early growth response 2, 
a target of the transcription factor NFAT, is required for the development and 
maturation of natural killer T cells. Nat Immunol 10, 306-313. 
 
Lee, A.J., Zhou, X., Chang, M., Hunzeker, J., Bonneau, R.H., Zhou, D., and Sun, 
S.C. (2010). Regulation of natural killer T-cell development by deubiquitinase 
CYLD. EMBO J 29, 1600-1612. 
 
Li, Y., Girardi, E., Wang, J., Yu, E.D., Painter, G.F., Kronenberg, M., and Zajonc, 
D.M. (2010). The Valpha14 invariant natural killer T cell TCR forces microbial 
glycolipids and CD1d into a conserved binding mode. J Exp Med 207, 2383-
2393. 
 
Lin, Y., Roberts, T.J., Wang, C.R., Cho, S., and Brutkiewicz, R.R. (2005). Long-
term loss of canonical NKT cells following an acute virus infection. Eur J 
Immunol 35, 879-889. 
 
Locci, M., Draghici, E., Marangoni, F., Bosticardo, M., Catucci, M., Aiuti, A., 
Cancrini, C., Marodi, L., Espanol, T., Bredius, R.G., et al. (2009). The Wiskott-
Aldrich syndrome protein is required for iNKT cell maturation and function. J 
Exp Med 206, 735-742. 
 
Lodolce, J.P., Boone, D.L., Chai, S., Swain, R.E., Dassopoulos, T., Trettin, S., 
and Ma, A. (1998). IL-15 receptor maintains lymphoid homeostasis by 
supporting lymphocyte homing and proliferation. Immunity 9, 669-676. 
 
Ma, A., Koka, R., and Burkett, P. (2006). Diverse functions of IL-2, IL-15, and IL-
7 in lymphoid homeostasis. Annu Rev Immunol 24, 657-679. 
 
MacDonald, H.R. (2000). CD1d-glycolipid tetramers: A new tool to monitor 
natural killer T cells in health and disease. J Exp Med 192, F15-20. 
 
 	   161	  
Mallevaey, T., Scott-Browne, J.P., Matsuda, J.L., Young, M.H., Pellicci, D.G., 
Patel, O., Thakur, M., Kjer-Nielsen, L., Richardson, S.K., Cerundolo, V., et al. 
(2009). T cell receptor CDR2 beta and CDR3 beta loops collaborate 
functionally to shape the iNKT cell repertoire. Immunity 31, 60-71. 
 
Mallevaey, T., Zanetta, J.P., Faveeuw, C., Fontaine, J., Maes, E., Platt, F., 
Capron, M., de-Moraes, M.L., and Trottein, F. (2006). Activation of invariant 
NKT cells by the helminth parasite schistosoma mansoni. J Immunol 176, 
2476-2485. 
 
Marrack, P., Scott-Browne, J.P., Dai, S., Gapin, L., and Kappler, J.W. (2008). 
Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu 
Rev Immunol 26, 171-203. 
 
Matsuda, J.L., Gapin, L., Sidobre, S., Kieper, W.C., Tan, J.T., Ceredig, R., Surh, 
C.D., and Kronenberg, M. (2002). Homeostasis of Vα14i NKT cells. Nat 
Immunol 3, 966-974. 
 
Matsuda, J.L., George, T.C., Hagman, J., and Gapin, L. (2007). Temporal 
dissection of T-bet functions. J Immunol 178, 3457-3465. 
 
Matsuda, J.L., Mallevaey, T., Scott-Browne, J., and Gapin, L. (2008). CD1d-
restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin 
Immunol 20, 358-368. 
 
Matsuda, J.L., Naidenko, O.V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, 
C.R., Koezuka, Y., and Kronenberg, M. (2000). Tracking the response of 
natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 
192, 741-754. 
 
Matsuda, J.L., Zhang, Q., Ndonye, R., Richardson, S.K., Howell, A.R., and 
Gapin, L. (2006). T-bet concomitantly controls migration, survival, and effector 
functions during the development of Valpha14i NKT cells. Blood 107, 2797-
2805. 
 
Mattner, J., Debord, K.L., Ismail, N., Goff, R.D., Cantu, C., 3rd, Zhou, D., Saint-
Mezard, P., Wang, V., Gao, Y., Yin, N., et al. (2005). Exogenous and 
endogenous glycolipid antigens activate NKT cells during microbial infections. 
Nature 434, 525-529. 
 
Mattner, J., Donhauser, N., Werner-Felmayer, G., and Bogdan, C. (2006). NKT 
cells mediate organ-specific resistance against Leishmania major infection. 
Microbes Infect 8, 354-362. 
 
 	   162	  
McNab, F.W., Berzins, S.P., Pellicci, D.G., Kyparissoudis, K., Field, K., Smyth, 
M.J., and Godfrey, D.I. (2005). The influence of CD1d in postselection NKT 
cell maturation and homeostasis. J Immunol 175, 3762-3768. 
 
McNab, F.W., Pellicci, D.G., Field, K., Besra, G., Smyth, M.J., Godfrey, D.I., and 
Berzins, S.P. (2007). Peripheral NK1.1 NKT cells are mature and functionally 
distinct from their thymic counterparts. J Immunol 179, 6630-6637. 
 
Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat Rev Immunol 
1, 135-145. 
 
Michel, M.L., Keller, A.C., Paget, C., Fujio, M., Trottein, F., Savage, P.B., Wong, 
C.H., Schneider, E., Dy, M., and Leite-de-Moraes, M.C. (2007). Identification 
of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway 
neutrophilia. J Exp Med 204, 995-1001. 
 
Michel, M.L., Mendes-da-Cruz, D., Keller, A.C., Lochner, M., Schneider, E., Dy, 
M., Eberl, G., and Leite-de-Moraes, M.C. (2008). Critical role of ROR-gammat 
in a new thymic pathway leading to IL-17-producing invariant NKT cell 
differentiation. Proc Natl Acad Sci U S A 105, 19845-19850. 
 
Milpied, P., Massot, B., Renand, A., Diem, S., Herbelin, A., Leite-de-Moraes, M., 
Rubio, M.T., and Hermine, O. (2011). IL-17-producing invariant NKT cells in 
lymphoid organs are recent thymic emigrants identified by neuropilin-1 
expression. Blood 118, 2993-3002. 
 
Minagawa, M., Watanabe, H., Miyaji, C., Tomiyama, K., Shimura, H., Ito, A., Ito, 
M., Domen, J., Weissman, I.L., and Kawai, K. (2002). Enforced expression of 
Bcl-2 restores the number of NK cells, but does not rescue the impaired 
development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor 
beta-chain-deficient mice. J Immunol 169, 4153-4160. 
 
Miyamoto, K., Miyake, S., and Yamamura, T. (2001). A synthetic glycolipid 
prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer 
T cells. Nature 413, 531-534. 
 
Molling, J.W., Kolgen, W., van der Vliet, H.J., Boomsma, M.F., Kruizenga, H., 
Smorenburg, C.H., Molenkamp, B.G., Langendijk, J.A., Leemans, C.R., von 
Blomberg, B.M., et al. (2005). Peripheral blood IFN-gamma-secreting 
Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients 
independent of tumor type or tumor load. Int J Cancer 116, 87-93. 
 
Molling, J.W., Langius, J.A., Langendijk, J.A., Leemans, C.R., Bontkes, H.J., van 
der Vliet, H.J., von Blomberg, B.M., Scheper, R.J., and van den Eertwegh, A.J. 
(2007). Low levels of circulating invariant natural killer T cells predict poor 
 	   163	  
clinical outcome in patients with head and neck squamous cell carcinoma. J 
Clin Oncol 25, 862-868. 
 
Monteiro, M., Almeida, C.F., Caridade, M., Ribot, J.C., Duarte, J., Agua-Doce, A., 
Wollenberg, I., Silva-Santos, B., and Graca, L. (2010). Identification of 
regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J Immunol 185, 
2157-2163. 
 
Monticelli, L.A., Yang, Y., Knell, J., D'Cruz, L.M., Cannarile, M.A., Engel, I., 
Kronenberg, M., and Goldrath, A.W. (2009). Transcriptional regulator Id2 
controls survival of hepatic NKT cells. Proc Natl Acad Sci U S A 106, 19461-
19466. 
 
Montoya, C.J., Jie, H.B., Al-Harthi, L., Mulder, C., Patino, P.J., Rugeles, M.T., 
Krieg, A.M., Landay, A.L., and Wilson, S.B. (2006). Activation of plasmacytoid 
dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-
talk with myeloid dendritic cells. J Immunol 177, 1028-1039. 
 
Moran, A.E., Holzapfel, K.L., Xing, Y., Cunningham, N.R., Maltzman, J.S., Punt, 
J., and Hogquist, K.A. (2011). T cell receptor signal strength in Treg and iNKT 
cell development demonstrated by a novel fluorescent reporter mouse. J Exp 
Med 208, 1279-1289. 
 
Moreira-Teixeira, L., Resende, M., Devergne, O., Herbeuval, J.P., Hermine, O., 
Schneider, E., Dy, M., Cordeiro-da-Silva, A., and Leite-de-Moraes, M.C. 
(2012). Rapamycin combined with TGF-beta converts human invariant NKT 
cells into suppressive Foxp3+ regulatory cells. J Immunol 188, 624-631. 
 
Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., 
Koezuka, Y., Kobayashi, E., and Fukushima, H. (1995). Structure-activity 
relationship of alpha-galactosylceramides against B16-bearing mice. J Med 
Chem 38, 2176-2187. 
 
Mycko, M.P., Ferrero, I., Wilson, A., Jiang, W., Bianchi, T., Trumpp, A., and 
MacDonald, H.R. (2009). Selective requirement for c-Myc at an early stage of 
Vα14i NKT cell development. J Immunol 182, 4641-4648. 
 
Nagarajan, N.A., and Kronenberg, M. (2007). Invariant NKT cells amplify the 
innate immune response to lipopolysaccharide. J Immunol 178, 2706-2713. 
 
Nakazato, K., Yamada, H., Yajima, T., Kagimoto, Y., Kuwano, H., and Yoshikai, 
Y. (2007). Enforced expression of Bcl-2 partially restores cell numbers but not 
functions of TCRgammadelta intestinal intraepithelial T lymphocytes in IL-15-
deficient mice. J Immunol 178, 757-764. 
 
 	   164	  
Nichols, K.E., Hom, J., Gong, S.Y., Ganguly, A., Ma, C.S., Cannons, J.L., 
Tangye, S.G., Schwartzberg, P.L., Koretzky, G.A., and Stein, P.L. (2005). 
Regulation of NKT cell development by SAP, the protein defective in XLP. Nat 
Med 11, 340-345. 
 
Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, 
K., Okumura, K., Van Kaer, L., Kawano, T., et al. (2000). The interface 
between innate and acquired immunity: glycolipid antigen presentation by 
CD1d-expressing dendritic cells to NKT cells induces the differentiation of 
antigen-specific cytotoxic T lymphocytes. Int Immunol 12, 987-994. 
 
O'Konek, J.J., Illarionov, P., Khursigara, D.S., Ambrosino, E., Izhak, L., Castillo, 
B.F., 2nd, Raju, R., Khalili, M., Kim, H.Y., Howell, A.R., et al. (2011). Mouse 
and human iNKT cell agonist beta-mannosylceramide reveals a distinct 
mechanism of tumor immunity. J Clin Invest 121, 683-694. 
 
Oestreich, K.J., Huang, A.C., and Weinmann, A.S. (2011). The lineage-defining 
factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J 
Exp Med 208, 1001-1013. 
 
Ohteki, T., Ho, S., Suzuki, H., Mak, T.W., and Ohashi, P.S. (1997). Role for IL-
15/IL-15 receptor β-chain in natural killer 1.1+ T cell receptor-αβ+ cell 
development. J Immunol 159, 5931-5935. 
 
Ohteki, T., Maki, C., Koyasu, S., Mak, T.W., and Ohashi, P.S. (1999). Cutting 
edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: 
evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple 
pathways. J Immunol 162, 3753-3756. 
 
Ohteki, T., Yoshida, H., Matsuyama, T., Duncan, G.S., Mak, T.W., and Ohashi, 
P.S. (1998). The transcription factor interferon regulatory factor 1 (IRF-1) is 
important during the maturation of natural killer 1.1+ T cell receptor-
alpha/beta+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T 
cells. J Exp Med 187, 967-972. 
 
Paget, C., Mallevaey, T., Speak, A.O., Torres, D., Fontaine, J., Sheehan, K.C., 
Capron, M., Ryffel, B., Faveeuw, C., Leite de Moraes, M., et al. (2007). 
Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells 
requires type I interferon and charged glycosphingolipids. Immunity 27, 597-
609. 
 
Pai, S.Y., Truitt, M.L., Ting, C.N., Leiden, J.M., Glimcher, L.H., and Ho, I.C. 
(2003). Critical roles for transcription factor GATA-3 in thymocyte 
development. Immunity 19, 863-875. 
 
 	   165	  
Parekh, V.V., Lalani, S., Kim, S., Halder, R., Azuma, M., Yagita, H., Kumar, V., 
Wu, L., and Kaer, L.V. (2009). PD-1/PD-L blockade prevents anergy induction 
and enhances the anti-tumor activities of glycolipid-activated invariant NKT 
cells. J Immunol 182, 2816-2826. 
 
Parekh, V.V., Singh, A.K., Wilson, M.T., Olivares-Villagomez, D., Bezbradica, 
J.S., Inazawa, H., Ehara, H., Sakai, T., Serizawa, I., Wu, L., et al. (2004). 
Quantitative and qualitative differences in the in vivo response of NKT cells to 
distinct alpha- and beta-anomeric glycolipids. J Immunol 173, 3693-3706. 
 
Parekh, V.V., Wilson, M.T., Olivares-Villagomez, D., Singh, A.K., Wu, L., Wang, 
C.R., Joyce, S., and Van Kaer, L. (2005). Glycolipid antigen induces long-term 
natural killer T cell anergy in mice. J Clin Invest 115, 2572-2583. 
 
Park, J.J., Kang, S.J., De Silva, A.D., Stanic, A.K., Casorati, G., Hachey, D.L., 
Cresswell, P., and Joyce, S. (2004). Lipid-protein interactions: biosynthetic 
assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily 
conserved. Proc Natl Acad Sci U S A 101, 1022-1026. 
 
Park, S.H., Benlagha, K., Lee, D., Balish, E., and Bendelac, A. (2000). Unaltered 
phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-
free mice. Eur J Immunol 30, 620-625. 
 
Park, S.H., Weiss, A., Benlagha, K., Kyin, T., Teyton, L., and Bendelac, A. 
(2001). The mouse CD1d-restricted repertoire is dominated by a few 
autoreactive T cell receptor families. J Exp Med 193, 893-904. 
 
Pasquier, B., Yin, L., Fondaneche, M.C., Relouzat, F., Bloch-Queyrat, C., 
Lambert, N., Fischer, A., de Saint-Basile, G., and Latour, S. (2005). Defective 
NKT cell development in mice and humans lacking the adapter SAP, the X-
linked lymphoproliferative syndrome gene product. J Exp Med 201, 695-701. 
 
Pei, B., Speak, A.O., Shepherd, D., Butters, T., Cerundolo, V., Platt, F.M., and 
Kronenberg, M. (2011). Diverse endogenous antigens for mouse NKT cells: 
self-antigens that are not glycosphingolipids. J Immunol 186, 1348-1360. 
 
Pellicci, D.G., Hammond, K.J., Uldrich, A.P., Baxter, A.G., Smyth, M.J., and 
Godfrey, D.I. (2002). A natural killer T (NKT) cell developmental pathway 
iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor 
stage. J Exp Med 195, 835-844. 
 
Pellicci, D.G., Patel, O., Kjer-Nielsen, L., Pang, S.S., Sullivan, L.C., 
Kyparissoudis, K., Brooks, A.G., Reid, H.H., Gras, S., Lucet, I.S., et al. (2009). 
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 
and V beta 7 semi-invariant NKT T cell receptors. Immunity 31, 47-59. 
 
 	   166	  
Pellicci, D.G., Uldrich, A.P., Kyparissoudis, K., Crowe, N.Y., Brooks, A.G., 
Hammond, K.J., Sidobre, S., Kronenberg, M., Smyth, M.J., and Godfrey, D.I. 
(2003). Intrathymic NKT cell development is blocked by the presence of alpha-
galactosylceramide. Eur J Immunol 33, 1816-1823. 
 
Peschon, J.J., Morrissey, P.J., Grabstein, K.H., Ramsdell, F.J., Maraskovsky, E., 
Gliniak, B.C., Park, L.S., Ziegler, S.F., Williams, D.E., Ware, C.B., et al. 
(1994). Early lymphocyte expansion is severely impaired in interleukin 7 
receptor-deficient mice. J Exp Med 180, 1955-1960. 
 
Porubsky, S., Speak, A.O., Luckow, B., Cerundolo, V., Platt, F.M., and Grone, 
H.J. (2007). Normal development and function of invariant natural killer T cells 
in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci 
U S A 104, 5977-5982. 
 
Raberger, J., Schebesta, A., Sakaguchi, S., Boucheron, N., Blomberg, K.E., 
Berglof, A., Kolbe, T., Smith, C.I., Rulicke, T., and Ellmeier, W. (2008). The 
transcriptional regulator PLZF induces the development of CD44 high memory 
phenotype T cells. Proc Natl Acad Sci U S A 105, 17919-17924. 
 
Rachitskaya, A.V., Hansen, A.M., Horai, R., Li, Z., Villasmil, R., Luger, D., 
Nussenblatt, R.B., and Caspi, R.R. (2008). Cutting edge: NKT cells 
constitutively express IL-23 receptor and RORgammat and rapidly produce IL-
17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180, 
5167-5171. 
 
Raghuraman, G., Geng, Y., and Wang, C.R. (2006). IFN-beta-mediated up-
regulation of CD1d in bacteria-infected APCs. J Immunol 177, 7841-7848. 
 
Rajpal, A., Cho, Y.A., Yelent, B., Koza-Taylor, P.H., Li, D., Chen, E., Whang, M., 
Kang, C., Turi, T.G., and Winoto, A. (2003). Transcriptional activation of known 
and novel apoptotic pathways by Nur77 orphan steroid receptor. EMBO J 22, 
6526-6536. 
 
Ranson, T., Vosshenrich, C.A., Corcuff, E., Richard, O., Laloux, V., Lehuen, A., 
and Di Santo, J.P. (2003). IL-15 availability conditions homeostasis of 
peripheral natural killer T cells. Proc Natl Acad Sci U S A 100, 2663-2668. 
 
Rauch, J., Gumperz, J., Robinson, C., Skold, M., Roy, C., Young, D.C., Lafleur, 
M., Moody, D.B., Brenner, M.B., Costello, C.E., and Behar, S.M. (2003). 
Structural features of the acyl chain determine self-phospholipid antigen 
recognition by a CD1d-restricted invariant NKT (iNKT) cell. J Biol Chem 278, 
47508-47515. 
 
Renukaradhya, G.J., Webb, T.J., Khan, M.A., Lin, Y.L., Du, W., Gervay-Hague, 
J., and Brutkiewicz, R.R. (2005). Virus-induced inhibition of CD1d1-mediated 
 	   167	  
antigen presentation: reciprocal regulation by p38 and ERK. J Immunol 175, 
4301-4308. 
 
Roy, K.C., Maricic, I., Khurana, A., Smith, T.R., Halder, R.C., and Kumar, V. 
(2008). Involvement of secretory and endosomal compartments in 
presentation of an exogenous self-glycolipid to type II NKT cells. J Immunol 
180, 2942-2950. 
 
Salio, M., Silk, J.D., and Cerundolo, V. (2010). Recent advances in processing 
and presentation of CD1 bound lipid antigens. Curr Opin Immunol 22, 81-88. 
 
Salio, M., Speak, A.O., Shepherd, D., Polzella, P., Illarionov, P.A., Veerapen, N., 
Besra, G.S., Platt, F.M., and Cerundolo, V. (2007). Modulation of human 
natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. 
Proc Natl Acad Sci U S A 104, 20490-20495. 
 
Savage, A.K., Constantinides, M.G., Han, J., Picard, D., Martin, E., Li, B., Lantz, 
O., and Bendelac, A. (2008). The transcription factor PLZF directs the effector 
program of the NKT cell lineage. Immunity 29, 391-403. 
 
Schmidt-Supprian, M., Tian, J., Grant, E.P., Pasparakis, M., Maehr, R., Ovaa, H., 
Ploegh, H.L., Coyle, A.J., and Rajewsky, K. (2004). Differential dependence of 
CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-
kappaB activation. Proc Natl Acad Sci U S A 101, 4566-4571. 
 
Schumann, J., Pittoni, P., Tonti, E., Macdonald, H.R., Dellabona, P., and 
Casorati, G. (2005). Targeted expression of human CD1d in transgenic mice 
reveals independent roles for thymocytes and thymic APCs in positive and 
negative selection of Valpha14i NKT cells. J Immunol 175, 7303-7310. 
 
Scott-Browne, J.P., Matsuda, J.L., Mallevaey, T., White, J., Borg, N.A., 
McCluskey, J., Rossjohn, J., Kappler, J., Marrack, P., and Gapin, L. (2007). 
Germline-encoded recognition of diverse glycolipids by natural killer T cells. 
Nat Immunol 8, 1105-1113. 
 
Seiler, M.P., Mathew, R., Liszewski, M.K., Spooner, C., Barr, K., Meng, F., Singh, 
H., and Bendelac, A. (2012). Elevated and sustained expression of the 
transcription factors Egr1 and Egr2 controls NKT lineage differentiation in 
response to TCR signaling. Nat Immunol 13, 264-271. 
 
Semmling, V., Lukacs-Kornek, V., Thaiss, C.A., Quast, T., Hochheiser, K., 
Panzer, U., Rossjohn, J., Perlmutter, P., Cao, J., Godfrey, D.I., et al. (2010). 
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs 
toward NKT cell-licensed DCs. Nat Immunol 11, 313-320. 
 
 	   168	  
Shen, S., Chen, Y., Gorentla, B.K., Lu, J., Stone, J.C., and Zhong, X.P. (2011a). 
Critical roles of RasGRP1 for invariant NKT cell development. J Immunol 187, 
4467-4473. 
 
Shen, S., Wu, J., Srivatsan, S., Gorentla, B.K., Shin, J., Xu, L., and Zhong, X.P. 
(2011b). Tight regulation of diacylglycerol-mediated signaling is critical for 
proper invariant NKT cell development. J Immunol 187, 2122-2129. 
 
Singh, N., Hong, S., Scherer, D.C., Serizawa, I., Burdin, N., Kronenberg, M., 
Koezuka, Y., and Van Kaer, L. (1999). Cutting edge: activation of NK T cells 
by CD1d and alpha-galactosylceramide directs conventional T cells to the 
acquisition of a Th2 phenotype. J Immunol 163, 2373-2377. 
 
Sivakumar, V., Hammond, K.J., Howells, N., Pfeffer, K., and Weih, F. (2003). 
Differential requirement for Rel/nuclear factor kappa B family members in 
natural killer T cell development. J Exp Med 197, 1613-1621. 
 
Skold, M., Xiong, X., Illarionov, P.A., Besra, G.S., and Behar, S.M. (2005). 
Interplay of cytokines and microbial signals in regulation of CD1d expression 
and NKT cell activation. J Immunol 175, 3584-3593. 
 
Smyth, G.K. (2004). Linear models and empirical bayes methods for assessing 
differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, 
Article3. 
 
Smyth, G.K. (2005). Limma: Linear models for Microarray Data (New York: 
Springer). 
 
Sriram, V., Du, W., Gervay-Hague, J., and Brutkiewicz, R.R. (2005). Cell wall 
glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands 
for NKT cells. Eur J Immunol 35, 1692-1701. 
 
Stanic, A.K., Bezbradica, J.S., Park, J.J., Matsuki, N., Mora, A.L., Van Kaer, L., 
Boothby, M.R., and Joyce, S. (2004a). NF-κB controls cell fate specification, 
survival, and molecular differentiation of immunoregulatory natural T 
lymphocytes. J Immunol 172, 2265-2273. 
 
Stanic, A.K., Bezbradica, J.S., Park, J.J., Van Kaer, L., Boothby, M.R., and 
Joyce, S. (2004b). Cutting edge: the ontogeny and function of Va14Ja18 
natural T lymphocytes require signal processing by protein kinase C theta and 
NF-kappa B. J Immunol 172, 4667-4671. 
 
Stanic, A.K., De Silva, A.D., Park, J.J., Sriram, V., Ichikawa, S., Hirabyashi, Y., 
Hayakawa, K., Van Kaer, L., Brutkiewicz, R.R., and Joyce, S. (2003). 
Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT 
 	   169	  
lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency. 
Proc Natl Acad Sci U S A 100, 1849-1854. 
 
Stetson, D.B., Mohrs, M., Reinhardt, R.L., Baron, J.L., Wang, Z.E., Gapin, L., 
Kronenberg, M., and Locksley, R.M. (2003). Constitutive cytokine mRNAs 
mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp 
Med 198, 1069-1076. 
 
Strasser, A., Harris, A.W., and Cory, S. (1991). bcl-2 transgene inhibits T cell 
death and perturbs thymic self-censorship. Cell 67, 889-899. 
 
Sugita, M., Cao, X., Watts, G.F., Rogers, R.A., Bonifacino, J.S., and Brenner, 
M.B. (2002). Failure of trafficking and antigen presentation by CD1 in AP-3-
deficient cells. Immunity 16, 697-706. 
 
Tahir, S.M., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G.J., Wilson, S.B., 
Balk, S.P., and Exley, M.A. (2001). Loss of IFN-gamma production by invariant 
NK T cells in advanced cancer. J Immunol 167, 4046-4050. 
 
Takahashi, T., and Strober, S. (2008). Natural killer T cells and innate immune B 
cells from lupus-prone NZB/W mice interact to generate IgM and IgG 
autoantibodies. Eur J Immunol 38, 156-165. 
 
Thomas, S.Y., Scanlon, S.T., Griewank, K.G., Constantinides, M.G., Savage, 
A.K., Barr, K.A., Meng, F., Luster, A.D., and Bendelac, A. (2011). PLZF 
induces an intravascular surveillance program mediated by long-lived LFA-1-
ICAM-1 interactions. J Exp Med 208, 1179-1188. 
 
Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.H., and Berg, L.J. (1995). 
Defects in B lymphocyte maturation and T lymphocyte activation in mice 
lacking Jak3. Science 270, 794-797. 
 
Thompson, J., Burger, M.L., Whang, H., and Winoto, A. (2010). Protein kinase C 
regulates mitochondrial targeting of Nur77 and its family member Nor-1 in 
thymocytes undergoing apoptosis. Eur J Immunol 40, 2041-2049. 
 
Thompson, J., and Winoto, A. (2008). During negative selection, Nur77 family 
proteins translocate to mitochondria where they associate with Bcl-2 and 
expose its proapoptotic BH3 domain. J Exp Med 205, 1029-1036. 
 
Tomura, M., Yu, W.G., Ahn, H.J., Yamashita, M., Yang, Y.F., Ono, S., Hamaoka, 
T., Kawano, T., Taniguchi, M., Koezuka, Y., and Fujiwara, H. (1999). A novel 
function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by 
antigen-presenting cells in the innate immune system. J Immunol 163, 93-101. 
 
 	   170	  
Townsend, M.J., Weinmann, A.S., Matsuda, J.L., Salomon, R., Farnham, P.J., 
Biron, C.A., Gapin, L., and Glimcher, L.H. (2004). T-bet regulates the terminal 
maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477-
494. 
 
Tupin, E., Kinjo, Y., and Kronenberg, M. (2007). The unique role of natural killer 
T cells in the response to microorganisms. Nat Rev Microbiol 5, 405-417. 
 
Tyznik, A.J., Tupin, E., Nagarajan, N.A., Her, M.J., Benedict, C.A., and 
Kronenberg, M. (2008). Cutting edge: the mechanism of invariant NKT cell 
responses to viral danger signals. J Immunol 181, 4452-4456. 
 
Uldrich, A.P., Crowe, N.Y., Kyparissoudis, K., Pellicci, D.G., Zhan, Y., Lew, A.M., 
Bouillet, P., Strasser, A., Smyth, M.J., and Godfrey, D.I. (2005). NKT cell 
stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, 
Bim-dependent contraction, and hyporesponsiveness to further antigenic 
challenge. J Immunol 175, 3092-3101. 
 
Vallabhapurapu, S., Powolny-Budnicka, I., Riemann, M., Schmid, R.M., Paxian, 
S., Pfeffer, K., Korner, H., and Weih, F. (2008). Rel/NF-kappaB family member 
RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced 
expansion of NKT cells. Eur J Immunol 38, 3508-3519. 
 
Van Kaer, L. (2005). α-Galactosylceramide therapy for autoimmune diseases: 
prospects and obstacles. Nat Rev Immunol 5, 31-42. 
 
Venkataswamy, M.M., and Porcelli, S.A. (2010). Lipid and glycolipid antigens of 
CD1d-restricted natural killer T cells. Semin Immunol 22, 68-78. 
 
Walunas, T.L., Wang, B., Wang, C.R., and Leiden, J.M. (2000). Cutting edge: the 
Ets1 transcription factor is required for the development of NK T cells in mice. 
J Immunol 164, 2857-2860. 
 
Wang, Z.Y., Kusam, S., Munugalavadla, V., Kapur, R., Brutkiewicz, R.R., and 
Dent, A.L. (2006). Regulation of Th2 cytokine expression in NKT cells: 
unconventional use of Stat6, GATA-3, and NFAT2. J Immunol 176, 880-888. 
 
Watarai, H., Sekine-Kondo, E., Shigeura, T., Motomura, Y., Yasuda, T., Satoh, 
R., Yoshida, H., Kubo, M., Kawamoto, H., Koseki, H., and Taniguchi, M. 
(2012). Development and function of invariant natural killer T cells producing 
t(h)2- and t(h)17-cytokines. PLoS Biol 10, e1001255. 
 
Wei, D.G., Curran, S.A., Savage, P.B., Teyton, L., and Bendelac, A. (2006). 
Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and 
consequences for microbial glycolipid recognition. J Exp Med 203, 1197-1207. 
 
 	   171	  
Wesley, J.D., Tessmer, M.S., Chaukos, D., and Brossay, L. (2008). NK cell-like 
behavior of Valpha14i NK T cells during MCMV infection. PLoS Pathog 4, 
e1000106. 
 
Wilson, M.T., Johansson, C., Olivares-Villagomez, D., Singh, A.K., Stanic, A.K., 
Wang, C.R., Joyce, S., Wick, M.J., and Van Kaer, L. (2003). The response of 
natural killer T cells to glycolipid antigens is characterized by surface receptor 
down-modulation and expansion. Proc Natl Acad Sci U S A 100, 10913-10918. 
 
Wu, D.Y., Segal, N.H., Sidobre, S., Kronenberg, M., and Chapman, P.B. (2003). 
Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp 
Med 198, 173-181. 
 
Wu, L., and Van Kaer, L. (2009). Natural killer T cells and autoimmune disease. 
Curr Mol Med 9, 4-14. 
 
Wu, L., and Van Kaer, L. (2011). Natural killer T cells in health and disease. 
Front Biosci (Schol Ed) 3, 236-251. 
 
Wu, Z., Xue, H.H., Bernard, J., Zeng, R., Issakov, D., Bollenbacher-Reilley, J., 
Belyakov, I.M., Oh, S., Berzofsky, J.A., and Leonard, W.J. (2008). The IL-15 
receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha 
function but is not required for trans-presentation. Blood 112, 4411-4419. 
 
Xu, H., Chun, T., Colmone, A., Nguyen, H., and Wang, C.R. (2003). Expression 
of CD1d under the control of a MHC class Ia promoter skews the development 
of NKT cells, but not CD8+ T cells. J Immunol 171, 4105-4112. 
 
Yamaguchi, Y., Motoki, K., Ueno, H., Maeda, K., Kobayashi, E., Inoue, H., 
Fukushima, H., and Koezuka, Y. (1996). Enhancing effects of (2S,3S,4R)-1-O-
(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol 
(KRN7000) on antigen-presenting function of antigen-presenting cells and 
antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol 
Res 8, 399-407. 
 
Yoshimoto, T., Bendelac, A., Hu-Li, J., and Paul, W.E. (1995). Defective IgE 
production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that 
promptly produce interleukin 4. Proc Natl Acad Sci U S A 92, 11931-11934. 
 
Yoshimoto, T., and Paul, W.E. (1994). CD4pos, NK1.1pos T cells promptly 
produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp 
Med 179, 1285-1295. 
 
Yu, K.O., Im, J.S., Molano, A., Dutronc, Y., Illarionov, P.A., Forestier, C., 
Fujiwara, N., Arias, I., Miyake, S., Yamamura, T., et al. (2005). Modulation of 
 	   172	  
CD1d-restricted NKT cell responses by using N-acyl variants of alpha-
galactosylceramides. Proc Natl Acad Sci U S A 102, 3383-3388. 
 
Yu, S., and Cantorna, M.T. (2008). The vitamin D receptor is required for iNKT 
cell development. Proc Natl Acad Sci U S A 105, 5207-5212. 
 
Yu, S., and Cantorna, M.T. (2011). Epigenetic reduction in invariant NKT cells 
following in utero vitamin D deficiency in mice. J Immunol 186, 1384-1390. 
 
Yuan, J., Crittenden, R.B., and Bender, T.P. (2010). c-Myb promotes the survival 
of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL. J 
Immunol 184, 2793-2804. 
 
Yue, X., Izcue, A., and Borggrefe, T. (2011). Essential role of Mediator subunit 
Med1 in invariant natural killer T-cell development. Proc Natl Acad Sci U S A 
108, 17105-17110. 
 
Zheng, Q., Zhou, L., and Mi, Q.S. (2012). MicroRNA miR-150 Is Involved in 
Valpha14 Invariant NKT Cell Development and Function. J Immunol 188, 
2118-2126. 
 
Zheng, X., Zhang, H., Yin, L., Wang, C.R., Liu, Y., and Zheng, P. (2008). 
Modulation of NKT cell development by B7-CD28 interaction: an expanding 
horizon for costimulation. PLoS One 3, e2703. 
 
Zhou, D., Mattner, J., Cantu, C., 3rd, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., 
Hudspeth, K., Wu, Y.P., Yamashita, T., et al. (2004). Lysosomal 
glycosphingolipid recognition by NKT cells. Science 306, 1786-1789. 
 
Zhou, L., Seo, K.H., He, H.Z., Pacholczyk, R., Meng, D.M., Li, C.G., Xu, J., She, 
J.X., Dong, Z., and Mi, Q.S. (2009). Tie2cre-induced inactivation of the 
miRNA-processing enzyme Dicer disrupts invariant NKT cell development. 
Proc Natl Acad Sci U S A 106, 10266-10271. 
 
Zhou, T., Cheng, J., Yang, P., Wang, Z., Liu, C., Su, X., Bluethmann, H., and 
Mountz, J.D. (1996). Inhibition of Nur77/Nurr1 leads to inefficient clonal 
deletion of self-reactive T cells. J Exp Med 183, 1879-1892. 
 
Zhou, X., Yu, S., Zhao, D.M., Harty, J.T., Badovinac, V.P., and Xue, H.H. (2010). 
Differentiation and persistence of memory CD8(+) T cells depend on T cell 
factor 1. Immunity 33, 229-240. 
 
 
 	   173	  
 
APPENDIX  
 
LIST OF PUBLICATIONS 
 
1. Gordy, L.E., Bezbradica, J.S., Dunkle, A.K., Stanic, A.K., Boothby, M.R., 
He, Y.W., Van Kaer, L., Joyce, S. (2011) IL-15 regulates homeostasis and 
terminal maturation of NKT cells. J Immunol; 187:6335-6345. 
 
2. Boelte, KC, Gordy, LE, Joyce, S, Thompson, MA, Yang, L and Lin, PC. 
(2011) Rgs2 mediates pro-angiogenic function of myeloid derived 
suppressor cells in the tumor microenvironment via upregulation of MCP-
1. PloS One; 6(4): e18534.  
 
3. Hoek, K.L., Gordy, L.E., Collins, P.L., Parekh, V.V., Aune, T.M., Joyce, 
S., Thomas, J.W., Van Kaer, L., Sebzda, E. (2010) Follicular B cell 
trafficking within the spleen actively restricts humoral immune responses. 
Immunity; 33(2):254- 265. 
 
4. Joyce, S., Gordy, LE. (2010) Natural killer T cell-a cat o’nine lives!  
EMBO; 29(9):1475-6. 
 
5. Florence, W.C., Xia, C.,Gordy, L.E., Chen, W., Zhang, Y., Scott-Browne, 
J.K., Kinjo, Y., Yu, K.O., Keshipeddy, S., Pellicci, D.G., Patel, O., Kjer-
Nielsen, L., McCluskey, J., Godfrey, D.I., Rossjohn, J., Richardson, S.K., 
Porcelli, S.A., Howell, A.R., Haykawa, K., Gapin, L., Zajonc, D.M. Wang, 
P.G., Joyce, S. (2009) Adaptability of the semi-invariant natural killer T-cell 
 	   174	  
receptor towards structurally diverse CD1d-restricted ligands. EMBO; 
28(22):3579-3590.   
 
6. Torres, V.J., Stauff, D.L., Pishchany, G., Bezbradica, J.S., Gordy, L.E., 
Iturregui, J., Anderson, K.L., Duman, P.M., Joyce, S., Skaar, E.P. (2007) A 
Staphylococcus aureus regulatory system that responds to host heme and 
modulates virulence. Cell Host & Microbe; 1:109-119.   
 
7. Bezbradica, J.S., Gordy, L.E., Stanic, A.K., Dragovic, S., Hill, T., Hawiger, 
J., Unutmaz, D., Van Kaer, L., Joyce, S. (2006) Granulocyte-Macrophage 
Colony-Stimulating Factor Regulates Effector Differentiation of Invariant 
Natural Killer T Cells during Thymic Ontogeny. Immunity; 25(3):487-497. 
 
 	   175	  
	  
 	   176	  
	  
 	   177	  
	  
 	   178	  
	  
 	   179	  
	  
 	   180	  
	  
 	   181	  
	  
 	   182	  
	  
 	   183	  
	  
 	   184	  
	  
 	   185	  
	  
 	   186	  
	  
 	   187	  
	  
 	   188	  
	  
 	   189	  
	  
 	   190	  
	  
 	   191	  
	  
 	   192	  
	  
 	   193	  
	  
 	   194	  
	  
 	   195	  
	  
 	   196	  
	  
 	   197	  
	  
 	   198	  
	  
 	   199	  
	  
 	   200	  
	  
 	   201	  
	  
 	   202	  
	  
 	   203	  
	  
 	   204	  
	  
 	   205	  
	  
 	   206	  
	  
 	   207	  
	  
 	   208	  
	  
 	   209	  
	  
 	   210	  
	  
 	   211	  
	  
 	   212	  
	  
 	   213	  
	  
 	   214	  
	  
 	   215	  
	  
 	   216	  
	  
 	   217	  
	  
 	   218	  
	  
 	   219	  
	  
 	   220	  
	  
 	   221	  
	  
 	   222	  
	  
 	   223	  
	  
 	   224	  
	  
 	   225	  
	  
 	   226	  
	  
 	   227	  
	  
 	   228	  
	  
 	   229	  
	  
 	   230	  
	  
 	   231	  
	  
 	   232	  
	  
 	   233	  
	  
 	   234	  
	  
 	   235	  
	  
 	   236	  
	  
 	   237	  
	  
 	   238	  
	  
 	   239	  
	  
 	   240	  
	  
 	   241	  
	  
 	   242	  
	  
 	   243	  
	  
 	   244	  
 
